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Introduction: The purpose of this dissertation is to synthesize and translate research on 
flavored tobacco in the United States in order to inform regulatory decision-making at the 
U.S. Food and Drug Administration. Three related manuscripts aim to: 1) synthesize 
existing research examining the use and attitudes/knowledge/perceptions of flavored 
tobacco in the United States, specifically focusing on how age and nonflavored tobacco 
use are correlated with flavored tobacco use; 2) estimate the relative health effects, 
compared to the status quo, that would be expected to result from a) a ban on combustible 
flavored tobacco products and b) a ban on all flavored tobacco products, and organize 
existing relevant research that informs the policy decision; and 3) determine acceptable 
ceiling costs for the policies considered in the second aim, and identify the minimum 
effectiveness levels at which these interventions would be considered cost-effective and 
cost-saving. 
 
Methods: We used a systematic review to achieve the first aim, and conducted a 
qualitative synthesis for included studies. To achieve the second aim, we developed a 
decision tree using TreeAge Pro 2014. This model compared three policy options: 1) the 
banning of all flavored combustible tobacco products, 2) the banning of all flavored 
tobacco products (inclusive of combustible and smokeless products), and 3) the status 
quo, in which only flavored cigarettes are banned. To achieve the third aim, we 
performed a threshold analyses to establish cost and performance standards for the policy 
options considered in the second aim. Microsoft Excel 2011 was used for this analysis.  
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Results: The results of the systematic review highlight the association between flavored 
tobacco use and young age, and suggest that flavoring may promote tobacco use in 
adolescent and young adult populations. The second manuscript, which examined the 
policy options among a young adult population, found that a ban on all flavored tobacco 
products would likely produce the most favorable outcome of the policy options 
considered. This finding is contingent upon the validity of the model’s underlying 
structural assumptions, as well as assumptions that determined the model’s parameter 
values. The results of the cost threshold analysis indicated that the cost of either policy 
option would need to reach well into the multi-billion dollar range in order for society to 
deem the cost of either of the policies to be unacceptable. The results of the effectiveness 
threshold analysis found that both policy options would be cost-effective if less than 1% 
of the expected number of averted adults smokers were actually averted. As with the 
model developed for the second manuscript, the parameter values used to conduct the 
threshold analyses were subject to uncertainty.  
 
Conclusions: The results of this dissertation speak to the FDA’s request for information 
and data to support the establishment of a product standard prohibiting flavors in at least 
some noncigarette tobacco products. The studies described here can be thought of as 
exploratory analyses that can be built upon and adapted to directly answer questions 
posed by the FDA. The model presented in the second manuscript, in particular, could be 
used to address a range of regulatory options, as it provides a general framework for 
considering the impact of policies intended to reduce the attractiveness of tobacco 
products, while taking into consideration the varying levels of risk presented by different 
 v 
products. Additional research should be conducted to inform the development of a more 
complex model that can provide additional insight into the effects of implementing the 
policies considered in this dissertation, as well as other regulatory options.  
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Chapter	  1	  -­‐	  INTRODUCTION	  
 
The health and economic consequences of tobacco use in the United States are 
substantial. Tobacco use is the primary preventable cause of premature morbidity and 
mortality (1). Between 2005-2009, cigarette use was responsible for at least 480,000 
annual premature deaths (1), and approximately 8.6 million individuals experienced 
serious smoking-attributable medical conditions in the year 2000 (2). These estimates do 
not include morbidity or mortality caused by the use of other forms of tobacco. 
Economically, smoking-attributable health care expenditures were estimated to be $175.9 
billion in 2013 (1). From 2005-2009, smoking-attributable premature death cost 
approximately $107.6 billion due to losses in productivity (1). 
 
The detrimental health effects of cigarette use have been widely acknowledged since the 
1960s, during which the Surgeon General released the first report on smoking and health 
(3). Since that time, researchers have identified an increasing number of diseases with 
which tobacco use is causally linked, including multiple forms of cancer and chronic 
obstructive pulmonary disease (1). 
 
Tobacco	  control	  legislation	  in	  the	  United	  States	  
Despite knowledge of the negative health consequences of tobacco use, efforts to 
minimize the burden inflicted by tobacco use were initially limited. The Federal Cigarette 
Labeling and Advertising Act of 1965 and the Public Health Cigarette Smoking Act of 
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1969 restricted cigarette advertising on radio and television programs, required that 
cigarette packages bear a health warning label, and called for an annual update on the 
health effects of smoking (3). The next large-scale restrictions imposed upon the tobacco 
industry resulted from the Master Settlement Agreement of 1998, in which the Attorneys 
General of 46 states sued the five largest tobacco companies in the United States (4). 
Provisions of the agreement forbade the industry from directly or indirectly targeting 
advertisements or marketing towards youth, and they imposed other prohibitions around 
marketing and advertising, including bans on outdoor advertising and the use of cartoon 
characters (4). These measures proved to be inadequate, as well over a fifth of adults and 
students continued to use tobacco in the early years of the 21st century (5).   
 
In order to address the continued contribution of tobacco use to morbidity and mortality 
in the U.S., in June of 2009, President Obama signed the Family Smoking Prevention and 
Tobacco Control Act (FSPTCA) into law. The FSPTCA grants the U.S. Food and Drug 
Administration (FDA) authority to regulate the manufacturing, marketing and sale of 
tobacco products. A notable provision of the FSPTCA is that the FDA must issue tobacco 
regulations that are “appropriate for the protection of the public health” (6).  In contrast to 
the individual-level “safe and effective” standard that FDA-regulated products are 
traditionally required to meet, this “public health standard” allows the FDA to consider 
the population-level effects of tobacco products when enacting regulatory decisions (7).  
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Regulation	  of	  flavored	  tobacco	  products	  
In Section 907 of the FSPTCA, cigarettes with characterizing flavors such as cherry, 
vanilla and grape were banned (6). The FSPTCA specifically states that 
…a cigarette or any of its component parts (including the tobacco, filter, or paper) shall 
not contain, as a constituent (including a smoke constituent) or additive, an artificial or 
natural flavor (other than tobacco or menthol) or an herb or spice, including strawberry, 
grape, orange, clove, cinnamon, pineapple, vanilla, coconut, licorice, cocoa, chocolate, 
cherry, or coffee, that is a characterizing flavor of the tobacco product or tobacco 
smoke (6).  
 
The term “characterizing flavor” is not explicitly defined in the FSPTCA. That is, there is 
no quantitative level that defines how much flavor or menthol needs to be in a product in 
order for it to be a “characterizing” trait. The term “additive” is defined, albeit loosely, as 
“any substance the intended use of which results or may reasonably be expected to result, 
directly or indirectly, in its becoming a component or otherwise affecting the 
characteristic of any tobacco product” (6). Although the term “characterizing flavor” is 
not explicitly defined, the FSPTCA does not restrict the FDA’s ability to take action 
applicable to menthol or other flavors, herbs or species not specified in Section 907 of the 
FSPTCA. The FDA has not provided a comprehensive list that specifies which products 
are illegal. Researchers conducting work related to flavored or menthol tobacco typically 
rely on brand designations to define what constitutes a flavored or menthol product (8). 
 
No explicit justification was given for the exclusion of menthol products from the ban; 
this omission was likely made because mentholated cigarettes comprise a large share—
approximately one third—of the cigarette market in the United States (9). While it can be 
argued that menthol is a type of flavor, because menthol was omitted from the flavored 
cigarette ban, the term “flavor” is typically understood not to include menthol in the 
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context of tobacco control policy. The manuscripts included in this dissertation will use 
these terms in a way that is consistent with tobacco control policy. “Flavored” products 
will be used to refer to products with characterizing flavors, excluding menthol.  
 
In addition to excluding menthol products, the ban included in the FSPTCA did not apply 
to non-cigarette tobacco products. Under the FSPTCA, the FDA has authority to enact 
regulations impacting cigarettes and cigarette tobacco, roll-your-own tobacco, and 
smokeless tobacco products (6), with the option to regulate other tobacco products 
following the passage of a “deeming regulation,” in which the FDA would specifically 
deem other products to fall under its authority. Thus, while smokeless tobacco products 
were excluded from the flavored product ban, the FDA does not currently possess the 
authority to extend the ban to other tobacco products.  
 
The FDA’s ability to enact a flavored tobacco ban for non-cigarette products, however, 
may soon change. In 2014, the FDA published a proposed ruling for the deeming 
regulation (10). While passage of the deeming regulation would not automatically extend 
the flavored tobacco ban to non-cigarette products, the proposed ruling indicates that the 
FDA would consider enacting such a regulation in the future, as it contains requests for 
comments and research on how to address flavored non-cigarette tobacco use (10).  
 
Policy	  context	  
A number of governmental bodies in the U.S. and worldwide have implemented bans on 
flavored tobacco products. Domestically, New York City, New York and Providence, 
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Rhode Island passed laws that prohibit the sale of flavored non-cigarette tobacco products 
such as cigars, cigarillos and smokeless tobacco (11). Maine passed a law banning the 
sale of flavored cigar products, and Illinois passed a law banning the sale of flavored 
rolling paper and blunt wraps (11). Other countries such as Canada, Australia and Brazil 
have also taken actions to reduce the use of flavored tobacco products. In Canada, the 
sale of cigarettes, little cigars, cigarillos, and blunt wraps weighing 1.4g or less that 
contain most flavoring agents (excluding menthol) is prohibited (12). The sale of fruit- 
and candy-flavored cigarettes is banned in several Australian states (13). Flavorings, 
including menthol, in all tobacco products are banned in Brazil (14).  
 
In addition to banning the sale of cigarettes with characterizing flavors, Section 907 of 
the FSPTCA allows the FDA to enact other standards for tobacco products, such as 
regulating tar and nicotine levels (6). However, the FDA is not allowed to reduce nicotine 
levels to zero, nor may it enact a ban on specific types of tobacco products (for example, 
the FDA may not ban all cigarettes, all smokeless tobacco or all little cigars) (6).  
 
Tobacco	  use	  among	  young	  adults	  
The definition of a “young adult” varies across tobacco control studies conducted in the 
U.S., with age ranges spanning from 18-24 to 18-35 (15-20). In the context of this 
dissertation, “young adult” should be understood to encompass 18-34 year olds, unless 
otherwise noted. Conceptually, “young adulthood” refers to a stage in which individuals 
are developmentally and socially distinct from children and older adults (21).  
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Tobacco use patterns in young adult populations have become of increasing interest to 
researchers in recent years. Young adults represent the tobacco industry’s youngest legal 
market in the U.S., and prevalence of tobacco products is especially high in this 
population (1, 22). The 2009-10 National Adult Tobacco Survey found that prevalence of 
products examined individually (cigarettes, cigars/cigarillos/small cigars, chew/snuff/dip, 
water pipes, snus) as well as use of any tobacco product decreased with increasing age, 
with prevalence highest among 18-24 year olds (22). Another study examining current 
use of multiple products found that rates of multiple product use were highest among 18-
24 year olds and 24-34 year olds compared with older adults (1). Additionally, over the 
past decade, tobacco control researchers have found that, contrary to previous 
assumptions that tobacco use behaviors were established before the age of 18, young 
adulthood is an important stage during which tobacco use is initiated and solidified (17, 
23, 24). Engaging in risk behaviors during this time may be considered socially 
acceptable and, thus, may facilitate the use of addictive substances such as tobacco (25, 
26). As such, public health initiatives that focus on lowering initiation and increasing 
cessation among young adults can play an important role in lowering long-term morbidity 
and mortality rates. Recent research has focused on learning more about the unique 
patterns of tobacco use in this age group (17, 23, 24, 27).  
 
Flavored	  tobacco	  use	  among	  young	  adults	  and	  FDA	  response	  
Data show that prevalence of flavored tobacco use is high among young adults and that it 
decreases with increasing age. A 2012 survey examining tobacco use among a nationally 
representative sample of young adults in the United States found that, among past 30-day 
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smokers, current flavored tobacco was 18.5% (95% CI: 15.2-22.2) (20). When examined 
by product, prevalence of flavored tobacco use was highest for hookah/shisha at 50% 
(95% CI: 36-64) and lowest for cigarettes at 1% (95% CI: 0.00-0.02) (20). The low rate 
of flavored cigarette use is likely due to the passage of the 2009 FSPTCA, which banned 
flavored cigarettes. This study found that young age was associated with flavored tobacco 
use, as the odds of being a current flavored tobacco user after controlling for menthol use, 
gender, race/ethnicity and education was 89% higher among 18-24 year olds when 
compared to 25-34 year olds (20). Estimates from the 2009-2010 National Adult Tobacco 
Survey found a similar trend; prevalence of flavored cigar use was highest (9.1%, 95% 
CI: 7.8-10.5) among 18-24 year olds and second highest among 25-44 year olds (3.1%, 
95% CI: 2.7-3.6) and decreased with increasing age (28).  
 
In its proposed deeming regulation, the FDA acknowledges the unique role that flavored 
tobacco products may play in facilitating tobacco use among young populations, noting 
that “many of the products proposed to be covered by this rule are offered in fruit and 
candy flavors, such as chocolate and grape flavors, making them especially attractive to 
children and young adults” (10). Further, in its request for comments on approaches to 
regulate flavored tobacco, the FDAs specifies that polices should “address the sale of 
candy and/or fruit-flavored tobacco products to children and young adults” (10). 
 
Dissertation	  overview	  and	  specific	  aims	  
The overarching goal of this dissertation is to synthesize existing research related to 
flavored tobacco use in the U.S., and to translate those findings into evidence that is 
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useful for FDA decision-makers who are considering policies to regulate the sale of 
flavored tobacco products.  
 
Specifically, the aims of this dissertation are to: 
Aim 1: synthesize existing research examining the use and 
attitudes/knowledge/perceptions of flavored tobacco use in the U.S., specifically 
focusing on how age and nonflavored tobacco use are correlated with flavored 
tobacco use 
 
Aim 2: begin to model the population-level health impact, compared to the status 
quo, expected to result from a) a ban on combustible flavored tobacco products 
and b) a ban on all flavored tobacco products, and to organize relevant research 
that informs the model 
 
Aim 3: determine acceptable ceiling costs for the policies considered in Aim 2, 
and identify the minimum effectiveness standards at which these interventions 
would be considered cost-effective and cost-saving 
 
Organization	  of	  dissertation	  
This dissertation is composed of three manuscripts and is organized into six chapters. 
Chapter 1 (the current chapter) provides background information to contextualize the 
studies presented in this dissertation, a brief introduction to the dissertation and an 
overview of the study aims. Chapter 2 describes the conceptual foundation of the 
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dissertation, provides additional background for Aims 2 and 3, and discusses the study 
methods used to address Aims 1-3.  Chapter 3 addresses Aim 1 through a systematic 
review of existing literature. Chapter 4 addresses Aim 2 through a decision model that 
generates expected health effects for the policy options under consideration, and Chapter 
5 establishes cost and effectiveness standards for these polices through threshold 
analyses. The final chapter integrates the study finding from Chapters 3-5 and presents 
recommendations for future research.  
Notes	  
I employed the first person plural (the editorial “we”) throughout this dissertation for 
readability purposes. However, I conducted most aspects of this research individually. 
Diana Lock contributed to parts of the systematic review, described in Chapter 3, that 
required two researchers. My thesis committee contributed in different capacities 
throughout the planning and execution of this project, primarily by providing guidance on 
major study design and analytic decisions.  
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Chapter	  2	  –	  SPECIFIC	  AIMS	  AND	  METHODS	  
 
Methodological	  conceptual	  framework	  
The methodological conceptual framework for this project is based upon a “three box 
model” developed by Holtgrave (1). This model illustrates the ways in which scientific 
information, quantitative policy analysis, and policy and program decision-making can 
interact; each domain (that is, each box) simultaneously informs and is informed by the 
other two. Holtgrave’s model is specific to HIV prevention. For this project, we applied 
the framework to tobacco control.  
 
Figure 2-1 illustrates this dissertation’s methodological conceptual framework. The 
methodologies lie in the “quantitative policy analysis” domain; the primary purpose of 
these methodologies is to synthesize and translate scientific research into information that 
is useful and digestible for policy and programmatic decision-makers – that is, to deliver 
information from the first domain to the third domain. The aims of this dissertation were 
developed in response to research priorities established by the FDA (the third domain). 
The results of this project will also serve to set the agenda for future scientific research 
(the first domain). That is, as research is synthesized and translated, gaps in the scientific 
literature will be elucidated which, if addressed, would help to improve the results of 
quantitative policy analyses (which, in turn, would improve the quality of data delivered 
to policy and program decision-makers).  
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The methodologies employed for the dissertation, as they relate to aims, are discussed 
below.  
Figure 2-1. Methodological conceptual framework  
 
 
Aim	  1:	  To	  synthesize	  existing	  research	  examining	  the	  use,	  attitudes,	  knowledge	  
and	  perceptions	  of	  flavored	  tobacco	  use	  in	  the	  United	  States,	  specifically	  
focusing	  on	  how	  age	  and	  nonflavored	  tobacco	  use	  are	  correlated	  with	  flavored	  
tobacco	  use	  
We used a systematic review to achieve Aim 1. The systematic review is a method used 
to identify, appraise, synthesize and evaluate research on a specific topic. As opposed to a 
traditional literature review, a systematic review uses prescribed, transparent methods 
that are designed to 1) gather all of the available literature on a topic through an extensive 
search of multiple databases and other resources with relevant literature, 2) extract data 
and compile estimates of association (if appropriate) between exposures and outcomes of 
interest, and 3) provide a comprehensive narrative of all of the evidence on a specific 
topic, including an evaluation of the quality and consistency of the evidence. A 
systematic review highlights gaps in the literature to inform future research, and can be 
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used to present synthesized information to decision-makers in an accessible format (2). 
We describe the details of the methodology for this aim in Chapter 3.  
 
Background	  for	  Aims	  2	  and	  3	  
To assess tobacco control policies in a timeframe that is short enough to inform imminent 
regulatory decisions, the FDA has shown an interest employing evidence from 
mathematical modeling studies (3, 4). We employ these types of models to achieve the 
second and third aims of this dissertation. This section provides a brief overview of some 
of the ways in which modeling techniques have been employed in tobacco control 
research to inform policymaking.  
 
Models have been used to inform and evaluate tobacco policy decisions in a variety of 
ways. Some key uses of models in tobacco control policy have been to: 1) evaluate public 
health objectives and provide recommendations for developing realistic goals for the 
future, 2) estimate the financial implications of proposed policies and programs to give 
decision-makers a sense of the affordability and cost-effectiveness of interventions in 
comparison to one another, 3) better understand the relationships between factors that 
influence smoking behaviors by visually and mathematically modeling those 
relationships, and 4) simulate the impact of policy changes on tobacco behaviors and 
health outcomes.  
 
In 1990, the U.S. Public Health Service established an objective to reduce the adult 
smoking prevalence to 13% by 2010. Mendez et al. subsequently developed a dynamic 
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model in order to determine whether this goal was realistic (5). By using estimates of the 
changes in overall population size and data from the National Health Interview Survey 
(NHIS) to model the inflow and outflow of smokers over time—and by testing their 
model under various assumptions about tobacco use behavior—the authors concluded 
that the health objective would be very difficult to achieve. The authors noted that failing 
to meet the objective had the potential to make significant public health successes appear 
to be unimpressive. While the purpose of modeling is not always to predict the future but, 
rather, to serve as a heuristic decision tool, Mendez et al.’s model was later shown to 
have been accurate in its findings (6). In this case, modeling could have been used in 
advance of setting the Healthy People 2010 goal to help establish objectives that were 
more feasible.  
 
In another application of modeling, Warner et al. used a simulation model to estimate the 
net cost and cost-effectiveness of a managed care organization (MCO) covering smoking 
cessation (7). The authors employed data from multiple MCOs to inform their analysis, 
and conducted sensitivity analyses in order to explore the role that uncertainty in their 
data had on the outcome of their of their model. The authors found that, while offering 
coverage for smoking cessation would modestly increase spending for MCOs, it was a 
cost-effective intervention that would likely ultimately save money. By conducting this 
type of analysis, Warner et al. were able to provide decision-makers in MCOs with 
evidence of the health and cost benefits of implementing a policy that they otherwise may 
have not considered. While the cost-effectiveness of a policy is often not decision-makers’ 
only consideration when implementing a change, it is often an important one. 
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The Center for Tobacco Products (CTP) at the FDA – which oversees the implementation 
of the FSPTCA – has made it a priority to understand the impact of its policies on long-
term tobacco use prevalence, morbidity and mortality (8). To meet this goal, the CTP 
contracted with Sandia National Laboratories to develop a dynamic modeling framework 
to assess the health-related outcomes in which the Center is interested (8). This 
framework models the relationships between tobacco use behaviors, policies, marketing 
educational messages, and other factors thought to influence the outcomes of interest. 
This model visually represents these relationships, and applies math to quantify them. 
This type of model bridges theory and data, highlighting what is known and what needs 
to be better understood in order to gain a comprehensive picture of tobacco use behaviors. 
Additionally, the Tobacco Products Scientific Advisory Committee, which advises the 
CTP, held a meeting in April 2014 in which it aimed to learn how modeling techniques 
can inform CTP decision-making (9). These activities illustrate the FDA’s interest in 
using modeling to better understand the impact of its policies on tobacco-related behavior 
and health. We developed this dissertation with FDA’s methodological interests in mind.   
 
The second and third manuscripts should be viewed as methodologically building upon 
existing analytic tools and systems science strategies to improve health planning and 
policies. The SimSmoke model—a simulation model developed by Levy (10)—is an 
example of the type of model this dissertation builds upon. The SimSmoke model has 
been used to evaluate tobacco control policies in various contexts by simulating the 
impact of policy changes on tobacco use and health outcomes.  In one application, the 
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model was used to examine the effects of a ban on menthol cigarettes in the U.S. (11). 
Levy et al. developed this study to respond to the FDA’s need to consider the effect that 
its policies are likely have on tobacco use initiation, cessation, and overall harm to the 
U.S. population, and the study’s results were used to inform TPSAC’s recommendation 
on menthol cigarettes (4).  
 
This background information provides context for Aims 2 and 3, described below.  
 
Aim	  2:	  To	  begin	  to	  model	  the	  population-­‐level	  health	  impact,	  compared	  to	  the	  
status	  quo,	  expected	  to	  result	  from	  a)	  a	  ban	  on	  combustible	  flavored	  tobacco	  
products	  and	  b)	  a	  ban	  on	  all	  flavored	  tobacco	  products,	  and	  to	  organize	  
relevant	  research	  that	  informs	  the	  model	  
Decision analyses are used to aid in the making of complex decisions that have important 
consequences, when a clear preference does not exist (12). Decision analyses are 
particularly useful tools in the short-term, when a decision needs to be made relatively 
quickly, and adequate time or resources are not available to conduct new experiments to 
inform the decision. That is to say, instead of conducting primary research to answer a 
question, decision analyses employ the best available evidence—or informed guesses, 
when there is a lack of data—to simulate the potential outcomes of various decision 
options. While decision analytic models can be predictive if robust data is available to 
inform them, this is not necessarily their primary purpose. Such models can also be used 
to synthesize existing knowledge to show decision-makers the consequences expected to 
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result from different decision alternatives, given what is already known. The decision 
model used to achieve Aim 2 is a heuristic, rather than predictive model.  
 
A decision tree is a type of decision analytic model; it is a tool that graphically represents 
the probability that various outcomes will arise as a result of possible decision options 
(12). To achieve Aim 2, the second manuscript employs a decision tree to compare the 
consequences of multiple tobacco control policy options and to organize the relevant 
research that informs the model. We describe the details of the methodology in Chapter 4.  
 
Aim	  3:	  To	  determine	  acceptable	  ceiling	  costs	  for	  the	  policies	  considered	  in	  Aim	  
2,	  and	  to	  identify	  the	  minimum	  effectiveness	  standards	  at	  which	  these	  
interventions	  would	  be	  considered	  cost-­‐effective	  and	  cost-­‐saving	  
Given that the government has limited resources, decision-makers must consider how the 
costs of proposed policies compare to one another, whether proposed policies are 
affordable, and whether they are cost-effective or cost-saving. Threshold analysis is an 
economic evaluation method that can be used to assess these considerations. Threshold 
analyses can be used to set performance standards for policies; they can tell you how 
many infections or cases of disease must be prevented in order for a policy to be 
considered cost-effective or cost-saving. In order to achieve Aim 3, we conducted 
threshold analyses to determine acceptable ceiling costs for these policies and to identify 
the minimum effectiveness standards at which these interventions would be considered 
cost-effective and cost-saving. Sensitivity analyses provided insight into how uncertainty 
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in parameter values might impact the interpretation of the results. We describe the details 
of this methodology in Chapter 5.  
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Chapter	  3	  -­‐	  Use,	  Attitudes,	  Knowledge	  and	  Perceptions	  of	  




Introduction: In April 2014, the U.S. Food and Drug Administration released a proposed 
deeming regulation in which it requested information and data to support the 
establishment of a product standard that would prohibit characterizing flavors in non-
cigarettes tobacco products. The objective of this systematic review is to identify, 
critically appraise, and summarize research on the use and 
attitudes/knowledge/perceptions of flavored tobacco products.  
Methods: We searched five electronic databases on September 19, 2013 for eligible 
studies and obtained additional records via grey literature searches, expert contacts and 
hand searching citations of relevant and included articles. Two independent coders 
assessed each retrieved record, extracted data from eligible studies and conducted quality 
assessments. We conducted a qualitative synthesis for included studies.  
Results: We included thirty-two studies in this review. The studies exhibited substantial 
heterogeneity and were of varied methodological quality. The results of these studies 
highlight the association between flavored tobacco use and young age. Qualitative data 
collected from adolescents and young adults suggest that flavoring in tobacco products is 
attractive to these populations. Current evidence addressing how flavored tobacco use 
might encourage tobacco initiation is inconclusive. Flavored tobacco use may be 
associated with dual use of other products.  
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Conclusion: The results suggest that the field would benefit from additional research 
investigating the use and attitudes/knowledge/perception of flavored tobacco. Valid and 
reliable measures to investigate these concepts should be standardized to facilitate meta-
analyses of multiple studies, and longitudinal data should be collected to track patterns of 
use over time.  
 
INTRODCUTION	  	  	  
The Family Smoking Prevention and Tobacco Control Act (FSPTCA) of 2009 gave the 
U.S. Food and Drug Administration (FDA) the ability to regulate tobacco products for 
the first time. As part of the FSPTCA, cigarettes with characterizing flavors such as 
cherry, vanilla and grape were banned (1). Notably, this ban did not apply to non-
cigarette products. On April 24, 2014, the FDA released a proposed deeming regulation 
in which it requested information and data to support the establishment of a product 
standard that would prohibit characterizing flavors in non-cigarette tobacco products (2).  
 
In the deeming regulation, the FDA highlights the relationship between flavored tobacco 
use and young age, stating that “many of the products proposed to be covered by this rule 
are offered in fruit and candy flavors, such as chocolate and grape flavors, making them 
especially attractive to children and young adults…findings indicate that flavored product 
use may influence tobacco-use patterns in young adulthood, a critical period when 
lifelong patterns of tobacco use are often established” (2). The FDA specifically asks 
what actions should be taken “to address the sale of candy and/or fruit-flavored tobacco 
products to children and young adults,” and it requests research to determine the 
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“likelihood that individuals who engage in flavored tobacco product use will initiate 
cigarette use and/or become dual users with cigarettes” (2). 
 
The objective of this systematic review is to identify, critically appraise, and summarize 
research on the use and attitudes/knowledge/perceptions of tobacco products with 
characterizing flavors in order to inform FDA decision-making. To our knowledge, no 
such review currently exists. In line with FDA interests, this review focuses specifically 
on how age and tobacco use status are correlated with flavored tobacco use.  
 
METHODS	  	  	  
Criteria	  for	  Considering	  Studies	  for	  this	  Review	  
The criteria for studies included in this review were selected in consultation with a team 
of tobacco control experts.  
 
Types	  of	  Studies	  
We included experimental studies, quasi-experimental studies, observational studies 
(including case control, cohort and cross sectional studies), case reports, case series, 
qualitative studies and mixed methods studies in this review.  
 
In terms of types of publication, we included full-length articles, short communications 
and dissertations reporting results from research studies in this review. We excluded 
commentaries, news articles, letters, opinion pieces, and review articles.  
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Types	  of	  Participants	  
We included studies in humans of any age, race/ethnicity, or gender. For a study to be 
eligible, study participants must have been assessed for at least one exposure of interest, 
as described below. We excluded studies examining humans at the genetic, cellular or 
biological level.  
 
Studies conducted with participants outside of the United States were initially included in 
the search. However, for this report, we focused on studies that recruited participants 
from the United States. As the purpose of this review is to inform policy decision-making 
in the United States, we made this decision in order to prioritize studies that are most 
relevant to this goal. The types of flavored tobacco products sold vary from country to 
country (3), as does the prevalence of tobacco use (4, 5), chemical makeup of seemingly 
similar tobacco products (6), and cultural contexts in which tobacco is used (7). 
Additionally, the regulatory environment with regard to flavored tobacco products has 
been rapidly changing from country to country in past five years; the product and flavor 
bans adopted across countries differ from one another, and these regulatory changes have 
been implemented according to varying timelines (1, 8, 9). Thus, this analysis focused on 
studies that recruited participants from the United States. A list of international studies 
that were excluded can be found in Appendix 3-1.  
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Type	  of	  Exposure/Intervention	  
We included studies that examined any type of tobacco product with a characterizing 
flavor. Given the 2009 FSPTCA’s exclusion of menthol in its definition of 
“characterizing flavor,” in the context of this study, any reference to flavored tobacco 
products should be understood to exclude menthol. We excluded studies that examined 
the use of flavored products without tobacco (such as products used for nicotine 
replacement therapy). Electronic cigarettes were included for this review.  
 
Primary exposures and interventions of interest for this review were the use of a tobacco 
product with a characterizing flavor, or the attitudes/knowledge/perceptions of such 
products. Attitudes/knowledge/perceptions were defined broadly; these concepts included 
any rating of the products of interest, indication of having positive or negative perception 
of these products, and beliefs about these products.  
 
Type	  of	  Outcomes	  
Because the research question for this review does not investigate a specific association 
but, rather, is intended to be a descriptive synthesis, we focused on outcomes at the 
"above skin" level; studies examining cellular, genetic and biological-level outcomes 
were excluded.  
 
Search	  Methods	  for	  Identification	  of	  Studies	  
We searched PubMed, CINHAL, Embase, LILACS and PsychInfo using search strategies 
designed specifically for each database with input from tobacco control experts and an 
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experienced informationist from the William H. Welch Medical Library, Johns Hopkins 
University. Search terms encompassed two concepts: 1) flavors and 2) tobacco products. 
Flavored terms included multiple derivatives of the word “flavor” (inclusive of American 
and British spelling conventions), as well as related terms such as “candy,” “herb,” 
“spice,” “sweet” and “taste.” Tobacco terms included a list of tobacco and nicotine 
products, as well as related words, such as: “smoking,” “e-cigarettes,” “snus,” 
“waterpipe,” “narghila,” “bidi,” and “smokeless.” The complete search strategies are 
available in Appendix 3-2. We searched each database from its inception to September 
19, 2013 without any language restriction.  
 
We searched the Global Health Observatory website (http://www.who.int/gho/en/) for 
grey literature resources on April 19, 2014. We also searched conference abstracts from 
the World Conference on Tobacco or Health, the Society for Research on Nicotine and 
Tobacco, and the Society for Research on Nicotine and Tobacco Europe using a list of 
key terms related to flavors, adapted from the electronic database search terms. We 
searched all available abstracts online for all years. We attempted to locate full text 
reports for all abstracts that contained flavor-related key terms. For full texts that could 
not be located, we contacted authors for additional information about their studies.  
 
We contacted twenty-three domestic and international experts who have conducted work 
related to flavored tobacco products to identify additional resources. We also hand-





Working independently, two researchers (SF and DL) reviewed 1) the titles and abstracts, 
and then 2) the full text articles. At the title and abstract review stage, studies were not 
excluded based on study design or publication type because we intended to be sensitive in 
order to capture all relevant literature at this stage. We conducted the full text review in 
two stages, whereby we first assessed studies based on participants, publication type and 
study design, and then on exposure of interest. This two-stage review process was used 
because we narrowed the criteria for eligible exposures after the title and abstract review. 
While flavored nicotine products and products intended to resemble tobacco or nicotine 
products (such as candy cigarettes) were initially included in the title and abstract review, 
they were excluded at the full text review stage in order to focus the review more 
specifically on products that the FDA might regulate with regard to their flavored 
content.  
 
We piloted the eligibility criteria on 25 studies prior to proceeding with the review of 
titles and abstracts, and on 10 studies prior to proceeding with the review of full texts. 
During each phase of the study selection process, we tagged each study as falling into one 
of the following categories: 1) both reviewers recommend record for inclusion, 2) both 
reviewers recommend record for exclusion, or 3) one reviewer recommends record for 
inclusion and one reviewer recommends record for exclusion. Records in the first and 
second category were included and excluded, respectively. SF and DL discussed records 
in the third category to achieve consensus.  
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Data	  Extraction	  	  
We developed a data extraction form, which was pilot tested by two researchers (SF and 
DL). The two researchers independently extracted data from each report, including: 
descriptive characteristics of study participants, study design and methods, prevalence of 
flavored tobacco use among the entire sample and subgroups, main results related to the 
use and attitudes/knowledge/perception of flavored tobacco products, funding and ethics, 
and questions to assess the risk of bias for each study. We implemented data extraction 
using a Google Form and an accompanying Excel spreadsheet. The data extractors 
piloted the form until an acceptable level of reliability was achieved. The data extraction 
items included in the Google Form can be found in Appendix 3-3.  
 
Risk	  of	  Bias	  	  
For each included report, we assessed the risk of selection bias, information bias, bias in 
the analysis, and reporting bias. For observational studies, we adapted the risk of bias 
assessment questions from an item bank developed by the Agency for Healthcare 
Research and Quality for studies of this type (10). For experimental studies, we adapted 
items from the Cochrane Collaboration’s risk of bias assessment tool (11). For qualitative 
studies, we adapted items from a previous form used in a systematic review of qualitative 
studies (12). We also consulted other sources for guidance in the development of these 
questions to ensure that the risk of bias form would be appliable to a diverse set of study 
designs (13-18). We did not conduct risk of bias assessments for case report/case series 
studies; we deemed the questions used to assess risk of bias to be not applicable to such 




We reported descriptive statistics for all studies, including a description of the sample 
(sample size, age range, mean age (SD), percent male), study aim, flavored tobacco 
products examined, socioeconomic information, racial and ethnic makeup, nonflavored 
tobacco use and flavored tobacco use. With regard to data extracted on the use and 
attitudes/knowledge/perceptions of flavored tobacco, this review focuses on the 
relationship between flavored tobacco and two study population characteristics: 1) age 
and 2) tobacco use status. We decided to prioritize these two characteristics, as opposed 
to other important factors such as race/ethnicity and gender, because internal tobacco 
industry documents and analyses of the industry’s marketing practices have shown that 
flavored tobacco products are targeted towards young populations (19-21) and, as 
researchers have noted, are likely intended to entice nonsmoking youth to initiate tobacco 
use or to encourage novice smokers to continue smoking (19-22). Indeed, in its recent 
request for flavor-related research, the FDA expressed interest in obtaining information 
on whether flavored tobacco product use impacts tobacco initiation and/or dual use (2). 
While industry documents have also shown that flavored products are intended to entice 
women (21) and minority populations (23) to smoke, FDA interests have largely focused 
on age and tobacco use status with regard to flavored tobacco. Thus, we focused our data 




We performed a qualitative synthesis for all included studies. In terms of reporting study 
findings, we synthesized results from cohort, quasi-experimental and experimental 
studies. For these studies, we reported results relating to 1) use of flavored tobacco 
products and 2) attitudes/knowledge/perception of these products separately. We 
synthesized results for qualitative and case control/case series studies independently from 
other studies. 
 
We analyzed results on the attitudes/knowledge/perception of flavored tobacco products 
by employing a framework proposed by Rees et al. (24). This framework – informed by 
the Theory of Reasoned Action – proposes that consumer responses to tobacco products 
can be divided into two broad categories: perception of the product and response to the 
product. A feedback loop exists between the two categories and, together, they determine 
the likelihood of initial tobacco use, experimentation and regular use. A visual of this 
model proposed by Rees et al. can be found in Appendix 3-4. In this model, perception 
of the product is comprised of five domains: risk perception, attitudes and beliefs about 
the product, social acceptability, outcome expectancies (such as satisfactory nicotine and 
sensory effects) and future use intentions. Response to the product is also comprised of 
five domains: nicotine reward, taste/sensory effects, conditional cue reactivity, affective 




Description	  of	  studies	  
We included thirty-two studies in this review. Of the 23 domestic and international 
experts we contacted for suggestions for resources, 10 responded. For records with 
incomplete information for assessment, we were able to locate contact information for 
authors of 31 of the studies; 16 of the authors responded to inquiries for additional 
information. The information for 50 records remained incomplete for assessment, as we 
were unable to obtain the full text or, in cases where no full text exists, detailed 
information about the study design, execution and results for these studies. Eleven of the 
records with incomplete information for assessment appear to have been conducted with 
participants drawn from outside of the United States and, thus, are likely not eligible for 
this analysis. Of the studies included in this review, almost half (15/32) were published in 
2009—the year in which the FSPTCA was passed—or later. Figure 3-1 illustrates the 
study selection process, including reasons for exclusion. 
 
Descriptive characteristics of the samples and their prevalence rates for nonflavored 
tobacco use can be found in Table 3-1. Data on flavored tobacco use prevalence is 
presented in Table 3-2, along with other results. Included studies consist of three case 
studies/case series, fourteen cohort studies, eight experimental or quasi-experimental 
studies and six qualitative studies. One additional study was included that compiled data 
from five previously conducted studies, but is not a formal meta-analysis (25). Products 
examined included kreteks (eight studies), hookah (eight studies), cigars (eight studies), 
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cigarettes (five studies), smokeless tobacco (five studies), e-cigarettes (four studies), and 
bidis (two studies). 
 
Cohort,	  Experimental	  and	  Quasi-­‐Experimental	  Studies	  
Use	  of	  flavored	  tobacco	  products	  
Table 3-2 provides data on the use of flavored tobacco products. This table is comprised 
of three sections:  
1) Flavored tobacco use assessed by age. This section includes cross-sectional 
data on flavored tobacco use by age, as well as for the entire sample (if reported), 
and results from statistical tests that assess the relationship between age and 
flavored tobacco use. 
2) Flavored tobacco use assessed by tobacco use status. This section includes 
cross-sectional data on dual use, patterns of flavored tobacco use over time, and 
results of statistical tests that assessed the relationship between flavored tobacco 
use and tobacco use behavior in general. 
3) Prevalence data on flavored tobacco use for all included studies that provide 
such data, but did not report these data by age or tobacco use status. If reported, 
prevalence for the entire sample is recorded in this section of Table 3-2. Three 
studies did not report prevalence for the entire sample (26-28); prevalence for 
these studies is reported according to school grade.  
Results from this table are described below. 
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Flavored	  tobacco	  use	  and	  age	  
Research suggests that flavored tobacco use is associated with young age. This 
relationship was assessed in six studies (25, 26, 29-33). The results of these studies can 
be found in the first section of Table 3-2. In the three studies that examined national 
samples, flavored tobacco use consistently increased with younger age (29, 31-33). Two 
studies statistically assessed the relationship between flavored tobacco use and age by 
examining age as a dichotomous variable (29, 30). Villanti et al. found that younger age 
(18-24) was significantly associated with flavored tobacco use when compared with older 
age (25-34), while Vander Weg et al. (2008) found no relationship between younger age 
(<20 years old) and flavored tobacco use when compared with older age (≥20 years old). 
These varying results can, perhaps be attributed to the different samples. The study by 
Villanti et al. was conducted with a nationally representative sample, while the study by 
Vander Weg et al. (2008) examined use among military recruits, who may be more 
inclined towards tobacco use in general when compared with the general population (34, 
35). 
 
Two studies examined other measures related to flavored tobacco use and age. Oliver et 
al. combined data from five previously conducted treatment or switching studies (36-40) 
and found no significant differences between current flavored and nonflavored smokeless 
tobacco users with regard to their mean age of first dip or mean age of daily/regular use. 
Soldz et al. (2003) found that the mean age of initiation for current kretek users was 
significantly higher than that for cigarettes and cigars, and there was no significant 
difference in mean age of initiation when compared to bidis (26). These findings do not 
 33 
directly speak to the role that flavoring plays in tobacco use initiation, as these data do 
not indicate whether the product used at initiation was flavored.  
 
Flavored	  tobacco	  use	  and	  tobacco	  use	  status	  
Five studies assessed the relationship between flavored tobacco use and tobacco use 
patterns, including dual use and progression to other tobacco products (25, 26, 29, 30, 
41). Cigarette smoking (30) and smokeless tobacco use (41) were associated with a 
significant increase in kretek use (OR=10.53, 99% CI: 8.41-13.20, p<.001 and OR=1.23, 
95% CI: 1.01-1.49, p=.04, respectively) and use of any menthol product was associated 
with a significant increase in any current non-menthol flavored tobacco use (OR=2.28, 
95% CI: 1.42-3.67, p<0.001) (29). Data from current smokeless tobacco users examining 
their flavored/nonflavored brand choices over time – from initiation to regular use to 
current use – suggested that flavoring may play a role in the maintenance of smokeless 
tobacco use (25). In a study conducted by Oliver et al., more current smokeless tobacco 
users chose a flavored product over a nonflavored product for first time use, first regular 
use and first daily use (25). Conversely, one study examined smoking initiation 
precedence among smokers of kreteks and other combustible tobacco products (cigars, 
bidis, and cigarettes – flavoring not specified, but assumed to be nonflavored) and found 
that, in all cases, the percent of individuals who initiated with kreteks was lower than the 
percent who initiated with the comparator product (26). Thus, evidence suggests that 
there may be an association between flavored tobacco use and dual use, and there is 





Flavored	  tobacco	  use	  –	  prevalence	  	  
Table 3-2 also provides data on flavored tobacco use prevalence that was not assessed by 
age or tobacco use status. Six of these studies examined use of kreteks (26-28, 30, 42, 
43); three examined cigarettes (29, 44, 45) and hookah (29, 42, 46); two examined 
smokeless tobacco (25, 29) and cigars (29, 44); and one examined bidis (28), pipes (29), 
and e-cigarettes (29). Of the 28 measures included in this section of the table, only one 
gives information about the frequency of use of a flavored product (45); all other 
measures provide information on current, ever or never use.  
 
Attitudes/Knowledge/Perception	  
Thirteen studies examined the attitudes/knowledge/perception of flavored tobacco 
products (27, 43, 45, 47-56). Of these studies, seven provided data on preferred flavored 
of tobacco (47, 49, 51-54, 56). The results of these measures can be found in Table 3-3. 
Fruit and mint flavors were popular, mentioned in six of these studies (47, 49, 51, 52, 54, 
56). Dawkins et al. assessed e-cigarette flavor choice by smoking status and found that 
current and ex-smokers did not differ with respect to their flavor preferences (51).  
 
Beyond flavor preference, seven studies assessed other measures of 
attitudes/knowledge/perception (27, 43, 45, 48-50, 55). These were analyzed by 
employing a framework proposed by Rees et al., described in the Methods section (24). 
We found four studies that assessed the domains encompassed by perception of the 
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product (27, 45, 48, 55). Two of these studies assessed attitudes and beliefs about the 
product (27, 45), four studies examined use intentions (27, 45, 48, 55), two studies 
examined outcome expectancies (27, 55), one study examined risk perception (27), and 
no studies examined social acceptability of these products. These results can be found in 
Table 3-4.  
 
The studies examining perception of the product differ in study design and analytic 
approaches. Manning et al. and Ashare et al. asked participants to rate flavored and 
nonflavored cigarette packages and advertisements, respectively (45, 55). Manning et al. 
examined sensation seeking (the preference for high stimulus arousals) as a mediator 
between package exposure and outcomes (hedonic beliefs, brand attitude and trial 
intentions), while Ashare et al. examined smoking status as a mediator between 
advertisement exposure and outcomes (positive and negative expectancies, and 
willingness to try). Soldz et al. (2005) asked participants to endorse statements about 
kreteks, some of which made comparisons to cigarettes; the authors examined results 
according to smoking status. Lastly, Pepper et al. assessed trial intentions among all 
respondents for flavored e-cigarettes versus e-cigarettes that had no flavor descriptor. The 
different study designs and analytic approaches preclude making a definitive overarching 
statement about whether “flavor matters” with regard to perception of tobacco products. 
However, a qualitative assessment of the results in Table 3-4 suggests that flavoring may 
impact the perception of tobacco products, giving respondents a more favorable 
perception of these products, and that smoking status may act as a mediator; positive 
perceptions of flavored tobacco products may increase with smoking intensity. This 
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assessment is made, however, without in-depth knowledge of the domains that were less-
assessed – i.e. social acceptability and risk perception. 
 
We found three studies that assessed the domains encompassed by response to the 
product (43, 49, 50). Two of these studies (43, 50) used items drawn from the Duke 
Sensory Questionnaire (DSQ) (57) and the Cigarette Evaluation Scale (CES) (58, 59). 
The third study used items from the DSQ, as well as measures from another study to 
assess “harshness,” “irritation” and “strength” (62) (54). All items were anchored on 
seven-point Likert scales (1=’not at all,’ 7=’extremely’ or ‘very’). Some items were 
collapsed to make composite scores, noted in Table 3-5. The way in which the item-
specific results were presented suggests that there may have been some variation across 
the three studies with regard to the way these measures were implemented. For example, 
Malson et al. (2002) and Malson et al. (2003) differ in the way certain items are described 
(“similarity to own brand” versus “different from their own brand”). Results in Table 3-5 
reflect the wording that was used to report measures in each paper. Reflective of 
reporting, only significant results are presented for Malson et al. (2003). The authors of 
this study state that “[a]ll other differences in subjective items were not statistically 
significant”(43). While the authors report using DSQ and CES items, they do not 
explicitly confirm that all items were assessed; thus, data on non-significant results for 
Malson et al. (2003) are missing from Table 3-5.  
 
The role that flavor plays in consumer product response is unclear; results are mixed with 
regard to how flavored products were rated when compared to nonflavored products. For 
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example, all three studies examined items assessing liking of the products. Malson et al. 
(2002) found that the strawberry Irie bidi was rated lower than participants’ own brand (a 
conventional cigarette) for liking (4.8 ± 0.9 versus 6.3 ± 0.7, respectively), but higher 
than the unflavored Sher bidi (3.9 ± 1.6) and the American Spirit cigarette (3.1 ± 2.2); 
Malson et al (2003) found that participants rated a clove cigarette higher than their own 
brand (a conventional cigarette) (6.1±0.5 versus 4.8±0.4, respectively); and O’Connor et 
al. found that participants rated a flavored cigarette (Camel Exotic) lower than an 
unflavored light cigarette (Camel Light) (3.0 (0.2) versus 4.5 (0.2), respectively). The 
lack of a discernable pattern in these results suggests that, 1) in measuring consumer 
responses to flavored tobacco products, the comparator products chosen from the wide 
range of unflavored tobacco may impact the direction and magnitude of the results, and 
2) consumer responses to flavored tobacco products may differ by specific product or 
flavor (i.e. all flavored tobacco products do not elicit equal responses).  
 
Risk	  of	  Bias	  –	  Cohort,	  Experimental	  and	  Quasi-­‐experimental	  studies	  
Results from the risk of bias assessment for the 23 studies described above can be found 
in Table 3-6. Six studies were vulnerable to selection bias, as they either provided 
concerning or incomplete descriptions of their recruitment strategies (26, 27, 32, 47, 49, 
55), one of which may have also applied varying inclusion/exclusion criteria across 
participants (47). The study conducted by Oliver et al (25), though not designed as a 
formal meta-analysis, combined data from five previous studies (36-40) and may have 
also been subject to selection bias; the way in which the previously conducted studies 
were identified was not clearly described. All studies may have been subject to 
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information bias, as the reliability and validity of all measures used were not established 
in any of the papers examined. Six studies may have been subject to information bias for 
not applying measures consistently across all study participants (45-47, 49, 51, 56).  
 
Qualitative	  Studies	  
The six qualitative studies differed with regard to their study purposes. Some studies 
explored questions that yielded in-depth findings with regard to flavored tobacco 
products, while others touched on relevant results, but were primarily focused on other 
themes. Thus, some studies produced richer flavor-related data than others.  
 
All of the qualitative studies examined adolescent or young adult populations. Two 
studies (60, 61) also included participants older than the age of 26. The qualitative studies 
were geographically diverse; settings included New York, Minnesota, Pennsylvania, 
Texas, Tennessee and Ohio. Data collection methods varied across studies. Three studies 
employed focus groups (42, 61, 62), two employed interviews (63, 64), and one 
employed observations and interviews (60). These studies examined diverse tobacco 
products, including non-combustible tobacco products (61-63), cigars (60), hookah (64), 
and hookah and cloves (42).  
 
Findings from the qualitative studies can be found in Table 3-7. Participants in all six 
studies perceived characterizing flavors in tobacco products to be an attractive attribute. 
Flavoring was seen as an appealing trait (61-63) and disguised risks of tobacco 
consumption (64). Participants in one study noted that flavoring of cigar products served 
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a functional use, as the flavoring concealed the smell of marijuana when cigars were used 
for blunts (60). Kreteks were also viewed positively for a functional purpose; participants 
noted that these products lasted longer than conventional cigarettes (42). Only one study 
(42) noted an undesirable attribute of a flavored product - that kreteks can be hard to 
locate for purchase and thus can be inconvenient to use. Together, the qualitative studies 
provide evidence that characterizing flavors in tobacco products are viewed as an 
attractive trait among users and nonusers of these products. 
 
Risk	  of	  Bias	  –	  Qualitative	  Studies	  
The risk of bias assessment can be found in Table 3-8. All of the studies were likely or 
potentially subject to recruitment bias, as recruitment strategies may have differed from 
participant to participant. Saturation was not mentioned in any of the six studies, and only 
one study confirmed that it performed member checking (63), potentially calling into 
question the validity of the findings. In considering the design of the included qualitative 
studies and their assessed risk of bias, the reviewers indicated that the conclusions drawn 
in half of the studies were questionable and not strongly supported (42, 60, 61).  
 
Case	  Studies/Case	  Series	  
Three case studies/case series met the inclusion criteria for this review (65-67). Two 
studies examined illness following kretek use (65, 66), and one study examined illness 
following cigar use (67). These studies elucidate potential questions for future research 




The 32 studies included in this review represent the literature conducted on the use and 
attitudes/knowledge/perception of flavored tobacco products in the United States. The 
high number of studies (50) that had incomplete information for assessment likely 
reflects the recent interest in flavored tobacco; many of these studies are abstracts that 
were presented at recent conferences. The included studies exhibited substantial 
heterogeneity with regard to products and populations examined, as well as the study 
designs and measures employed. The studies were of varied methodological quality.  
 
The results of these studies highlight the association between flavored tobacco use and 
young age. In national samples, flavored tobacco use consistently increased with 
decreasing age, and qualitative data collected from adolescents and young adults suggest 
that the flavoring in tobacco products is attractive to these populations. Current evidence 
addressing how flavored tobacco use might encourage tobacco initiation is inconclusive; 
however, evidence suggests that flavored tobacco use may be associated with dual use. 
There are no “gold standard” studies that address these questions.  
 
The risk of bias assessment points to the need for more rigorously conducted qualitative 
studies to assess the use, attitudes, knowledge and perceptions of tobacco products with 
characterizing flavors. All studies may have been subject to information bias, as the 
reliability and validity of all measures used were not established in any of the papers 
examined. This may be because many measures in the field of tobacco control research 
have been used for a long time and may be thought to be well-established (68). However, 
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research shows that self-reported measures may be particularly problematic when used in 
adolescent populations (69), a target audience for flavored tobacco products.  
 
Additional research is needed to investigate how flavored tobacco use impacts tobacco 
use initiation and patterns of use in generalizable populations. To expand the evidence on 
the use of flavored tobacco products, future studies should ideally collect longitudinal 
data in a generalizable population. Following a group of naïve smokers over time to 
examine how flavoring impacts tobacco use initiation, progression to other tobacco 
products and dual use would be ideal. However, the FDA appears to be interested in 
ruling on flavored tobacco products in the near future, and waiting for the results of a 
longitudinal study may not be practical. To assess potential flavored-related policies in 
timeframe that is short enough to inform imminent regulatory decisions, then, the FDA 
might consider synthesizing existing evidence to inform decision models examining the 
results of various policy options. Such a model should consider how ruling on specific 
flavored products might impact initiation and switching patterns between tobacco 
products, as well as the ways in which the detrimental health effects of tobacco use vary 
according to product and duration of use.  
 
With regard to the relevancy of these results to FDA decision-making, it is noteworthy 
that none of the studies included in this review assessed the ways in which the use or 
attitudes/knowledge/perceptions of flavored tobacco has changed as a result of flavored 
tobacco product bans. Pre-post studies that survey individuals before and after the 
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implementation of a flavored tobacco product ban could generate knowledge to directly 
inform to FDA regulatory decisions.  
 
This review is subject to several limitations. In scope, this review was restricted to 
participants recruited in the United States, and it focused on age and tobacco use as 
correlates of the use and attitudes/knowledge/perception of flavored tobacco products. In 
focusing the analysis in this way, results from studies conducted in other countries remain 
unknown, and important findings such as those elucidating relationships between 
socioeconomic status or race/ethnicity and tobacco use are potentially overlooked. 
However, this review is intended to inform FDA decision-making and, thus, the results of 
this study highlight the most relevant data available at this time. As noted in the Results, 
interest in flavored tobacco use has piqued in recent years. It is likely that new research 
has been conducted and disseminated since the time at which studies were collected for 
this review, and this study does not reflect the findings of those studies. Thus, the topics 
investigated in this review should continue to be explored as new research is conducted. 
A primary strength of this study includes the thorough search for eligible records – a 
process which included searching multiple electronic databases, conferences abstracts 
and grey literature resources, contacting experts, and hand searching all included studies. 
The broad inclusion criteria used to identify studies looking at the 
attitudes/knowledge/perception of flavored products is also a strength of this study. By 
broadly defining these concepts, we were able to capture the range of studies that have 
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Appendix 3-1. International studies that were not included in the analysis 
Study ID is defined as: First author, year of publication 
o Study ID (Citation): Akhter, 2008 (70) 
Country: Bangladesh 
Title: Relationship between betel quid additives and established periodontitis among Bangladeshi 
subjects 
o Study ID (Citation): Amin, 2010 (71) 
Country: Saudi Arabia 
Title: Harm perception, attitudes and predictors of waterpipe (shisha) smoking among secondary school 
adolescents in Al Hassa, Saudi Arabia 
o Study ID (Citation): Borgan, 2013 (72) 
Country: Bahrain. 
Title: Beliefs and perceptions toward quitting waterpipe smoking among café waterpipe tobacco 
smokers in Bahrain 
o Study ID (Citation): Etter, 2010 (73) 
Country: France, Canada, Belgium, Switzerland 
Title: Electronic cigarettes:  a survey of users 
o Study ID (Citation): Figueiredo, 2012 (74) 
Country: Brazil 
Title: Use of flavored cigarettes among Brazilian adolescents: a step toward nicotine addiction? 
o Study ID (Citation): Gunaseelan, 2007 (75) 
Country: Areca nut use among rural residents of Sriperambudur Taluk: a qualitative study 
Title: India 
o Study ID (Citation): Hammond, 2013 (76) 
Country: United Kingdom 
Title: The effect of cigarette branding and plain packaging on female youth in the United Kingdom 
o Study ID (Citation): Israel, 2003 (77) 
Country: Water pipe (sisha) smoking in cafes in Egypt 
Title: Egypt 
o Study ID (Citation): Leatherdale, 2011 (78) 
Country: Canada 
Title: Cigar, cigarillo, and little cigar use among Canadian youth: are we underestimating the magnitude 
of this problem? 
o Study ID (Citation): Nakhostin-Roohi, 2010 (79) 
Country: Iran 
Title: Hookah smoking in students:  prevalence, pattern of smoking, situational characteristics and 
motivation of use 
o Study ID (Citation): Soetiarto, 1999 (80) 
Country: Indonesia 
Title: The relationship between habitual clove cigarette smoking and a specific pattern of dental decay 
in male bus drivers in Jakarta, Indonesia 
o Study ID (Citation): White, 2012 (81) 
Country: Brazil 
Title: The potential impact of plain packaging of cigarette products among Brazilian young women:  an 
experimental study 
o Study ID (Citation): WHO, 2010 (82) 
Country: Egypt 
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Appendix 3-2. Electronic database search terms 
Database Flavor key terms Tobacco key terms 
PubMed 
 
Flavoring Agents* [Mesh] OR “flavor”[tw] OR 
“flavour”[tw] OR “flavors” [tw] OR “flavours”[tw] OR 
“flavored”[tw] OR “flavoured”[tw] OR “flavoring”[tw] 
OR “flavouring”[tw] OR “candy” [Mesh] OR 
“candy”[tw] OR “herb”[tw] OR “spice”[tw] OR 
“sweet”[tw] OR “taste” [Mesh] OR “taste” [tw] OR 
“clove” [tw] OR “sweetening agents” [Mesh] OR 
(“additive"[tw] AND “tobacco”[tw]) OR 
(“additives”[tw] AND “tobacco”[tw]) 
“Smoking” [Mesh] OR Tobacco* [Mesh] OR Tobacco, 
Smokeless* [Mesh] OR “Tobacco Products” [Mesh] OR 
“Tobacco Use Cessation” [Mesh] OR “tobacco” [tw] OR 
cigar* [tw] OR “bidi”[tw] OR “bidis”[tw] OR 
“smokeless”[tw] OR “snus”[tw] OR “smoker”[tw] OR 
“smokers”[tw] OR “e-cigarette”[tw] OR “e-cigarettes” OR 
“nicotine” [tw] OR Nicotine*[Mesh] OR “hookah” [tw] OR 





MW Flavoring Agents OR Flavor OR Taste OR TX 
flavor* OR flavour* OR candy OR herb OR spice 
OR spices OR sweet OR taste OR clove OR 
“sweetening agents” OR (TX “additive" AND 
“tobacco”) OR (TX “additives” AND “tobacco”) 
 
MJ Smoking OR Tobacco OR Smokeless OR TX 
Smoking OR Tobacco OR Smokeless OR cigar* OR bidi 
OR bidis OR snus OR smoker OR smokers OR e-
cigarette* OR nicotine OR hookah* OR waterpipe* OR 




MH:"Flavoring Agents" OR MH:"sweetening 
agents" OR MH:"candy" OR MH:"spices" OR 
MH:"taste" OR flavor$ OR flavour$ OR flavored OR 
flavoured OR flavoring OR flavouring OR herb OR 
taste OR clove OR sweet OR doce OR dulce OR  
additive$ OR aditivo 
 
MH:"tobacco" OR MH:"Smoking" OR MH:"Cigarette" OR 
MH:"tobacco, smokeless" OR MH:"tobacco use 
cessation" OR MH:"tobacco products" OR MH:"Smoking 
Cessation" OR MH: "tobacco use disorder" OR MH: 
"Consumption of tobacco-derived products" OR tobacco 
OR bidi$ OR smokeless OR snus OR e-cigarette$ OR 
cigarette$ OR cigarillo$ OR cigar$ OR charuto OR 
smoker$ OR fumador OR fumante OR nicotine OR 
nicotina OR hookah OR narguille OR narghile OR 





SU Taste Perception OR “Flavoring Agents” OR 
“flavor” OR “flavour” OR “flavors” OR “flavours” OR 
“flavored” OR “flavoured” OR “flavoring” OR 
“flavouring” OR “candy” OR “herb” OR “spice” OR 
“sweet” OR “taste” OR “clove” OR “sweetening 
agents” OR (“additive" AND “tobacco”) OR 
(“additives” AND “tobacco” 
SU Tobacco Smoking OR SU Smokeless Tobacco OR 
SU Smoking Cessation OR SU Nicotine OR “Smoking” 
OR “Tobacco” OR “Smokeless Tobacco” OR “Tobacco 
Products” OR “Tobacco Use Cessation” OR “tobacco” 
OR “cigar” OR “cigars” OR “cigarette” OR “cigarettes” 
OR “cigarillo” OR “cigarillos” OR “bidi” OR “bidis” OR 
“smokeless” OR “snus” OR “smoker” OR “smokers” OR 
“e-cigarette” OR “e-cigarettes” OR “nicotine” OR 




‘flavoring agent’ OR ‘flavor’:ab,ti OR ‘flavour’:ab,ti 
OR ‘flavors’:ab,ti OR ‘flavours’:ab,ti OR 
‘flavored’:ab,ti OR ‘flavoured’:ab,ti OR 
‘flavoring’:ab,ti OR ‘flavouring’:ab,ti OR ‘candy’:ab,ti 
OR ‘sugar’ OR ‘herb’ OR ‘herb’:ab,ti OR ‘spice’ OR 
‘spice’:ab,ti ‘sweet’:ab,ti OR ‘sweetness’ OR ‘taste’ 
OR ‘taste’:ab,ti OR ‘clove’ OR ‘clove’:ab,ti OR 
‘sweetening agent’/mj OR (‘additive’:ab,ti AND 
‘tobacco’:ab,ti) OR (‘additives’:ab,ti AND 
‘tobacco’:ab,ti) 
 
‘Smoking’ OR ‘tobacco’/exp OR ‘tobacco’:ab,ti OR 
‘smokeless tobacco’ OR ‘smoking cessation’ OR 
‘cigar’:ab,ti OR ‘cigars’:ab,ti OR ‘cigarette’:ab,ti OR 
‘cigarettes’:ab,ti OR ‘cigarillo’:ab,ti OR ‘cigarillos’:ab,ti 
OR ‘bidi’:ab,ti OR ‘bidis’:ab,ti OR ‘smokeless’:ab,ti OR 
‘snus’:ab,ti OR ‘e-cigarette’:ab,ti OR ‘e-cigarettes’:ab,ti 
OR  ‘nicotine’ OR ‘nicotine gum’ OR ‘hookah’:ab,ti OR 




Appendix 3-3. Data extraction form (conducted with Google Forms) 
Note: Some questions in this form were answered in an Excel sheet; this sheet is not shown here.  
 
Flavor Review -- Data Extraction Form 
*Required  
1. StudyID (First author, year of publication) * 
2. Authors * 
3. Title * 
4. Journal * 
5. Year of Publication * 
6. Volume * 
7. Issue * 
8. Page Numbers * 




Descriptive Characteristics of Study Participants 
Answer all questions for the total sample -- i.e., the participants answering questions about flavored tobacco. 
(For qualitative studies, if flavors are not specifically asked about but simply emerged as a theme, the total 
sample is all participants in the study.) 
 
If the paper contains two DISTINCT samples (the participants are both recruited separately and the 
characteristics for each group are ONLY reported separately), fill out all information for the two groups 
 
Use the following format when there are two groups: 
 
Total study sample 
Group1 30; Group2 41 
 
Age: Range 
Group1 15--17; Group2 18+ 
 
10. Total study sample 
Enter "n." If it is not reported or you cannot identify the number, enter "NR/Can't tell."  
 
11. Age: Range 
If it is not reported or you cannot identify the number, enter "NR/Can't tell." 
 
12. Age: Mean 
If it is not reported or you cannot identify the number, enter "NR/Can't tell." 
 
13. Age: SD 
If it is not reported or you cannot identify the number, enter "NR/Can't tell." 
 
14. Age: SE 
If it is not reported or you cannot identify the number, enter "NR/Can't tell." 
 
15. Age: CI 
Enter the 95% CI using the following format: 20-60. If something other than the 95% CI is reported, 
please specify (e.g. 90% CI: 30--60). If it is not reported or you cannot identify the number, enter 
"NR/Can't tell." 
 
16. Sex: Males 
Enter: n (%). If it is not reported or you cannot identify the number, enter "NR/Can't tell."  
 
17. Sex: Females 
Enter: n (%). If it is not reported or you cannot identify the number, enter "NR/Can't tell."  
 
18. Specify countries in which participants were recruited 
Type “NR” for not reported. If more than one country, separate them by semicolon (;). Do NOT put 
period at the end. For all countries, spell out country name (e.g., United Kingdom rather than UK) 
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19. If applicable, go to the Excel spreadsheet and fill out information for: Race/Ethnicity, Tobacco 
Use Status, and SES.* 
When complete, write “done” in the box below 
 
20. Notes on this section 
Enter questions, areas of confusion, information that you think should be highlighted, shortcomings 
in the form in capturing relevant information 
 
Study Design and Methods 
 21. Study aim 
Record verbatim, with quotation marks, the study aim described in one of the following sections of 
the article using this order of priority: Introduction, Abstract, and other sections of this article. Type 
“NR” if there is no study aim found in this article.  
 
22. Inclusion/Exclusion criteria 
Record verbatim, with quotation marks, the inclusion/exclusion criteria for participants described in 
one of the following sections of the article using this order of priority: Methods, Abstract, and other 
sections of this article. Type “NR” if there is no inclusion/exclusion criteria found in this article.  
 
23. Study Design 
Mark only one oval.  
o Case control 
o Case report 
o Case series 
o Cohort – cross sectional (one time point) 
o Cohort – cross sectional (multiple time points) 
o Cohort – prospective 
o Cohort – retrospective 
o Experimental 
o NR/Can’t tell 
o Qualitative 
o Quasi-experimental 
o Mixed methods 
o Nested case control 
o Other: ______________ 
 
24. Use/attitude/knowledge/perception assessed for the following FLAVORED tobacco products 
Check all that apply.  
ú Betel quid 
ú Bidis 
ú Chew 










ú Other combustible products 
ú Other non-combustible products 
ú NR/Can’t tell 
 
25. Notes on this section  
 
Prevalence of Flavored Tobacco Use 
26. Is the prevalence of flavored tobacco use reported in this study, either for the total sample or for 
specific subgroups (or both)? 
Mark only one oval 
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o Yes 
o No à After the last question in this section, skip to question 29 
o Can’t tell, Shari and Diana to discuss à After the last question in this section, skip to 
question 29 
 
27. If “Yes,” go to the Excel document and enter prevalence information 
When complete, write “done” in the box below 
 
28. Notes for this section 
Enter questions, areas of confusion, information that you think should be highlighted, shortcomings 
in the form in capturing relevant information 
 
Main Results Section  
Fill this section out if there is information related to the use/attitudes/knowledge/perceptions of flavored 
tobacco use (beyond prevalence information) reported in the paper. 
 
29. Please go to the Excel spreadsheet and fill out information for the Results sections 
When complete, type "done" in the box below 
 
30. Notes for this section 
Enter questions, areas of confusion, information that you think should be highlighted, shortcomings 
in the form in capturing relevant information 
 
Funding and Ethics 
31. Was the source(s) of monetary or material support (“funding”) for study reported in article? 




32. If “Yes” to above, specify funding source 
If “No” to above, type “n/a” 
 
33. Did the author report any conflict of interest? 
Mark only one oval. 
o One or more authors reported a conflict of interest 
o All authors reported NO conflict of interest 
o NR/Can't tell 
 
34. If applicable, did the authors report an ethical review? 
Mark only one oval. 
o Yes 
o No 
o Not applicable 
 
35. Notes on this section 
Enter questions, areas of confusion, information that you think should be highlighted, shortcomings 
in the form in capturing relevant information 
 
Risk of Bias 
36. Do the inclusion/exclusion criteria vary across the comparison groups of the study? * 
For studies with one group, replace "groups" with "individuals." 
Mark only one oval. 
o Yes, varies ("flag") 
o Partially: some, but not all criteria, applied to all groups or not clearly stated if some 
criteria are applied to all groups/individuals ("flag) 
o No, does not vary (no flag) 
o Cannot determine: article does not specify, but seems that application across 
groups/individuals does not vary (no flag) 
o Cannot determine: article does not specify, but seems that application across 
groups/individuals might vary ("unsure flag") 
 
37. Explanation for rating 
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If notes for the previous question, please include. If no notes, write "n/a" 
 
38. Does the strategy for recruiting participants into the study differ across groups? * 
For studies with one group, replace "groups" with "individuals." 
Mark only one oval. 
o Yes, differs ("flag") 
o No, does not differ (no flag) 
o Cannot determine, but seems that strategy may differ ("unsure flag") 
o Cannot determine, but strategy does not seem to differ (no flag) 
 
39. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
40. Is the selection of the comparison group inappropriate, after taking into account feasibility and 
ethical considerations? 
Please take into consideration the study design. 
Mark only one oval. 
o Yes, inappropriate ("flag") 
o No, not inappropriate (no flag) 
o Cannot determine or no description of the derivation of the comparison group ("unsure 
flag") 
o Not applicable: study does not include a comparison group (case series, one study group) 
 
41. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
42. Does the study fail to account for important variations in the execution of the study from the 
proposed protocol? 
Consider intensity, duration, frequency, route, setting, and timing of intervention/exposures. 
Mark only one oval. 
o Yes, fails to account ("flag") 
o Partially, fails to account ("flag") 
o No, does not fail to account (no flag) 
o Cannot determine ("unsure flag") 
o Not applicable: not an intervention study or no variations 
 
43. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
44. Was the outcome assessor not blinded to the intervention or exposure status of participants? 
Mark only one oval. 
o Yes, not blinded ("flag") 
o No, blinded (no flag) 
o Not applicable: assessor cannot be blinded 
o Applicable, but can't tell/not discussed ("unsure flag") 
 
45. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
46. Were valid and reliable measures used to assess inclusion/exclusion criteria, 
intervention/exposure outcomes, participant health benefits and harms, and confounding? 
Mark only one oval. 
o Yes, valid and reliable measure used (no flag) 
o No, valid and reliable measure not used ("flag") 
o Cannot determine or measurement approach not reported; the authors did not discuss the 
reliability and/or validity of the measures used ("unsure flag") 
 
47. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
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48. Were the measures used to assess inclusion/exclusion criteria, intervention/exposure 
outcomes, participant health benefits and harms, and confounding implemented consistently across 
all study participants? 
Mark only one oval. 
o Yes, measures were implemented consistently across all study participants (no flag) 
o Partially; some measures used consistently across all study participants ("flag") 
o No, measures were not used consistently across all study participants ("flag") 
o Cannot determine or measurement approach not reported;; the authors did not discuss 
whether their measures were implemented consistently, but seems OK (no flag) 
o Cannot determine or measurement approach not reported;; the authors did not discuss 
whether their measures were implemented consistently, but seems questionable ("unsure 
flag") 
 
49. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
 50. Was the length of follow--up different across study groups? 
For studies with one group, replace "groups" with "individuals." If different lengths of follow--up 
were adjusted by statistical techniques, (e.g., survival analysis), the answer is no. Studies in which 
differences in follow--up were ignored should be answered yes. 
Mark only one oval. 
o Yes, different ("flag") 
o No, not different or remedied through analysis (no flag) 
o Not applicable: cross--sectional 
o Applicable but cannot determine ("unsure flag") 
 
51. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
52. In cases of high loss to follow--up (or differential loss to follow--up), was the impact assessed 
(e.g., through sensitivity analysis or other adjustment method)? 
Attrition is measured in relation to the time between baseline (allocation in some instances) and 
outcome measurement for both retrospective and prospective studies and could include data loss 
from switching. Attrition rates may vary by outcome and time of measurement. Apply criterion for 
relevant standards for the study design and topic. Cochrane standard for attrition is 20 percent for 
shorter term (<1 year) and 30 percent for longer term (≥ 1 year). 
Mark only one oval. 
o Yes, impact assessed (no flag) 
o No, impact not assessed ("flag") 
o Cannot determine ("unsure flag") 
o Not applicable: no loss to follow--up or loss to follow--up was not considered to be high, 
cross-sectional study, or case--control study selected on outcome 
 
53. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
 54. Are any important primary outcomes missing from the results? 
Mark only one oval. 
o Yes, important outcome(s) missing ("flag") 
o No important outcome(s) missing (no flag) 
o Cannot determine ("unsure flag") 
 
55. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
56. Are results believable taking study limitations into consideration? 
Please consider other sources of bias that have not been asked about (and if they exist, make note 
in the explanation section). Please also consider biases that have been asked about in other 
questions in this form, and whether those biases undermine the believability of the results. 
Mark only one oval. 
o Yes, believable (no flag) 
o No, not believable ("flag") 
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o Unsure ("unsure flag") 
 
57. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
58. Any attempt to balance the allocation between the groups or match groups (e.g., through 
stratification, matching, propensity scores). 
Mark only one oval. 
o Yes or study accounts for imbalance between groups through a post hoc approach such 
as multivariate analysis (no flag) 
o No or cannot determine ("flag") 
o Not applicable: study does not include a comparison group (case series or one study 
group) 
 
59. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
60. Were important confounding variables not taken into account in the design and/or analysis 
(e.g., through matching, stratification, interaction terms, multivariate analysis, or other statistical 
adjustment such as instrumental variables)? 
Please consider tobacco use status as a confounding variable. Please also consider what each 
study is asking, and other confounding variables that might be appropriate to consider. 
Mark only one oval. 
o Yes, not accounted for or not identified ("flag") 
o Partially: some variables taken into account or adjustment achieved to some extent ("flag") 
o No: taken into account (no flag) 
o Cannot determine ("unsure flag") 
o Not applicable: this study that does not try and establish the causal association between 
an exposure and outcome 
 
61. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
62. Were the techniques employed in the analysis appropriate for the study design and question of 
interest? 
Mark only one oval. 
o Yes (no flag) 
o No ("flag") 
o Cannot determine;; not clearly stated;; not sure ("unsure flag") 
 
63. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
64. Where applicable, was the allocation sequence adequately generated? 
Mark only one oval. 
o Yes (no flag) 
o No ("flag") 
o Applicable, but can't tell ("unsure flag") 
o Not applicable for this study 
 
65. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
66. Where applicable, was the allocation adequately concealed? 
Mark only one oval. 
o Yes (no flag) 
o No ("flag") 
o Applicable, but can't tell ("unsure flag") 
o Not applicable for this study 
 
67. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
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68. Where applicable, was knowledge of the allocated intervention adequately prevented during the 
study? 
Mark only one oval. 
o Yes (no flag) 
o No ("flag") 
o Applicable, but can't tell ("unsure flag") 
o Not applicable for this study 
 
69. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
70. Is this a qualitative study? 
Mark only one oval. 
o Yes 
o No à Stop filling out this form. 
 
Risk of Bias – Qualitative Study Questions 
 
71. Were the data transcribed verbatim (i.e., were audiotapes, videotapes, or field notes used)? 
Mark only one oval. 
o Yes, data transcribed verbatim (no flag) 
o No, data not transcribed verbatim ("flag") 
o Can't tell/not discussed ("unsure flag") 
 
72. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
73. For interviews and focus groups, were the questions predefined? 
Mark only one oval. 
o Yes, questions predefined (no flag) 
o No, questions not predefined ("flag") 
o Can't tell/not discussed ("unsure flag") 
 
74. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
75. For interviews and focus groups, was the facilitator/interviewers trained? 
Mark only one oval. 
o Yes, trained (no flag) 
o No, not trained ("flag") 
o Can't tell/not discussed ("unsure flag") 
 
76. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
77. Was saturation mentioned? 
o Mark only one oval. 
o Yes, mentioned (no flag) 
o No, not mentioned ("flag") 
 
78. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
79. Was there a description of how the research themes were identified? 
Mark only one oval. 
o Yes, description (no flag) 
o No, no description ("flag") 
 
80. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
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81. Were the research findings were analyzed by more than one assessor? 
Mark only one oval. 
o Yes, more than one (no flag) 
o No, only one ("flag") 
o Can't tell/not discussed ("unsure flag") 
 
82. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
83. Were participant answers reviewed for clarification (i.e., member check)? 
Mark only one oval. 
o Yes, reviewed (no flag) 
o No, not reviewed ("flag") 
o Can't tell/not discussed ("unsure flag") 
 
84. Explanation for rating 
If notes for the previous question, please include. If no notes, write "n/a" 
 
85. Were sequences from the original data presented (i.e. quotes)? 
Mark only one oval. 
o Yes, presented (no flag) 
o No, not presented ("flag") 
 
86. Explanation for rating 






Appendix 3-4. A hypothetical model of consumer responses to tobacco products. Taken from Reese 




























Figure 3-1. Flowchart of included studies 
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Study Aim Flavored 
Products 
Sample Description 
(When provided: sample 
size, age range, mean age 
(SD), % males) 
Socioeconomic status 
Race/Ethnicity 
Nonflavored tobacco use % (95% CI) 
Cohort - cross sectional (one time point) 
Aljarrah, 
2009 
Assess characteristics and 
perceptions of hookah users in 
relation to the belief about hookah 
smoking harmfulness 
  
Hookah 235 hookah café patrons 
aged 17-35 in and nearby 
downtown San Diego; mean 
age 21.8; 57% male 
Race/Ethnicity  Cigarettes  
African American  6.6% Yes  28.4% 
Asian 11% No 71.6% 
Latino 22.4% Hookah 
Middle Eastern 21.5% Daily 13.5% 
Other 5.7% Weekly 35.2% 
White 32.9% Monthly 24.4% 
  Six month 27.0% 
Allen, 
2003 
Summarize tobacco use prevalence 
estimates from the 2002 NYTS and 




26119 middle and high 
school students in public and 
private schools nation-wide 
- Tobacco  
Middle school students  
2002 - Any current use 13.3% (±1.4) 
2000 - Any current use 15.1%(±1.5) 
High school students  
2002 - Any current use 28.4%(±1.7) 
2000 – Any current use 34.5%(±1.9) 
Cigarettes  
Middle school students  
2002 – Current use 10.1%(±1.2) 
2000 – Current use  11.0%(±1.2) 
High school students  
2002 – Current use 22.9%(±1.6) 
2000 – Current use 28.0%(±1.7) 
Cigars  
Middle school students  
2002 – Current use 6.0%(±0.7) 
2000 – Current use 7.1%(±1.0) 
High school students  
2002 – Current use 11.6%(±0.9) 
2000 – Current use 14.8%(±1.1) 
Pipes  
Middle school students  
2002 – Current use 3.5%(±0.5) 
2000 – Current use 3.0%(±0.4) 
High school students  
2002 – Current use 3.2%(±0.6) 
2000 – Current use 3.3%(±0.4) 
Smokeless Tobacco  
Middle school students  
2002 – Current use  3.7%±0.8 
2000 – Current use 3.6%(±0.9) 
High school students  
2002 – Current use 6.1%(±1.1) 




Add to the current knowledge of the 
nature of e-cigarette users, its use, 
and its effects 
E-cigarettes 1347 respondents to an 
online survey hosted on the 
University of East London 
website with links from The 
Electronic Cigarette 
Company and Totally 
Wicked E-Liquid websites; 
mean age 43.39 (11.99); 
70% male 
Education:  Cigarettes 
Masters/PhD/equiv 14% Former 83% 
Degree 30% Current 16% 
Higher teaching qual/equiv 10% Never 4% 
A level/SCE higher/equiv 13% E-cigarettes 
O level/GCSE (Grade A-
C)/equiv 
9% Ever  100% 
CSE Grade 2-5/0 Levels 
(Grades 
D&E)/GCSE(grades D-
G)/NVQ level 1 
3%  
CSE undergrad 1%  
Other 20%  
Race/Ethnicity   
Black <1%   
Mixed 2%   
White 96%   
Asian  1%   
King, 
2013 
Determine national and state-
specific estimates of the prevalence 
and sociodemographic correlates of 
flavored cigar smoking among U.S. 
adults 
Cigars 118215 non-institutionalized 
adults aged ≥18 years who 
were respondents to the 
2009–2010 National Adult 
Tobacco Survey 






Compare the prevalence of flavored 
cigarette use among older 
adolescent and young adult 
smokers (17–26 years old) and adult 
smokers aged 25 years and older 
from two national telephone surveys 
conducted during 2004 and 2005 
Cigarettes NYSCS: 1444 young adults 
17-24 years olds who had 
smoked at least 20 lifetime 
cigarettes, and smoked in 
the previous 30 days; 53.6% 
male 
 
AHCSS: 825 adults aged 
≥25 years who smoked at 




NYSCS: Race/Ethnicity Cigarettes 
Hispanic 9.2% Current 100% 
Non-Hispanic 9.8%   
Non-Hispanic White 75.8%   
Other 5.2%   
AHCSS: Race/Ethnicity   
Hispanic 6%   
Non-Hispanic White 76.8%   
Non-Hispanic Black 12%   
Other 5.2%   
Pepper, 
2013 
Explore awareness of e cigarettes 
among males ages 11-19 and their 
willingness to try them. 
E-cigarettes 228 adolescent males aged 
11-17 who were recruited 
through their parents, who 
were members of a panel of 
U.S. households constructed 
using random digit dialing 
and address based 
sampling; mean age 15.1 
(2.1); 100% male 
Household income Cigarettes 
 <$60000 48% Nonsmoker 91% 
 ≥$60000 52% Smoker 9% 
 Parent education E-cigarettes 
 High school or less 44% 0.88%*** 
 Some college or more 56%  
 Race  
 Non-white 20%   
 White 80%   
 Ethnicity  
 Hispanic/Latino 17%   
 Non-Hispanic Latino 83%   
Regan, (1) Determine the proportion of Cigars 4556 adults aged 18+ who - Dissolvable tobacco  
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2012 adults in this sample who were 
aware of each of these products; (2) 
Assess the percentage of adults in 
this sample who were currently 
using these products; and (3) 
Examine the public’s beliefs 
regarding harm caused by use of 
these products. 
 completed the 2009 
ConsumerStyles survey 
Ever 0.5% 
 Current 0.3% 
 Snus 
 Ever 5.4% 




Address the lack of knowledge 
about the about the knowledge, 
attitudes, beliefs, and smoking 
patterns of waterpipe users in U.S. 
young adults 
Hookah Café: 101 tobacco waterpipe 
users aged 18+, recruited 
via a flyer posted and 
circulated in the café, and 
also by word-of mouth; 
71.3% male 
 
Internet: 201 respondents 
aged 18+ to a threat on 
HookahForum.com; use was 
not used to determine 
eligibility, though the forum 
exists solely for waterpipe 
tobacco smokers; 80.1% 
male 
Student status Tobacco other than hookah/cigarettes 
Student 57.0% Past month use 33% 
Non student 43.0% None 67% 
Years of education  Hookah and cigarettes 
≤12 years 25.4% Past month 25.9% 
≥13 years 74.6% Hookah and other tobacco products 
Race/Ethnicity  Past month 20.0% 
Other 15.4% Cigarettes  
White 84.6% 84.6% Past month 53.7% 
  No past month 46.3% 
  Hookah  
  Ever use 100% 
  Past month use 94.1% 
  No past month use 5.9% 
  Frequency of use 
    Yearly 11.5% 
    Monthly 28.5% 
    Weekly 41.2% 
    Daily 18.8% 
    Past month frequency 
    0-1 times 18.4% 
    2-10 times 50.7% 
    11-20 times 18.4% 
    21+ times 12.5% 
    Hookah and no other substance 
    Past month 37.8% 
Soldz, 
2003  
Discuss the prevalence of youth use 
of cigars, bidis, and kreteks, and 
characteristics of users 
Kreteks 5016 students in grades 7-
12 throughout 
Massachusetts; 48.9% male 
School status   Cigarettes  
Public and parochial 
students 
100% Ever 33.7% (31.5-
36.0) 




0.6% All cigars 
Asian/Pacific Islander 3.7% Ever 18.2% (16.7-
19.9) 
Black (not Hispanic) 2.1% Current 5.9% (5.1-
6.7) 
Hispanic/Latino 8.4% Regular cigars 
Black (not Hispanic) 2.1% Ever 16.4% (14.9-
18.0) 
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Other 4.1% Current 4.7% (4.1-
5.4) 
  Little cigars/cigarillos  
  Ever 11.9% (10.7-
13.2) 
  Current 3.4% (2.8-
4.0) 
  Smokeless tobacco  
  Ever 4.6% (4.0-
5.4) 
  Current  1.7% (1.3-
2.2) 
  Bidis  
  Ever 6.5% (5.6-
7.5) 




Investigate young people’s attitudes 
toward and beliefs about these 
alternative tobacco products 
Kreteks 5016 students in grades 7-
12 throughout 
Massachusetts; 48.9% male 
School status   Cigars 
 Public school students 100% No use 81.8% 
 Race/Ethnicity  Ever 12.3% 
 Asian/Pacific Islander  3.7% Current 5.9% 
 Black 2.1% Bidis (among those who had heard of 
bidis) 
 Hispanic 8.4% No use 72.0% 
 Other 4.6% Ever 20.2% 
 White 81.2% Current 7.1% 
Suftin, 
2014 
 (1) Describe the variety of 
substances that young adults smoke 
from hookahs; (2) Determine 
whether subtypes or classes of 
hookah users exist based on the 
types of substances smoked and (3) 
Describe the correlates associated 
with these classes 
  
Hookah 1509 undergraduate 
students attending eight 
universities (seven public 
and one private) in North 
Carolina; 46% male 
Education Status  Cigarettes  
College student  100% Never smoker 30%  
Mother’s highest education Former/experimenter 29.0% 
4-year college or higher 57% Current nondaily 33% 
Some college or less 43% Current daily 8.0% 
Father’s highest education Hookah  
4-year college or higher 61% Ever 44% 
Some college or less 52%   
Race/Ethnicity   
African American  4%   
Asian/Pacific Islander 2%   
Hispanic 4%   
Other 5%   




Examine the prevalence and 
correlates of ST use among female 
Air Force recruits in an attempt to 
better understand the factors related 
to ST use in females 
Kreteks 9087 female recruits who 
entered Air Force Basic 
Military Training from 
October 1999 to October 
2000; mean age 20.2 (2.6); 
0% male 
Family income  Cigarettes 
≤$25000 31% Daily or occasional 30.4% 
>$25000-$45000 27.3% Smokeless tobacco 
>$45000-$70000 23.4% Daily or occasional 0.4% 
>$70000 18.2% Former 0.2% 
Education  Ever 6.6% 
High school graduate/GED 73.1%   
Some college 26.9%  
Race/Ethnicity   
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Asian/Pacific Islander  4.4%  
Black 25.7%   
Hispanic 10.3%  
Native American 1.1%   
Other 3.6%   




Evaluate the use of several different 
alternative tobacco products (bidis, 
cigars, kreteks, pipes, and ST) in a 
large sample of young adults who 
are particularly vulnerable to 
tobacco use given their age and 
military status. 
Kreteks 31107 active duty recruits 
who entered Air Force Basic 
Military Training from 
October 1999 to September 
2000; 74.8% male 
Family income  Cigarettes 
≤$25000 26% Current 32.7% 
>$25000-$45000 25.9% Cigars  
>$45000-$70000 25.2% 12.3% (11.8-12.8)  
>$70000 22.9% Pipes  
Education  1.1% (0.9-1.2)  
High school graduate/GED 78.9% Smokeless  
Some college 21.1% 6.7% (6.3-7.0)  
Race/Ethnicity  Bidis  
African American  18.7% 2.0% (1.8-2.3) 
Asian American/Pacific 
Islander 
4%   
Caucasian 63.5%   
Hispanic 10.1%   
Native American 0.8%   
Other 2.9%   
Villanti, 
2013 
Identify the prevalence of current 
flavored tobacco product use, dual 
use of flavored and menthol 
products, and sociodemographic 
predictors of flavored tobacco 
product use in a nationally 












982 young adults aged 18–
34 years drawn from GfK’s 
Knowledge Panel.® All 
included participants 
reported past 30-day use of 
any tobacco product and 
provided information on the 
use of flavored brands 
- 
 
Any tobacco product 
Past 30 day 100% 
Quasi-experimental and experimental studies 
Ashare, 
2007 
Investigate college students' 
expectancies for flavored and non-
flavored cigarettes and the degree 
to which expectancies and smoking 
status predicted intentions to try a 
brand 
Cigarettes 424 undergraduates an in 
introductory psychology 
class; Mean ages for 
nonsmokers 19.2 (2.2); 
Susceptible/Experimenter 
19.3 (3.4); Regular 19.3 
(2.1); 43% male 
Student Status Cigarettes 
College students 100% Nonsmoker 59% 
Nonsmoker Susceptible/Experimenter 26% 
African American 9% Regular 15% 
Asian/Pacific Islander 19%   
Hispanic 5%   
White, Non-Hispanic 67%   
Susceptible/Experimenter   
Asian/Pacific Islander 17%   
Hispanic 6%   
White, Non-Hispanic 79%   
Regular smoker   
African-American 2%    
Asian/Pacific Islander 32%   
Hispanic 9%   
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White, Non-Hispanic 56%   
Cobb, 
2011 
Compare the subjective effect profile 
of waterpipe tobacco and cigarette 
smoking 
Hookah 54 healthy individuals aged 
18-50 from the Richmond, 
VA community with no intent 
to quit smoking; mean age 
21.2(2.3); 67% male 
Race/Ethnicity   Cigarettes 
Non-white  31% At least 5/wk for past mo. 100% 
White 69% Hookah 
  At least 2/mo. for past 6 mo. 100% 
Blank, 
2011a 
Determine the extent to which the 
acute effects of waterpipe tobacco 
smoking were due to nicotine 
exposure 
Hookah 37 healthy, non-regular 
marijuana users aged 18-50 
with no past use of other 
drugs; mean age 20.5 
(12.77); 78.4% male 
Race/Ethnicity  Cigarettes 
African American 8.1% Current >5/month 100% 
Asian 18.9% Hookah  
Caucasian 54.1% Current 2-5 times/month 100% 
Hawaiin/Pacific Islander  2.7%   
Mixed/Other Ethnicity 16.2%   
Blank, 
2011b 
Evaluate the cardiovascular 
response, toxicant exposure, 
subjective effects, and puffing 
topography of Black & Mild cigarillos 
Cigars 16 greater Richmond, VA 
community volunteers aged 
18-55; mean age 27.7(10.8); 
62.5% male 
Race/Ethnicity  Cigarettes 
White  31% Smoker 56% 
Non-white 69% Nonsmoker 44% 
  Cigarillos (Black & Milds) 
  Used 5+ Black & Mild 




  Cigarettes and Cigarillos (Black & Milds) 
  Concurrent use  56% 
Malson, 
2002 
Determine whether smoking bidis, 
an additive-free cigarette, and 
conventional cigarettes caused 
similar biochemical, physiological 
and subjective effects 
Bidis 10 healthy, local community 
volunteers with a history of 
bidi use, aged 20-37; mean 
age 24.5; 90% male 
- Cigarettes 
Current (regular) 100% 
Malson, 
2003 
Compare the changes in exhaled 
CO, cardiovascular effects, and 
subjective effects of clove versus 
conventional cigarettes 
Kreteks 10 local community 
volunteers aged 19-46 who 
had previous smoked either 
clove or bidi cigarettes 
without adverse reactions; 
mean age 30.3; 70% male 
- Cigarettes 
Current (regular) 100% 
Bidis 
Ever use 100% 
Manning, 
2009 
Examine the interactive effects of 
cigarette package flavor descriptors 
and sensation seeking on 
adolescents’ brand perceptions 
Cigarettes 253 high school students at 
a school in either the central 
or southeast United States 
who received parental 
consent; mean age 15.7; 
40% male 
Race/Ethnicity Cigarettes 
Southeastern School  Southeastern School  
African American 29% Past month 26%  
Central School Central School   
Mexican American  11% Past month 17% 
O'Connor, 
2007 
Explore differences in puff 
topography and cigarette ratings 
between flavored and unflavored 
Camels among college student 
smokers 
Cigarettes 20 participants aged 18-30 
who smoked at least 100 
lifetime cigarettes, and were 
not trying to quit; 50% male 
Student Status Cigarettes  




Explore young adults’ perceptions of 
snus, dissolvable tobacco products, 
and electronic cigarettes and 






66 residents of the 
Minneapolis-St. Paul, MN, 
area aged 18-26 who had 
either used some tobacco in 
the past 30 days or could 
School Status  Cigarettes 
4-y college student or 
graduate  
47% Past 30 day 70% 
≤ 2-y college student or 
graduate  
53% No past 30 day 30% 
 68 
specify where they had seen 
tobacco advertisements 
during the past 30 days; 
39% male 
Race/Ethnicity Other combustible products 
African American  6% Past 30 day 15% 
Asian 29% No past 30 day 85% 
Other 9% Smokeless tobacco  
White 56% Past 30 day 3% 
  No past 30 day 97% 
Griffiths, 
2011 
Investigate the growing practice of 
hookah consumption among college 
students 
Hookah 20 college-aged individual, 
aged 18-23, who have 
current or past hookah 
smoking experience; mean 
age 20.1; 50% male 
Student/Job Status  Cigarettes 
College student  95% Smoker 5% 
Receptionist 5% Socially 10% 
Race/Ethnicity  Occasionally 10% 
African American  10% Past 10% 
Caucasian 70% Nonsmoker 65% 
German 5% Hookah  
Indian 5% Current or past 100% 
Jamaican 5%   
Mexican 5%   
Lavo, 
2004 
Add to the existing body of 
smokeless tobacco research the 






20 adjudicated adolescents 
aged 15-17 selected from a 
residential facility in 
Northeast Pennsylvania; 
mean age 15.85 
Familial Status  Smoke tobacco  
Single parent  55% 15%  
Both parents 40% Smokeless tobacco  
Other relative 5% 20%  
Income Smoke and smokeless tobacco  
An overview shows participants had 




Liu, 2012 Examine perceptions of traditional 
and novel smokeless tobacco 
products and packaging among 






Smokeless tobacco users in 
four rural Ohio counties; 23 
adolescents and 38 adults; 
mean ages adolescents 17.2 
(0.8); adults 28.9 (12.9); 
Adolescents 100% male; 
Adults 100% male 
 
Education  Cigarettes  
Adolescents  Adolescents   
<High school 65.2% Smokers 56.5% 
Missing 34.8% Nonsmokers 39.1% 
Adults  Adults  
High school of GED 26.3% Smokers 31.6% 
Some college 68.4% Nonsmokers 39.1% 
≥College 5.3% Smokeless Tobacco  
Work for Pay  Adolescents  
Adolescents  </= 5 days per week 43.5% 
Full-time 4.4% 6-7 days/week 43.5% 
Part-time 43.5% Missing 13% 
No 47.8% Adults  
Missing 4.4% <=5 days/week 34.2% 
Adults  6-7 days/week 65.8% 
Full-time 36.8% Total sample  
Part-time 50% Current 100% 
No 13.2%   
Place of Residence    
Adolescents     
Live with both parents 21.7%   
Live with one parent 13%   
Live with other 30%   
Missing 35%   
Household Income    
Adults    
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<$15000 15.8%   
$15000-$24999 15.8%   
$25000-$34999 21.1%   
$35000-$49999 5.3%   
≥$50000 31.6%   
Missing 10.5%   
Race    
Adolescents    
African American 4.4%   
Missing 4.4%   
Other 17.4%   
White 73.9%   
Adults   
White 100%  
Ethnicity   
Adolescents   
Non-Hispanic 78.3%  
Hispanic 17.4%  
Missing 4.4%  
Adults   
Hispanic 2.6%  
Non-Hispanic 97.4%  
Richter, 
2008 
Learn the appeal of nontraditional 
tobacco product and understand 
factors related to their use 
Hookah,* 
cloves 
137 young adult smokers 
aged 18-22 in Dallas, Texas 
and Chattanooga, 
Tennessee who had tried or 
used nontraditional tobacco 
products 
Student Status   Cigarettes  
College students  50% Current 100% 
Non-college students 50% Cigars  
Race/Ethnicity  Ever (Swisher Sweets) 87% 
African Americans  26% Ever (Black & Mild) 96% 
Hispanics 23% Bidis  
Non-Hispanic Whites 51% Ever 23% 
Sifaneck, 
2005 
Explore reasons for selection of 
different tobacco products available 
in the legal commercial market 
Cigars 92 marijuana/blunt users 
aged 14-35 who are 
residents of New York City 
neighborhoods and are 
diverse with regard to age, 
race/ethnicity, gender and 
class/neighborhood; 57% 
male 
Race/Ethnicity  Cigar-for-blunts  
100% 
 










in the course of ST product use, 
from initiation to regular use, in an 
intervention seeking population; 
examine whether users of flavored 
ST products differ from nonflavored 
users on a number of characteristics 
tobacco 
products 
smokeless tobacco users 
aged 18-70; mean ages: 
mean ages no flavor 
smokeless tobacco use 
37.3(7.7); flavor tobacco use 
32.5(7.8) 
 
Studies 1-4: Adult 
smokeless tobacco users 
who were interested in 
reducing use but not quitting; 
Study 1: only recruited those 
who were using 
Copenhagen or Kodiak 
Wintergreen brand 
smokeless tobacco 
products. Study 5: 
smokeless tobacco users, 
regardless of their desire to 




















Case report/case series 
Al-Saieg, 
2007 
Analyze cases of acute eosinophilic 
pneumonia following smoking of 
flavored cigars for characteristic 
features 
Cigars Two patients aged 23 and 
53 who presented at a 





Describe examples of severe 
illnesses possibly resulting from 
smoking clove cigarettes 
Kreteks Two patients aged 19 and 
16 who presented at a 





Describe a patient in whom, after 
she smoked a clove cigarette, 
pneumonia complicated by lung 
abscess developed 
Kreteks One patient aged 18 who 
presented at a hospital, 
unspecified location; 0% 
male 
- - 
*Product was described by authors as being flavored, but question was not given confirming that participants were asked about the flavored version of these products 
















Sample Measures/Analysis Age (years) or 
Population 
% (95% CI) Result 













































Chi-squared test for independence, past 30 day 
use of any flavored cigarette (Camel Exotic 















Age significantly associated with 









Chi-squared test for independence, past 30 day 














Age significantly associated with 








Chi-squared test for independence, past 30 day 























Chi-squared test for independence, past 30 day 























Chi-squared test for independence, past 30 day 
use of any flavored cigarette (Camel Exotic 








Age significantly associated with 






Smoking Survey  
Chi-squared test for independence, past 30 day 








Age significantly associated with 





Smoking Survey  
Chi-squared test for independence, past 30 day 














Smoking Survey  
Chi-squared test for independence, past 30 day 














Data drawn from five 
studies  
Current mean age; mixed-effects analysis of 
variance model, fitted with flavor (yes, no) as a 
fixed effect and a random effect for individual 












Data drawn from five 
studies  
Mean age of first dip; mixed-effects analysis of 
variance model, fitted with flavor (yes, no) as a 
fixed effect and a random effect for individual 












Data drawn from five 
studies  
Mean age of daily regular use; mixed-effects 
analysis of variance model, fitted with flavor (yes, 
no) as a fixed effect and a random effect for 












Cigar Use Reasons 
Evaluation 
Mean age of initiation by product; “robust test of 
the significant of mean differences in these ages 
among participants reporting lifetime use of both 












Cigar Use Reasons 
Evaluation 
Mean age of initiation by product; “robust test of 
the significant of mean differences in these ages 
among participants reporting lifetime use of both 












Cigar Use Reasons 
Evaluation 
Mean age of initiation by product; “robust test of 
the significant of mean differences in these ages 
among participants reporting lifetime use of both 








Difference in mean (SE) = 0.10 





Survey to assess 
alternative forms of 
tobacco use in a 
population of young 
adult military recruits 
Multivariable logistic regression; model includes 
gender, race and ethnicity, educational attainment, 
income and marital status; looks at current use of 
kreteks by age 
<20 years old 





No significant association found 
Villanti, Legacy Young Adult Multivariable logistic regression of any current   OR (95% CI) 
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2013 Cohort Study, Wave 2 flavored tobacco use compared to no flavored 
tobacco use; controls for gender, race/ethnicity, 




N/R 1.89 (1.14-3.11) (p<0.05) 
1.0  Referent 
Villanti, 
2013 
Legacy Young Adult 
Cohort Study, Wave 2 




N/R Younger age was a predictor of 
flavored tobacco product use 
Section 2: Flavored Tobacco Use, Assessed by Tobacco Use Status 
Oliver, 
2013 
Data drawn from five 
studies  
Z-test comparing percent of users who started with 
a nonflavored product and now use a flavored 
product with percent of users who started with a 
flavored product and now use a nonflavored 
product 
 
Users who started with a 
nonflavored product and 
now use a flavored 
product 
 
Users who started with a 
flavored product and now 







ST users who started by using 
nonflavored products were more 
likely to switch to mint-flavored 
products compared with the 




Data drawn from five 
studies  
Z-test comparing percent of users who started with 
a nonflavored product and now use a nonflavored 
product with percent of users who started with a 
flavored product and now use a flavored product 
 
Users who started with a 
nonflavored product and 
now use a nonflavored 
product 
 
Users who started with a 
flavored product and now 






ST users who started with a 
mint-flavored product were more 
likely to currently use a mint-
flavored product compared with 
those who continue with 
nonflavored products (p=.001). 
No coefficient given. 
Soldz, 
2003 
Cigar Use Reasons 
Evaluation 
Smoking initiation precedence among users of 
kreteks and cigars 
Initiated with kreteks 
Initiated with cigars 







Cigar Use Reasons 
Evaluation 
Smoking initiation precedence among users of 
kreteks and bidis 
Initiated with kreteks 
Initiated with bidis 







Cigar Use Reasons 
Evaluation 
Smoking initiation precedence among users of 
kreteks and cigarettes 
Initiated with kreteks 
Initiated with cigarettes 







Cigar Use Reasons 
Evaluation 
Current kretek use, by cigarette use Current cigarette smokers 







Cigar Use Reasons 
Evaluation 
Ever kretek use, by cigarette use Current cigarette smokers 










Simple odds ratio (unadjusted) looking at ever use 




Never smokeless tobacco 
use  
 OR (95% CI) 
4.49 (3.79-5.31), p<.001 
 







Multivariate odds ratio (adjusted) looking at ever 




Never smokeless tobacco 
use 
 OR (95% CI) 
1.23 (1.01-1.49), p=.04 
 




Survey to assess 
alternative forms of 
tobacco use in a 
population of young 
adult military recruits 







 OR (99% CI) 
10.53 (8.41-13.20), p<.001 
1.0  Referent 
Villanti, 
2013 
Legacy Young Adult 
Cohort Study, Wave 2 
Multivariable logistic regression of any current 
flavored tobacco use compared to no flavored 
tobacco use; controls for gender, race/ethnicity, 
and education 
 
Any menthol use 
No menthol use 
 
N/R 
OR (95% CI) 
2.28 (1.42-3.67), p<0.001 
1.0  Referent 
Section 3: Flavored Tobacco Use, Overall or by Other Measures of Prevalence 
Allen, 
2003 
2000 National Youth 
Tobacco Survey 
Current use of kreteks Middle school students 
(grades 6-8) 









2000 National Youth 
Tobacco Survey 
Current use of bidis* Middle school students 
(grades 6-8) 








2002 National Youth 
Tobacco Survey 
Current use of kreteks Middle school students 
(grades 6-8) 








2002 National Youth 
Tobacco Survey 
Current use of bidis* Middle school students 
(grades 6-8) 










Ever use of kreteks 10 local community 
volunteers aged 19-46 
who had previous smoked 
either clove or bidi 





High school students 
at a school in either 
the central or 
southeast United 
States  
Smokes flavored cigarettes at least once in a while High school students;  
mean age 15.7 
19  
Oliver, Data drawn from five Current mint flavor use – smokeless tobacco  55.8  
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2013 studies  
Oliver, 
2013 
Data drawn from five 
studies  
Ever mint flavor use – smokeless tobacco  79.4  
Regan, 
2012 
ConsumerStyles Ever use of flavored cigarettes Adults aged ≥18 years, 
nationally representative, 
who had heard of flavored 
cigarettes 
27.4 (20.9-33.9) N/A 
Regan, 
2012 
ConsumerStyles Ever use of flavored little cigars Adults aged ≥18 years, 
nationally representative, 







Young adult smokers 
aged 18-22 in Dallas, 
Texas and 
Chattanooga, 
Tennessee who had 
tried or used 
nontraditional tobacco 
products 
Ever use of hookah Young adult smokers aged 
18-22 in Dallas, Texas and 
Chattanooga, Tennessee 






Young adult smokers 
aged 18-22 in Dallas, 
Texas and 
Chattanooga, 
Tennessee who had 
tried or used 
nontraditional tobacco 
products 
Ever use of kreteks Young adult smokers aged 
18-22 in Dallas, Texas and 
Chattanooga, Tennessee 






Cigar Use Reasons 
Evaluation 
Ever use of kreteks Middle and high school 
students from 12 school 
districts across 
Massachusetts 
8.9 (7.8-10.1) N/A 
Soldz, 
2003 
Cigar Use Reasons 
Evaluation 
Current use of kreteks Middle and high school 
students from 12 school 
districts across 
Massachusetts 
3.1 (2.4-3.9) N/A 
Soldz, 
2005 
Cigar Use Reasons 
Evaluation 
Never use of kreteks Middle and high school 
students from 12 school 
districts across 
Massachusetts who had 




Cigar Use Reasons 
Evaluation 
Ever use of kreteks Middle and high school 









Massachusetts who had 
heard of kreteks/cloves 
Soldz, 
2005 
Cigar Use Reasons 
Evaluation 
Current use of kreteks Middle and high school 
students from 12 school 
districts across 
Massachusetts who had 




Online survey, part of 
the Study to Prevent 
Alcohol-Related 
Consequences 
Ever use of hookah Students from eight 
colleges in North Carolina 
reporting ever smoking 





Survey to assess 
alternative forms of 
tobacco use in a 
population of young 
adult military recruits 





Legacy Young Adult 
Cohort Study, Wave 2 
Current use of cigars/cigarillos/bidis 18-34 year olds, nationally 
representative sample 





Legacy Young Adult 
Cohort Study, Wave 2 
Current use of cigarettes 18-34 year olds, nationally 
representative sample 
1% (95% CI: 0.00-0.02)  
Villanti, 
2013 
Legacy Young Adult 
Cohort Study, Wave 2 
Current use of cigars 18-34 year olds, nationally 
representative sample 





Legacy Young Adult 
Cohort Study, Wave 2 
Current use of pipes 18-34 year olds, nationally 
representative sample 
38% (95% CI: 18-63)  
Villanti, 
2013 
Legacy Young Adult 
Cohort Study, Wave 2 
Current use of chewing tobacco 18-34 year olds, nationally 
representative sample 





Legacy Young Adult 
Cohort Study, Wave 2 
Current use of dip/snuff 18-34 year olds, nationally 
representative sample 
8% (95% CI: 3-21)  
Villanti, 
2013 
Legacy Young Adult 
Cohort Study, Wave 2 
Current use of dissolvable tobacco 18-34 year olds, nationally 
representative sample 





Legacy Young Adult 
Cohort Study, Wave 2 
Current use of hookah 18-34 year olds, nationally 
representative sample 





Legacy Young Adult 
Cohort Study, Wave 2 
Current use of e-cigarettes 18-34 year olds, nationally 
representative sample 
13% (95% CI: 6-27)  
* Product was described by authors as being flavored, but question was not given confirming that participants were asked about the flavored version of these products 
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Type of Product Measure Result 
Aljarrah, 
2009 
Hookah Favorite hookah tobacco 
flavor 
Mint (22%), combination of fruit flavors (19%), individual fruit flavors (most were less than 5%). 
Blank, 2011 Hookah Preferred waterpipe 
flavor 
Apple/double apple (n = 8, 22%), mint (n=6, 16%), strawberry (n = 6, 16%), mango (n = 4, 11%), peach (n = 
3, 8%), cherry (n = 2, 5%), watermelon (n = 2, 5%), grape (n=1, 3%), mixed fruit (n=1, 3%), orange (n=1, 
3%), guava (n=1, 3%), rose (n=1, 3%), vanilla (n=1, 3%).  
Cobb, 2011 Hookah Preferred waterpipe 
flavor 
Fruit flavors (e.g. mango, strawberry and melon) (n=46, 85%), mint (n=4, 7%), vanilla (n=2, 4%), X on the 




Hookah Favorite flavor of tobacco "Apple" (n=31, 15.7%), "Other fruit" (n=75, 38.1%), "Mint" (n=18, 9.1%), "No particular flavor" (n=30, 15.2%), 





Hookah Type of tobacco favored 95.9% of participants favored "flavored" tobacco. 4.1% of participants favored "sometimes flavored or not 
flavored" tobacco. 
Blank, 2011 Cigars Preferred Black & Mild 
cigarillo flavor 




Cigarettes Flavor choice Seven Exotic Blends were offered. The most popular were: Twist (a citrus flavor) (n=7, 35%), Dark Mint (n=4, 
20%), Warm Winter Toffee (n=3, 15%), Izmir Stinger (n=3, 15%), Mandarin Mint (n=2, 10%), and Crema 
(n=1, 1%). No significant differences in outcome measures were noted between Twist and the other flavored 
varieties (p values>.50).  
Dawkins, 
2012** 
E-cigarettes Preferred e-cigarette 
flavor  
Participants could endorse more than one option. Favorite flavors among the entire sample were: tobacco 
(n=664, 53%), fruit (n=421, 33%), mint/menthol (n=357, 28%), chocolate/sweet flavor (n=231, 18%), coffee 
(n=167, 13%), other (n=196, 16%), vanilla (n=156, 12%), alcohol related (n=49, 4%) and flavorless (n=11, 




Table 3-4. Perception of product 










Hedonic beliefs, measured 
with a multi-item scale 
assessing the likelihood that 
the brand is enjoyable, 
relaxing and good tasting 
2 (descriptor: flavored 
vs. traditional) x2 
(sensation seeking: 
high vs. low) x2 (school 
location) x3 (brand) 
repeated measures 
ANCOVA model, with 
brand as the only 
within-participants 
factor 
There was a significant main effect of package descriptor (F (1, 215) =18.36, p,0.001). The 
flavor descriptors (M=3.50) led to more positive beliefs about the hedonic qualities of the 
brands than the traditional descriptors (M=2.64). This effect was qualified by a significant 
interaction between package descriptor and sensation seeking (F (1, 215) =10.17, p=0.002). 
Among lower sensation seekers, hedonic brand beliefs did not differ between the two 
package descriptor conditions (p=0.32; MTraditional=2.81, MFlavor=3.03). Within the higher 
sensation-seeking group, the flavor descriptors (M=3.98) led to more favorable hedonic 
brand beliefs than the traditional descriptors (M=2.47; p,0.001). 
  Brand attitude, measured 
with a multi-item scale 
assessing perceptions from 
the point of view of another 
person (such as an 
acquaintance or friend) 
 There was a significant interaction between package descriptor and sensation seeking (F (1, 
211)=10.47, p<.001). A contrast revealed a marginally significant effect (p=0.10) of the 
cigarette descriptor within the lower sensation-seekers’ condition such that attitudes were 
more favorable among those exposed to the traditional descriptors (M=2.91) than the flavor 
descriptors (M=2.53). A second contrast revealed a significant effect (p=0.003) of the 
descriptor manipulation among higher sensation seekers with brand attitudes being more 




Kreteks taste good Contingency table 
techniques 
Endorsement of this statement increased monotonically and significantly (p<0.001) by 
smoking status: No use 2.0% (95% CI: 1.3-2.9); Lifetime use 69.6% (95% CI: 64.1-74.6); 
Current use 86.4% (95% CI: 79.1-91.4) Endorsing this item was found to predict use of 
kreteks (OR=98.77, 95% CI: 35.19-277.23). 
  Kreteks smells good  Endorsement of this statement increased monotonically and significantly (p<0.001) by 
smoking status: No use 9.1% (95% CI: 7.4-11.1); Lifetime use 67.6% (95% CI: 62.2-72.6); 
Current use 81.6% (95% CI: 73.9-87.4) 
  Kreteks are more natural 
than cigarettes 
 Endorsement of this statement increased monotonically and significantly (p<0.001) by 
smoking status: No use 7.9% (95% CI: 6.5-9.6); Lifetime use 34.2% (95% CI: 29.4-39.4); 






positive expectancies and 
willingness to try flavored 
and nonflavored cigarettes 
Logistic regression 
analysis of “Intention to 
Try” as a function of 
smoking status, positive 
expectancies and 
negative expectancies 
Across all brands, positive expectancies significantly predicted the likelihood one would try a 
brand. Odds ratios indicated that as positive expectancies increased one point, participants 
were 1.6 (95% CI: 0.6-1.0, p<0.01, for Salem Regular), 2 (95% CI: 1.4-2.7, p<0.001, for 
Salem Silver), 1.8 (95% CI: 1.3-2.5, p<0.001, for Camel Light), and 2.4 (95% CI: 1.7-3.4, 
p<0.001, for Camel Exotic) times more willing to try that particular brand.   
  Relationship between 
negative expectancies and 
intention to try flavored and 
nonflavored cigarette 
brands 
 Negative expectancies were not reliably related to intention to try Camel Light, Camel Exotic, 
or Salem Silver. Negative expectancies predicted a modest reduction in intention to try 




Trial intentions, measured 
with a single item, a scale 
anchored by “very unlikely” 
(1) and “very likely” (7) that 
asked participants “In the 
future, how likely is it that 
your friends with try [brand 
name] cigarettes? 
2 (descriptor: flavored 
vs. traditional) x2 
(sensation seeking: 
high vs. low) x2 (school 
location) x3 (brand) 
repeated measures 
ANCOVA model, with 
brand as the only 
within-participants 
factor 
The only other significant effect was an interaction between package descriptor and 
sensation seeking (F(1, 215)=8.92, p=0.003). In assessing the interaction, a contrast 
revealed that among lower sensation seekers trial intentions were marginally greater in the 
traditional descriptor condition (M=3.19) than the flavor descriptor condition (M=2.77; 
p=0.07). Among the higher sensation seekers, the flavored descriptors (M=3.36) led to 
higher trial intentions than the traditional descriptors (M=2.53; p=0.01). 
 Pepper, 
2013 
Participants were asked: “If 
one of your best friends 
were to offer you an e-
cigarette, would you try it?” 
and “If one of your best 
friends were to offer you a 
flavored e-cigarette 
(chocolate, mint, apple, 
etc.), would you try it?” 
Logistic regression 13.2% of participants answered that they were “probably” or “definitely” willing to try both 
types of e-cigarettes. 3.9% of participants answered that they were “probably” or “definitely” 
willing to try the flavored e-cigarettes, but not the e-cigarettes that were not specifically 
described as “flavored.” 1.3% answered that they were “probably” or “definitely” willing to try 
the e-cigarettes that were not specifically described as “flavored,” but not the flavored e-
cigarettes. The difference between the number of participants willing to try a flavored e-
cigarette versus the number willing to try an e-cigarette that was not described as “flavored” 
did not significantly differ (p=.15). 
 Soldz, 
2005 
Kreteks are something 
different to try 
Contingency table 
techniques 
Endorsement of this statement increased monotonically and significantly (p<0.001) by 
smoking status: No use 10.8% (95% CI: 9.0-12.8); Lifetime use 60.6% (95% CI 54.7-66.2); 
Current Use 79.0% (95% CI: 70.5-85.6). Endorsing this item was found to predict use 







around flavored (Salem 
Silver, Camel Exotics) 
cigarette brands compared 
to nonflavored (Salem 
Regular, Camel Lights) 
cigarette brands 
Repeated measures 
ANOVAs (3 Smoking 
Status x 4 Brand 
Types). Smoking status 
was a between-subjects 
factor and brand was a 
within-subjects factor 
Positive expectancies were influenced by flavor, with higher positive expectancies for Salem 
Silver compared to Salem Regular across smoking status (brand F(1,421)=155.6, p<0.001, 
partial η2 =0.27; Salem Silver vs. Regular x Smoking Status, F<1). Similarly, Camel Exotics 
produced greater positive expectancies than did Camel Lights (brand F(1,421)=38.4, 
p<0.001, partial η2 =0.08).  
 
This difference was at least as strong among susceptible/experimenters (M=0.45, 
F(1,109)=30.6, p<0.01, partial η2 =0.22) as it was for regular smokers (M=0.43, F(1,63)=8.6, 
p<0.0, partial η2 =0.12), with only a modest effect among committed nonsmokers (M=0.14, 
F(1,249)=5.4, p<0.05, partial η2 =0.02; Camel Exotic vs. Light x Smoking Status 
F(2,421)=4.9, p<0.01, partial η2=0.02) 
  Negative expectancies 
around flavored and 
nonflavored cigarette 
brands; intention to try 
flavored and nonflavored 
cigarette brands. 
 Across all groups, Camel Lights were rated more negatively than were Camel Exotics 
(F(1,421)=8.2, p<0.01, partial η2 =0.02), an effect that did not reliably vary by smoking status 
(F(2,421)=2.0, p=0.11). For Salem, the non-flavored product was also rated more negatively 
than the flavored product; however, this effect was reliable among the nonsmoker and 
susceptible/experimenter groups (F(1,249)=37.6, pb0.01, partial η2=0.13 and F(1,109)=10.1, 
p<0.01, partial η2 =0.09, respectively; Salem vs. Salem Silver x Smoking Status F(2, 
421)=3.3, p<0.05), but not the regular smokers (F<1). 
 Soldz, 
2005 




Endorsement of this statement increased monotonically and significantly (p<0.001) by 
smoking status, from No use 2.3% (95% CI: 1.5-3.4); Lifetime use 21.4% (95% CI: 17.1-





Risk Perception Soldz, 
2005 
Kreteks are not as bad for 




Endorsement of this statement increased monotonically and significantly (p<0.001) by 
smoking status, from no use (3.6%, 2.6-4.9) to lifetime use (15.1%, 11.3-19.9) to past month 
use (28.8%, 21.2-37.8). 
Social acceptability N/R    
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Table 3-5. Response to product 
Response domain Study ID 
(first author, year 
published) 
Measure  Comparators*   Significance 
Nicotine reward Malson, 2002  Irie Bidi 
(strawberry) 
American Spirit ® Sher Bidi Own Brand F-test 
  High in nicotine 4.7 ± 1.8  5.2 ± 1.7 4.2 ± 1.9  5.2 ± 1.1 No differences 
Taste/sensory effects Malson, 2002  Irie Bidi 
(strawberry) 
American Spirit ® Sher Bidi Own Brand  F-test 
  Liking 4.8 ± 0.9a 3.1 ± 2.2a 3.9 ± 1.6 6.3 ± 0.7 F[3,27] = 11.23, p<0.001 
  Satisfaction (DSQ) 4.8 ± 1.3a  3.1 ± 2.2a  3.7 ± 1.7a  6.3 ± 0.7 F[3,27] = 10.68, p<0.001 
  Satisfaction (maximum=14)b (CES) 9.2 ± 2.4a   6.1 ± 4.3a  8.4 ± 3.4a  12.6 ± 1.2 F[3,27] = 9.11, p<0.001 
  Enjoyment of sensations in throat and 
chest  4.7 ± 1.1  2.8 ± 1.8a  3.7 ± 1.8a  5.7 ± 0.1 
F[3,27] = 7.16, p<0.001 
  Strength (maximum=35)b 21.4 ± 5.4  22.3 ± 9.3  18.6 ± 5.9a  24.6 ± 7.4 Not reported 
  Craving relief  4.7 ± 1.8a  5.4 ± 2.0  4.1 ± 2.0a  6.0 ± 0.9 F[3,27] = 3.88, p<0.05 
 Malson, 2003  Clove Cigarette   Own Brand  Dependent t-test 
  Liking of taste 6.1±0.5   4.8±0.4 t(9)=2.25, P<.05 
  Reduction in hunger for food 2.1±1.5   3.0±1.9 t(9)=2.1, P<.10 
 O’Connor, 2007  Exotic Light   F-test 
  Liking 3.0 (0.2) 4.5 (0.2)   F[1,18] = 3.8, p=.07 
  Satisfaction (DSQ) 4.2 (0.3) 4.2 (0.3)   F[1,18] = 0.3, p=.88 
  Strength (maximum=35)b 19.1 (1.) 18.3 (1.0)   F[1,18] = 0.8, p=.40 
  Harshness/irritation/strength scaleb  
Lights smoked first 







F[1,18] = 11.9, p=.003 
Conditional cue 
reactivity 
N/R       
Affective and 
behavioral response 
Malson, 2002  Irie Bidi 
(strawberry) 
American Spirit ® Sher Bidi Own Brand  F-test 
  Psychological reward (maximum=35)b  17.5 ± 5.4  13.2 ± 6.5  14.3 ± 7.3  19.3 ± 6.5 F[3,27] = 2.86, p=0.056 
Personal acceptability Malson, 2002  Irie Bidi 
(strawberry) 
American Spirit ® Sher Bidi Own Brand  F-test 
  Similar  1.9 ± 1.1a  2.1 ± 1.3a  1.6 ± 1.0a  7.0 ± 0.0 F[3,27] = 84.84, p<0.001 
  Aversion (maximum=14)b  6.1 ± 3.5  6.0 ± 2.5  4.3 ± 2.1  3.5 ± 1.8 No differences 
 Malson, 2003  Clove Cigarette   Own Brand Dependent t-test 
  Different from own brand 1.9±1.2   6.5±1.3 t(9)=10.2, P<.001 
 O’Connor, 2007  Exotic Light   F-test 
  Similar 2.8 (0.3) 4.2 (0.4)   F[1,18]=5.8, p=.03 
Results from O’Connor et al. are reported as mean (standard error); results from Malson et al. (2002, 2003) are reported at mean (±standard deviation).  
*For all comparators, own brand = conventional, nonfiltered cigarettes 
a Indicates significant difference from own brand (p<0.05, Dunnett’s test). 




Table 3-6. Risk of bias, non-qualitative studies* 
StudyID 
































































































































































exclusion criteria ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ N/A ✔ ✔ X ✔ ✔ ✔ ✔ ✔ ✔ 
Recruitment strategy ✔ ✔ ? ✔ ? ✔ ✔ X ✔ ✔ ✔ ✔ ? N/A ✔ ✔ X X X ✔ ✔ ✔ ✔ 
Selection of the 
comparison group  N/A ✔ ✔ ✔ ✔ ✔ N/A N/A N/A N/A N/A ✔ ✔ ✔ N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Outcome assessor 
blinding  N/A N/A N/A N/A ✔ N/A N/A N/A N/A N/A N/A N/A ? N/A N/A N/A N/A N/A N/A ✔ N/A N/A N/A 
Valid and reliable 
measures  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 
Measures 
implemented 
consistently  X ✔ ✔ ✔ ✔ ✔ X ✔ ✔ ✔ ✔ ? X N/A ✔ ✔ X ✔ ✔ X ✔ ? ✔ 
Length of follow-up  N/A N/A N/A ✔ N/A ✔ N/A N/A N/A N/A N/A N/A N/A ✔ N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Loss to follow-up  N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Primary outcomes 
missing  ✔ ✔ X ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ? ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ X ✔ 
Results believable ? ✔ ? ✔ ✔ ✔ ? ✔ ✔ ? ✔ ✔ X ? ? ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ 
Attempt to balance 
the allocation N/A N/A ✔ X N/A N/A N/A N/A N/A N/A N/A X N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Confounding 
variables  N/A N/A ✔ ✔ ✔ ✔ N/A N/A ✔ N/A N/A ✔ X ✔ ✔ N/A N/A N/A N/A N/A ✔ N/A N/A 
Analytic techniques  ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ? ✔ ✔ ? ✔ ✔ ✔ ✔ ✔ ✔ 
Allocation sequence 
generation N/A N/A ? ? ? N/A N/A N/A N/A N/A N/A ? ? N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Allocation 
concealment N/A N/A N/A N/A ✔ N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Knowledge of the 
allocated intervention 
prevented N/A N/A N/A N/A ✔ N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
*A checkmark indicates that the study was not susceptible to bias. An “X” indicates that the study was susceptible to bias. A question mark indicates that it was unclear if the study was 
susceptible to bias. “N/A” indicates that this question was not applicable for the study.  
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Flavored Tobacco Products 
Assessed 
Topic Explored  Summary of Main Result/s 
Choi, 2012 E-cigarettes, Snus, Orbs, Other 
non-combustible products 
General perceptions of new tobacco 
products and e-cigarettes 
Participants thought the flavors of dissolvable tobacco products 
made them fun and interesting to use. Female participants 
described the pill-form dissolvable tobacco products (Camel 
Orbs) as “candy that gives you a little buzz” and ‘fresh and minty.’ 
Griffiths, 2011 Hookah/water pipe Conditions and occasions under 
which participants engaged in hookah 
smoking, their beliefs and attitudes 
about hookah versus cigarette 
smoking, and their knowledge of risks 
and health outcomes of hookah 
smoking 
The authors found that the appealing fruit-flavored sheesha 
disguised the true risks of hookah smoking and supported the 
illusion of being safer than cigarettes for participants. These 
factors led to the tendency among participants to rationalize away 
the risks of sheesha smoking and to contradict prior knowledge or 
general beliefs about smoking. Participants’ view that the fruit 
flavors contained in sheesha are similar to foods contributed to 
their denial of the possible presence of toxins in sheesha that 
may cause harm. Several participants also balked at the idea that 
hookah may be even remotely addictive, claiming that what is 
smoked is mostly herbs or flavored tobacco that does not contain 
the same ingredients as cigarettes.  
Lavo, 2004 Chew, Spit, Other non-
combustible products 
Taste as an influence upon the 
consumption behavior of adolescents 
Subjects indicated that their behavior regarding product 
consumption was governed by the taste of the products 
consumed. Subjects’ statements indicated a preference for 
mentholated or “minty” tasting products; they expressed 
preferences for Skoal Wintergreen or Skoal Mint. In relation to the 
consumption of smokeless tobacco, subjects reported that their 
preferred brand was chosen because it was sweet and did not 
even taste like tobacco.  
Liu, 2012 Chew, Snus, Orbs, Other non-
combustible products 
Adult perceptions of smokeless 
products 
Adults perceived the weak taste and candy-like flavor of novel ST 
products as characteristics designed to target adolescents. Adults 
viewed novel ST products as starter products designed to entice 
youth and get them addicted. 
Richter, 2008 Hookah/water pipe, 
Kreteks/cloves 
Reasons for initiating and using non-
traditional tobacco products 
Reasons for initiation of cloves included curiosity about the smell 
and taste of the products. Reasons for continuing to smoke these 
products included the perceived strength and convenience of 
these products. Participants perceived clove cigarettes as being 
“strong.” Smoking these products resulted in "getting more" than 
from a traditional cigarette. Clove cigarettes were noted to last 
longer than traditional cigarettes. Several participants noted that 
the ability to smoke non-traditional tobacco products like clove 
cigarettes over several sessions was seen as a convenience and 
a result to continue using the product. At the same time, some 
participants noted that non-traditional tobacco products like 
cloves could be harder to locate for purchase and therefore were 
inconvenient to use.  
Sifaneck, 
2005 
Cigar products (cigars, little 
cigars, cigarillos) 
Reasons for using flavored cigar-for-
blunts 
Blunt users reported that flavored cigar-for-blunts and blunt wraps 
help them conceal their consumption and possession of an illicit 
drug, especially in public locations. 
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Table 3-8. Risk of bias, qualitative studies* 
StudyID 
(first author, year published) Choi, 2012 
Griffiths, 






criteria ✔ ? ✔ ✔ ✔ ? 
Recruitment strategy X X ? X X X 
Selection of the 
comparison group  N/A N/A N/A ✔ ✔ N/A 
Outcome assessor 
blinding  N/A N/A N/A N/A N/A N/A 
Valid and reliable 
measures  ? ? ? ? ? ? 
Measures implemented 
consistently  ✔ ✔ ✔ ? ? ✔ 
Length of follow-up  N/A N/A N/A N/A N/A N/A 
Loss to follow-up  N/A N/A N/A N/A N/A N/A 
Primary outcomes 
missing  ✔ ✔ ✔ ✔ ✔ X 
Results believable ✔ ✔ ✔ X ? ? 
Attempt to balance the 
allocation N/A N/A N/A ✔ X N/A 
Confounding variables  N/A N/A N/A N/A N/A N/A 
Analytic techniques  ✔ ✔ ✔ X ✔ ? 
Data transcribed verbatim ✔ ✔ ✔ ✔ ✔ ✔ 
Questions predefined ✔ ✔ ✔ ✔ ✔ ? 
Facilitator/interviewers 
trained ✔ ? ✔ ✔ ✔ ? 
Saturation X X X X X X 
Research themes ✔ ✔ ✔ ✔ ✔ X 
Analysis by more than 
one assessor ✔ ? X ✔ ✔ ? 
Participant answers 
reviewed ? ? ✔ ? ? ? 
Sequences from data 
presented ✔ ✔ ✔ ✔ ✔ ✔ 
*A checkmark indicates that the study was not susceptible to bias. An “X” indicates that the study was susceptible to 
bias. A question mark indicates that it was unclear if the study was susceptible to bias. “N/A” indicates that this 
question was not applicable for the study. 
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Chapter	  4	  -­‐	  Policy	  Options	  to	  Regulate	  Flavored	  Tobacco	  
Products:	  Development	  and	  Results	  of	  a	  Heuristic	  Model	  
 
ABSTRACT	  
Introduction:  The goals of this study were to develop a heuristic decision tree in order 
to begin to model the population-level health impact of different approaches to regulating 
the sale of flavored tobacco products, and to organize relevant research that informs the 
model.  
Methods: We developed a decision tree to compare three policy options: 1) the banning 
of all flavored combustible tobacco products, 2) the banning of all flavored tobacco 
products (inclusive of combustible and smokeless products), and 3) the status quo, in 
which only flavored cigarettes are banned. The model examines outcomes for a cohort of 
healthy 18-year-old never tobacco users. The timeframe for the model is 15 years and the 
analytic horizon spans the lifetime. The model estimates health effects, expressed on a 
unitless scale. We conducted univariate and multivariate sensitivity analyses to assess 
uncertainty in the model.  
Results: The results of this heuristic model found that a ban on all flavored tobacco 
products would likely produce the most favorable outcome of the policy options 
considered. The parameters that contributed to the majority of the uncertainty in the 
model were: 1) the probability of combustible tobacco initiation under the status quo, 2) 
the probability of smokeless tobacco initiation under the status quo, and 3) the health 
effect associated with dual (combustible/smokeless) tobacco use. In the multivariate 
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analysis, the preferred decision option changed for 13.3% of combinations of values 
tested. 
Conclusions: This model provides a framework for examining regulatory approaches 
intended to reduce the attractiveness of tobacco products. It weighs the impact of 
reducing the attractiveness of some products but not others, while taking into 
consideration the varying levels of risk that different products present. This analysis 
serves as a first step to developing more complex model; future studies should update this 
model as relevant evidence is published.  
 
INTRODUCTION	  
Under the Family Smoking Prevention and Tobacco Control Act (FSPTCA) of 2009, 
cigarettes with characterizing flavors, excluding menthol, were banned in the United 
States (1). This ban did not apply to non-cigarette tobacco products. However, in April 
2014, the U.S. Food and Drug Administration (FDA) published a proposed ruling in 
which it requested research and data to support the extension of the flavored cigarette ban 
to other tobacco products (2). 
 
As part of the FSPTCA, the FDA is mandated to issue tobacco regulations “appropriate 
for the protection of the public health” (1). In contrast to the individual-level “safe and 
effective” standard that FDA-regulated products are traditionally required to meet, this 
public health standard allows the FDA to consider the population-level effects of tobacco 
products when enacting regulatory decisions (3). Specifically, the FDA is to consider the 
effect that a tobacco product will likely have on 1) initiation of tobacco product use 
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among non-users, 2) cessation of tobacco product use among users, and 3) overall risks 
and benefits to the entire population (1). 
 
“Traditional” scientific evidence, such as data from randomized controlled trials (RCTs), 
is rarely sufficient to directly inform these criteria. There are often limits to the 
generalizability of RCTs, and the outcomes in which we are interested—such as health 
effects—are often not measureable in the short-term, particularly when examining the 
effect of a tobacco control policy or intervention on a young population (4, 5). To assess 
tobacco control policies in a timeframe that is short enough to inform imminent 
regulatory decisions, the FDA has shown an interest employing evidence from 
mathematical modeling studies (6, 7).  
 
The goals of this study were to develop a heuristic decision tree, a type of mathematical 
model, in order to begin to model the population-level health impact of different 
approaches to regulating the sale of flavored tobacco products, and to organize the 
relevant research that informs the model. This model compares three policy options, and 
while the output identifies a preferred regulatory approach among the three options, it is 
not intended to be predictive model. Rather, this is a heuristic model that employs the 
best available evidence to inform a policy decision that may need to be made within a 
short timeframe. As a heuristic tool, this model is intended to present a preliminary 
framework that can be used to consider the effects of tobacco control policies, organize 
relevant data, and determine which parameters have the greatest influence on population-
level health (8). We chose the following policy options to represent alternative 
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conceptual approaches to reducing the harm caused by tobacco use: 
§ The banning of all flavored combustible tobacco products 
§ The banning of all flavored tobacco products (inclusive of combustible and 
smokeless products) 
§ The status quo, in which only flavored cigarettes are banned 
 
We chose the banning of all flavored combustible tobacco products to exemplify a harm 
reduction approach to tobacco control. While smokeless tobacco use presents unique 
harms when compared to combustible tobacco use, if it is used instead of combustible 
tobacco, the risk of experiencing negative health effects is reduced (9). By banning 
flavored combustible products but not flavored smokeless products, smokeless tobacco is 
made more attractive to tobacco users who enjoy flavored products. Thus, this approach 
aims to promote smokeless tobacco as an alternative to combustible tobacco. 
 
There are many types of policies aimed at reducing the negative effects of tobacco use 
that could be characterized as harm reduction policies. For example, proponents of a 
harm reduction approach often point to Sweden for a successful example of this strategy; 
in Sweden, an increase in prevalence of the smokeless tobacco product “snus” 
corresponded with a decline in smoking prevalence (10, 11). While the banning of all 
flavored combustible tobacco products was chosen to exemplify a harm reduction 
approach to tobacco control in the context of this paper, it should be noted that this policy 
option is not the only available strategy that could represent a harm reduction approach.   
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Opponents of harm reduction strategies often emphasize the negative unintended 
consequences that such policies may produce. The banning of all flavored combustible 
products may have unintended consequences, as it is successful only if users who engage 
in combustible tobacco use substitute their use of combustible products with smokeless 
products. If these combustible users initiate smokeless tobacco without reducing 
combustible use – or, if the uptake of smokeless tobacco causes these individuals to delay 
smoking cessation – then the promotion of smokeless tobacco products may actually 
cause more, rather than less, harm when compared to a ban on all flavored products or the 
status quo. 
 
We chose to examine the effects of a ban on all flavored tobacco products in this model, 
because this policy takes the potential unintended consequences of a harm reduction 
approach into consideration and acknowledges that all tobacco use poses health risks. 
Thus, a ban on all flavored tobacco products represents a differing conceptual approach 
to tobacco control, in which all tobacco products, regardless of their relative harm to one 
another, are discouraged.  
 
In this analysis, a ban on all flavored combustible tobacco products and a ban on all 
flavored tobacco products are compared with the status quo, a scenario in which the 2009 
ban on flavored cigarettes exists, but no additional flavored tobacco bans are enacted. In 




As a conceptual underpinning, this model assumes that flavoring in tobacco products is 
an attractive trait that increases consumer use of tobacco (12). In this paper, “flavored” 
should be understood to exclude menthol, as menthol cigarettes were not included in the 
2009 ban on flavored cigarettes. We used TreeAgePro 2014 to conduct this analysis.  
 
Model	  Framework	  
The decision tree is illustrated in Figure 4-1. This model focuses on a young adult 
population, defined as 18-34 year olds. According to the U.S. Census Bureau, 18-34 year 
olds make up approximately 23% of the U.S. population (13), and approximately 23% 
(95% CI: 21-25) of 18-34 year-olds use some form of tobacco product (14). Research has 
shown that tobacco use behaviors are initiated and solidified during young adulthood (15-
17), and analyses of tobacco industry documents have revealed that flavored tobacco 
products are specifically targeted towards young populations (18-20). Thus, the decision 
tree examines outcomes for cohort of healthy 18-year-old never tobacco users. 
 
The timeframe for the model is fifteen years. Policies are implemented at time point zero 
(T0), and all tobacco-related behavioral changes are assumed to occur between T0 and 
T15. We chose this timeframe because adults who quit smoking before the age of 35 are 
thought to avoid most of the negative health effects associated with cigarette use (21). 
Thus, 15 years represents a time frame after which a differential health effect will be seen 
among individuals with varying tobacco-related behavioral outcomes. The behavioral 
changes that occur between T0 and T15 are assumed to “freeze” at T15 and persist until 
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death; this model assumes a lifetime analytic horizon.  
 
Between T0 and T15, subjects undergo two major behavioral transitions, highlighted in 
Figure 4-1:  
• First behavioral transition: During the first transition, individuals initiate 
combustible tobacco use, initiate smokeless tobacco use, or never initiate tobacco 
use. While some literature has considered “dual initiators” (22, 23) – individuals 
who begin using two tobacco products within the same year – this model assumes 
that product initiation must occur sequentially.  
• Second behavioral transition: During the second transition, individuals who 
initiate tobacco use proceed to 1) continue use of the type of product (combustible 
or smokeless) with which they initiated (“persist”), 2) initiate use of a second type 
of product (combustible or smokeless) without stopping use of the product with 
which they initiated (“dual use”), 3) initiate use of a second type of product 
(combustible or smokeless) while stopping use of the product with which they 
initiated (“switch”), or 4) cease using tobacco altogether (“quit”).  
This simplified approach to representing tobacco use patterns over time reflects the depth 
of the data available to inform this model; insufficient data were available to inform a 
more complex Markov model.   
 
In this model, combustible tobacco products include all cigar products (including 
cigarillos and little cigars), bidis, kreteks, hookah/shisha and pipes. Because flavored 
cigarettes have already been banned in the United States, they were excluded from this 
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model. When data differentiated between cigarette use and other combustible tobacco use, 
we chose data describing other combustible tobacco use to inform the model. However, 
when only cigarette-specific data were available, we employed these data. Smokeless 
tobacco products include snuff, snus, spit, chew, and dissolvable tobacco products. E-
cigarettes were excluded from this model because the usage patterns and health effects of 
e-cigarettes are not yet well understood.  
 
Outcomes	  
This model estimates health effects, expressed on a unitless scale, in which higher 
numerical values represent worse health outcomes. This approach was developed by 
Mejia et al. to assess the effects of promoting smokeless tobacco as a harm reduction 
strategy in the United States (24). Mejia et al. established a scale based on a panel of nine 
experts who were asked to assess the relative risk of mortality for users of a low-
nitrosamine smokeless tobacco product compared to cigarette smokers (9). The panel 
perceived the low-nitrosamine smokeless tobacco product to present at least a 90% 
reduction in relative risk. On the health effects scale, Mejia et al. intentionally ranked 
dual use of cigarettes and smokeless tobacco as less harmful than current cigarette 
smoking under the assumption that, if smokeless tobacco were promoted for harm 
reduction, dual users would reduce the number of cigarettes consumed upon uptake of 
smokeless tobacco.  
 
The outcomes in this model possess the same utility values employed by Mejia et al., 
excluding the value assigned to dual use. The model presented in this paper reflects 
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uncertainty with regard to whether dual use is likely to present reduced, equal, or 
increased harm when compared with combustible tobacco use (25). We established 
parameter values for dual use that reflect this uncertainty in consultation with a 
biostatistician to ensure that the distribution of the parameter values would, 
mathematically, operate properly within the model. The utility values employed in the 
model are presented in Table 4-1. For the sensitivity analysis, we assigned dual use a 
utility value that is greater than 100 – as opposed to maintaining a scale with a maximum 
value of 100 – because the panel of experts who provided data to inform Mejia et al.’s 
scale were told that a risk greater than that presented by cigarette use-only should be 
ranked higher than 100 (9). The 5th and 95th percentile values were used as minimum and 
maximum values in the analysis. In mathematical models, discounting is sometimes used 
to emphasize the present value costs and benefits over future costs and benefits (26). 
Conceptually, the outcomes on the health effects scale are already discounted. 
 
Table 4-1. Tobacco-related behavioral outcomes and their utility values 
 Mean Minimum Value Maximum Value 
Combustible use only 100 -  - 
Never use  0 - -  
Former use 5 1 15 
Smokeless use only 11 5  20 




We explain the rationale for selecting the parameter values used in the below. When 
available, we used relevant data to produce best-guess estimates for the parameters. In 
cases where relevant data were unavailable, the authors’ assumptions (clearly stated) 




There are no existing longitudinal studies conducted with a young adult population to 
inform the probability estimates in this model. Thus, we consulted other types of data to 
obtain reasonable probability estimates for the status quo scenario. When initiation 
estimates were not available, we used prevalence data in their place. Mendez, Warner and 
Courant (1998) have used this approach for modeling initiation in a cohort of 18 year 
olds (27); this approach was evaluated six years after the model was first employed, and 
observed data were found to fit the original model’s projections closely (28). Probability 
estimates for the status quo scenario, along with their rationales, can be found in Table 4-
2. 
 
No data were available to directly inform parameter estimates for the two other policy 
scenarios under consideration. Thus, the status quo parameter estimates served as a 
reference point for estimating the remaining probability values. In estimating these 
values, we considered the underlying assumption that flavoring in tobacco is an attractive 
trait that drives initiation and persistence of tobacco use. Calculations for these values are 
discussed below. Table 4-3 contains a summary of all parameter definitions.  
 
Ban	  on	  all	  flavored	  tobacco	  products	  
We assume that a ban on all flavored tobacco products impacts only individuals who 
would have initiated tobacco use with a flavored product under the status quo. Villanti et 
al. found that, among 18-34 year olds, 29.8% of current combustible tobacco users used a 
flavored combustible tobacco product in the past 30 days, and 8.2% of current smokeless 
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tobacco users used a flavored smokeless tobacco product in the past 30 days (29). For the 
present model, we employed these values as flavored tobacco initiation rates. In a 
previous study, Levy et al. modeled the effects of a menthol cigarette ban in the United 
States (30). The authors of this study examined three scenarios, in which menthol 
cigarette initiation rates were reduced by 10%, 20% and 30% after the implementation of 
the ban. We applied these values in the present model. As a baseline value, we assumed 
that 20% of individuals who would have initiated tobacco use with a flavored product 
under the status quo do not initiate tobacco use at all. We assumed the remaining 80% of 
these individuals initiate tobacco use with a nonflavored version of the product with 
which they would have otherwise initiated under the status quo. For the pessimistic and 
optimistic scenarios, we assumed 10% and 30% reductions in initiation, respectively. 
Values for the parameters representing the second behavioral transition in the model – in 
which tobacco initiators can switch products, become dual users, quit tobacco, or 
continue use of the product with which they initiated - are identical to their corresponding 
probabilities under the status quo.  
 
Ban	  on	  combustible	  flavored	  tobacco	  products	  
The model assumes that a ban on flavored combustible products impacts only those who 
would have used a flavored combustible product under the status quo. The parameter 
values for combustible tobacco initiation under this scenario are identical to those 
estimated for combustible tobacco initiation under a ban on all flavored tobacco products. 
However, because flavored smokeless tobacco is still available in this scenario, we 
assumed that some individuals who do not initiate combustible tobacco due to the ban 
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instead initiate smokeless tobacco use. This supposition is consistent with an analysis in 
which researchers examined cigarillo use trends among Canadian youth following a ban 
on flavored cigarillos (31). The results of this study showed that there was a reduction in 
the overall use of cigarillos after the ban, and that there was a small increase in the use of 
regular cigars, which were still permitted to be flavored. The authors suggested that the 
flavor ban produced a net decrease in cigar use, but that the increase in regular cigar use 
may have been an unintended consequence of the ban. Thus, as a baseline value for the 
first behavioral transition in the present model, half of the individuals who did not initiate 
combustible tobacco use due to the ban on flavored combustible tobacco products instead 
initiate smokeless tobacco use; the other half never initiate tobacco use. The low value 
for this parameter models a scenario in which all of the individuals who did not initiate 
combustible tobacco use due to the ban never initiate tobacco, and the high value models 
a scenario in which all of those individuals instead initiate smokeless tobacco use. 
 
For the second behavioral transition, because flavored smokeless tobacco products are 
available under this scenario, switching rates from combustible to smokeless products, as 
well as rates of dual use among combustible initiators, are higher than they are under the 
status quo. The model assumes that a 3% increase in the rates of switching to smokeless 
products and transitioning to dual use occurs compared to the status quo. The minimum 
and maximum values model 1% and 6% increases, respectively. The probability of 
quitting tobacco among combustible tobacco initiators remains constant when compared 
to the status quo. Among smokeless tobacco initiators, rates of switching to combustible 
tobacco and rates of dual use are lower than they are under the status quo. The model 
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assumes that a 3% decrease in switching rates to combustible products and transitioning 
to dual use occurs when compared to the status quo. The minimum and maximum values 
model 6% and 1% decreases, respectively. The probability of quitting tobacco among 
smokeless tobacco initiators remains constant when compared to the status quo.  
 
The estimates for the first and second behavioral transitions are not directly informed by 
data; they are intended to be conservative values. 
 
Analysis	  
We used TreeAgePro 2014 to calculate the expected utility for each policy option. To 
calculate the expected utility, TreeAgePro multiplies the value of each outcome for each 
branch by its estimated probability, and sums the products of those calculations for each 
branch of the tree. Lower expected utilities represent favorable (less harmful) outcomes 
in this analysis. We performed sensitivity analyses to assess the robustness of the 
expected utility calculations and to determine how the results of the decision tree changes 
given uncertainty in the data. We conducted univariate analyses on all variables with 
uncertain parameter values to identify the variables that drive the model and ensure that 
the model was operating as expected. Variables having the most impact on the model 
were investigated further in multivariate analyses.  
 
RESULTS	  
The output of this heuristic model found that, under the baseline scenario, the expected 
utility for the status quo was 18.91. This value was higher (representing increased harm) 
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when compared to the ban on combustible flavored tobacco products, which produced a 
utility value of 18.42, as well as the ban on all flavored tobacco products, which produced 
a utility value of 17.97. These relative rankings can be understood with regard to the 
unitless scale upon which the model’s outcome was based; a cohort of 100% 
combustible-only tobacco users would have produced an expected utility of 100, and a 
cohort of 100% never tobacco users would have produced an expected utility of 0.  
 
We conducted univariate sensitivity analyses and generated a tornado diagram. The 
analysis included all variables for which there was uncertainty. Figure 4-2 illustrates the 
main results of the analysis, and Appendix 4-1 contains detailed results. In Figure 4-2, 
the longest bars, located at the top of the diagram, represent variables that have the 
greatest impact on the model output. The hashed vertical line represents the expected 
utility value for the status quo. Bar extensions to the left of the hashed vertical line 
represent values lower than the expected utility value, and bar extensions to the right of 
the hashed vertical line represent values higher than the expected utility value. We 
identified nine variables that contributed to uncertainty in the expected values generated 
by the model, listed in Table 4-4. Three variables contributed 83% of the uncertainty in 
the model; these variables represented 1) the probability of combustible tobacco initiation 
under the status quo, 2) the probability of smokeless tobacco initiation under the status 
quo, and 3) the health effect associated with dual (combustible/smokeless) tobacco use.  
 
It is reasonable that these three variables were found to be the most impactful, which 
suggests that the model operated as expected. The first transition in the model, in which 
tobacco initiation occurs, is the major determinant of the terminal outcome. That is, there 
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is substantially less switching between branches during the second behavioral transition, 
as opposed to the first. Of the first transitions, the probability of combustible tobacco 
initiation and the probability of smokeless tobacco initiation under the status quo have the 
widest high/low ranges; this occurred by design, as we used the tobacco initiation rates 
from the status quo scenario to inform the tobacco initiation rates for the ban on all 
flavored tobacco products and the ban on combustible flavored tobacco products based 
on those for the status quo. Thus, the uncertainty about the first transition values under 
the status quo should be understood to reflect uncertainty about the first transition 
probabilities under the other scenarios. With regard to the uncertainty around the health 
effect associated with dual (combustible/smokeless) tobacco use – this parameter was 
specifically intended to be uncertain and impactful upon model results. These results 
indicate that the model operated at expected.  
 
To address 83% of the uncertainty in the model, we further investigated the probability of 
combustible tobacco initiation under the status quo, the probability of smokeless tobacco 
initiation under the status quo, and the health effect associated with dual 
(combustible/smokeless) tobacco use. For the multivariate analyses, we conducted three 
two-way analyses, where each variable under consideration was analyzed along with each 
of the other two variables of interest. Appendix 4-2 contains the complete results of these 
analyses.  
 
In the analysis that varied the probability of combustible tobacco initiation under the 
status quo and the probability of smokeless tobacco initiation under the status quo, the 
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most favorable expected value was 16.53 and the least favorable expected value was 
21.58. We examined seventy-five combinations of values for the two parameters. For 8% 
of the combinations, the expected utility values changed such that the most favorable 
policy option was the status quo, as opposed to a ban on all flavored tobacco products. 
The expected utility values can be found in Appendix 4-2. This finding reinforces the 
importance of obtaining valid data to inform the initial transition probabilities. 
 
When we varied the health effect of dual use with the initial transition probabilities, 
13.3% of the combinations of values changed the preferred policy option such that a ban 
on combustible products would be favored, and 2.7% of the combinations of values 
changed the preferred decision such that the status quo would be favored. The changes in 
the preferred decision option do not occur when the health effect of dual use is only 
modeled to be slightly more or less harmful than combustible tobacco use-only; they 
occur at the extreme values assigned to the health effect outcome for dual use. In order to 
bolster confidence in the results, it is necessary to conduct research to determine whether 
dual users of combustible and smokeless products are likely to be exposed to more or less 








The results of this analysis found that, given the structural and parameter assumptions 
upon which this model was built, a ban on all flavored tobacco products would likely 
produce the most favorable outcome when compared to a ban on combustible flavored 
products or the status quo. In the base case scenario, the expected utilities for the status 
quo, ban on combustible flavored tobacco products, and ban on all flavored tobacco 
products were 18.91, 18.42 and 17.97, respectively. The scale from which these values 
were derived represented informed best guesses by experts about the relative harm 
associated with tobacco use behaviors included in this model. While the difference 
between the highest and lowest expected utilities (0.94) was small, when applied to the 
model’s large hypothetical cohort of young adults in the United States, a small 
improvement in the outcome value represents health benefits to a substantial number of 
individuals.  
 
In the sensitivity analysis, three parameters were found to account for 83% of the 
uncertainty in the model: 1) the probability of combustible tobacco initiation under the 
status quo, 2) the probability of smokeless tobacco initiation under the status quo, and 3) 
the health effect associated with dual (combustible/smokeless) tobacco use. In the 
Table 4-4. Variables that contribute to model uncertainty, listed in descending order of importance 
Variable 
Risk Percent* Cumulative 
Risk Percent* 
Probability of combustible tobacco use - status quo 0.46717182 0.46717182 
Probability of ST initiation - status quo 0.220366608 0.687538428 
Health effect from dual use 0.147320554 0.834858982 
Probability of switching to ST use among combustible initiators - status quo 0.053534168 0.88839315 
Probability of quitting tobacco use among combustible initiators - status quo 0.050409557 0.938802708 
Health effect from ST use 0.038872179 0.977674886 
Probability of quitting tobacco use among ST initiators - status quo 0.01597113 0.993646016 
Health effect from former tobacco use 0.003301299 0.996947315 
Probability of continuing to use ST among ST initiators - status quo 0.003052685 1 
*The Risk Percent measures the total uncertainty represented by the variable. The Cumulative Risk Percent is a 
cumulative version of the Risk Percent. 
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multivariate analysis, the rankings of the decision options changed for 13.3% of 
combinations of values tested across the three two-way analyses. These findings suggest 
that implementing at least one of the bans is likely to produce a favorable health effect at 
the population level; however, there is a small chance that implementing a ban could 
cause a negative health effect.  
 
Assumptions about parameter values contributed to uncertainty in the results, and 
research should be conducted to address this uncertainty for future iterations of the 
model. The Methods section, and specifically Table 4-2, provides an overview of the 
data that were available to inform the parameters in this model. This overview highlights 
the lack of directly relevant, generalizable data to inform this model. For example, 
prevalence data were used to inform parameters representing initiation in this model.  
Future studies should collect product- and flavor-specific data that explicitly investigates 
tobacco experimentation and initiation behaviors, as well as longitudinal data to track use 
over time. In general, the lack of data available to inform directly the parameter estimates 
emphasizes the need to monitor polytobacco use patterns in order to gain a better 
understanding of the types of products with which non-users initiate tobacco use, and the 
extent to which adding or removing certain products from the marketplace is likely to 
increase or decrease exposure to harm.  
 
Structural assumptions also contributed to uncertainty in the results of this analysis. This 
model presents a simplified version of the environment in which tobacco use occurs and 
the factors impacting tobacco use in a number of ways. For example, representing 
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tobacco use behaviors with only two opportunities for individuals in the model transition 
behaviors – as well as assuming that tobacco use behaviors are unchanged after T15 – 
does not reflect actual tobacco use patterns. Conceptually, a Markov model may better 
represent tobacco use behaviors over time.  However, data were not available to support 
the development of a Markov model. As better data become available, the decision tree 
that we present in this paper can be used as a framework to inform a model that reflects 
more complex behavior changes over time.  
 
Given the limited availability of data to inform the model, we aimed to be conservative in 
estimating the effects of the policies under consideration. That is, the estimated impact of 
the two product bans would likely be greater than the results of this model indicate. First, 
by focusing on a young adult cohort, we did not assess the impact of the policies for other 
age groups. We chose the young adult cohort because this group is likely to experience 
the greatest impact from a ban on flavored tobacco products. However, if the FDA were 
to implement either of the bans considered in this model, other age groups would likely 
experience effects, as well. Thus, the impact of the bans would likely be greater than this 
model suggests. Second, this model did not examine the effects of the policies on 
individuals who initiated tobacco use prior to T0. It is likely that individuals already using 
flavored tobacco products– particularly those using flavored products exclusively – might 
quit tobacco or reduce their tobacco use if their flavored product of choice were banned.  
 
This model was also, perhaps, conservative in its assumptions about the health effects of 
dual use, which contributes to the finding that a ban on all flavored products is likely 
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preferred to a ban on combustible flavored products. For the health effect of dual use, we 
assigned a range of utility values representing a possible 13% decrease or 10% increase 
in harm when compared to combustible-only users. We chose these values to capture 
uncertainty with regard to whether dual users are more or less likely to be exposed to 
harm than combustible-only users.  In the sensitivity analysis, when we employed the 
lower value for the health effect of dual use (representing a 13% decrease in harm) 
alongside varied values for the initial transition probabilities, a ban on combustible 
flavored products was sometimes preferred over a ban on all flavored products. This is 
notable because the outcome values in this model do not take intensity or frequency of 
tobacco use into consideration. In actuality, if a dual user significantly reduces 
combustible use, the reduction in harm when compared to combustible-only use could be 
much more significant than the values in the current model reflect. Thus, a model that 
incorporates changes in intensity and frequency of tobacco use may find that a harm 
reduction approach is a preferred over a ban on all flavored combustible products.  
 
This model provides a framework for examining regulatory approaches intended to 
reduce the attractiveness of tobacco products. It weighs the impact of reducing the 
attractiveness of some products but not others, while taking into consideration the 
varying levels of risk that those different products present. This model could be adjusted 
to address a range of policy issues. For example, in the proposed ruling published in 
April 2014, the FDA asks, “Does one's use of fruit and candy-flavored nicotine liquids 
impact the likelihood that such individual will initiate use of combustible tobacco 
products and/or become a dual user with combustible tobacco products? How should that 
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affect FDA's regulatory decisions regarding e-cigarettes (2)?” The model presented in 
this paper could be built upon to address this question directly. 
 
CONCLUSION	  
This heuristic model synthesizes the best available evidence to provide decision-makers 
with data on potential approaches to regulating the sale of flavored tobacco products. 
While this model was limited by the research available to inform its parameter values, it 
provides a framework for examining regulatory approaches intended to reduce the 
attractiveness of tobacco products. It weighs the impact of reducing the attractiveness of 
some products but not others, while taking into consideration the varying levels of risk 
that different products present. Thus, as additional data is collected, this model can be 
updated. Models such as this one may serve as an important resource for policymakers at 













Table 4-2. Probability estimates – status quo scenario 
Pathway Definition Base Case Estimate 
(Range) 







0.167 (0.148-0.187) The 2013 Youth Risk Behavior Survey estimated that 16.7% 
(95% CI: 14.8-18.7) of 12th grade students smoked a cigar in 










0.695 (0.532-0.8415) The 2012 National Adult Tobacco Survey estimated that, 
among adults aged 18+ using tobacco, 92.08% use 
combustible products only (33). This figure includes those who 
initiated with smokeless products but no longer use them, as 
well as data for older adults; thus, this estimate may be high. A 
longitudinal study conducted in Oregon in which 7th and 9th 
grade boys were followed over two years between 1994 and 
1999 found that, of individuals who used cigarettes at the first 
time point, 47% used cigarettes and not smokeless tobacco at 
the second time point (34). Given the brief follow up period 
and the potentially dated nature of the data, this estimate may 
be low. An average of these two estimates was calculated in 
order to obtain the base case value for this parameter.  The 
lower and upper parameter values were estimated based on 
the upper and lower values for the other parameters.  







0.132 (0.025-0.24) The 2012 National Adult Tobacco Survey estimated that, 
among adults aged 18+ using tobacco, 2.448% use 
combustible products only (33). This figure includes those who 
initiated with smokeless products but no longer use them. A 
longitudinal study conducted in Oregon in which 7th and 9th 
grade boys were followed over two years between 1994 and 
1999 found that, of individuals who used cigarettes at the first 
time point, 24% were using both combustible and smokeless 
tobacco (34). An average of these two estimates was 
calculated in order to obtain the base case value for this 
parameter. 








0.033 (0.0165-0.066) The estimate for the base case value was obtained by 
subtracting the sum of the other parameters from 1. The upper 
and lower parameter values were estimated to be twice as 
large at the base case value, and half as large as the base 
case value, respectively.   









0.14 (0.117-0.162) Among 16-17 year olds who initiated tobacco use with 
cigarettes (as opposed to initiating with smokeless tobacco or 
with cigarettes and smokeless tobacco at the same time), 
48.6% (95% CI: 46.3-50.9) smoked at least 100 cigarettes in 
their lifetime, and 42.8 (95% CI: 40.5-45.2) were current 
cigarette smokers (past 30 days) (22). Therefore, we assume 
that, among those who initiate tobacco use with cigarettes, 
smoking “doesn’t stick” at this age for 5.8% of the sample 
(math: 48.6%-41.8% = 5.8%). This number may be high, as 
16-17 year olds still may develop regular cigarette smoking 
habits as older adolescents and young adults. It has also been 
estimated that 8.2% (95% CI: 5.9-10.5) of 18-24 year olds 
recently achieved smoking cessation (35); this was among 
current smokers who smoked for at least 2 years and former 
smokers who quit in the past year. Among individuals who 
initiate with combustible tobacco use, and taking into 
consideration both individuals who develop regular smoking 
habits and those who do not, we assume that 14% will quit 
tobacco use by age 24 (math: 5.8% + 8.2% = 14%).  The 
 107 
Table 4-2. Probability estimates – status quo scenario 
lower and higher values of the confidence intervals for these 
estimates were used to obtain the lower and higher parameter 
values in a similar fashion. 




0.094 (0.079-0.113) The 2013 Youth Risk Behavior Survey estimated that 9.4% 
(95% CI: 7.9-11.3) of 12th graders had used smokeless 










0.386 (0.376-0.397) The 2003, 2005 and 2007 National Surveys on Drug Use and 
Health found that, among adults age 18+ who initiated with 
smokeless tobacco, 48.8% (95% CI: 46.7-50.8) had smoked at 
least 100 cigarettes in their lifetime (22). We assume, then, 
that 51.2% (math: 100%-48.8%) of smokeless tobacco 
initiators never “make it” to dual use. A longitudinal study 
conducted in Oregon in which 7th and 9th grade boys were 
followed over two years between 1994 and 1999 found that, of 
individuals who used smokeless tobacco at the first time point, 
26% reported continuing with smokeless tobacco use only at 
follow up (34). An average of these two values was calculated 
to obtain the base case value for this parameter. The lower 
and higher values of the confidence interval for the NSDUH 
estimate were averaged with 26% to obtain the lower and 
higher parameter values.  







0.33 (0.153-0.435) The 2003, 2005 and 2007 National Surveys on Drug Use and 
Health found that, among 16-17 year olds who initiated with 
smokeless tobacco, 18.4% (95% CI: 14.4-23.0) were current 
cigarette smokers (22). This includes both dual users and 
those who switched to cigarettes, so this would be a high 
estimate of dual use. At the same time, this figure only 
includes 16-17 year olds; some individuals will develop dual 
use habits as older adolescents and young adults. Among 
adults aged 18+ in the same sample, 27.9% (95% CI: 25.9-
30.0) of those who initiated with smokeless tobacco were 
current cigarette smokers (22). A longitudinal study conducted 
in Oregon in which 7th and 9th grade boys were followed over 
two years between 1994 and 1999 found that, of individuals 
who used smokeless tobacco at the first time point, 40% 
reported dual use at follow up (34). Additionally, one study 
looking at middle and high school students found that 60.2% 
(95% CI: 50.0-69.6) of current smokeless tobacco users were 
also current cigarette users (23). Taking all of these estimates 
into consideration, We assume that 33% of those who initiate 
with smokeless tobacco will become dual users as a base 
case estimate. The lower and upper parameter values were 
estimated based on the upper and lower values for the other 
parameters. 
 








0.144 (0.072-0.288) The estimate for the base case value was obtained by 
subtracting the sum of the other parameters from 1.  The 
upper and lower parameter values were estimated to be twice 
as large at the base case value, and half as large as the base 
case value, respectively.   









0.14 (0.117-0.162) It is unknown whether individuals who initiate with smokeless 
tobacco are more or less likely than those who initiate with 
combustible tobacco to quit tobacco by age 24. Therefore, we 
assume the probability of quitting tobacco altogether is the 
same between these two groups.  
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Table 4-2. Probability estimates – status quo scenario 
Never initiation Probability of 
never initiating 
tobacco use 
0.739 (0.70-0.773) This estimation was obtained by subtracting the number of 
combustible and smokeless initiators from the total sample. 
This number is close to the number of high school students 
who were estimated never to have tried any tobacco product in 
2012 (76.7%) (35), so it is likely a good estimate. The lower 
and upper parameter values were estimated based on the 
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Health effect from combustible tobacco use 100 100 100 
Health effect from dual (combustible/smokeless) tobacco use 100 87 110 
Health effect from never tobacco use 0 0 0 
Health effect from former tobacco use 5 0 5 
Health effect from smokeless tobacco use 11 5 20 
Probability of initiating combustible use - ban on all flavored tobacco products 0.157 0.152 0.162 
Probability of ST initiation - ban of all flavored tobacco products 0.092 0.092 0.093 
Probability of initiating combustible tobacco use - ban on flavored combustible tobacco products 0.157 0.152 0.162 
Probability of dual use among combustible initiators – ban on combustible flavored products 0.136 0.133 0.14 
Probability of quitting tobacco among  combustible initiators - ban on combustible flavored products 0.14 0.117 0.162 
Probability of smokeless tobacco use among combustible initiators - ban on combustible flavored products 0.034 0.033 0.035 
Probability of initiating with smokeless tobacco - ban on combustible flavored products 0.099 0.094 0.104 
Probability of combustible use among ST initiators - ban on combustible flavored products 0.140 0.135 0.143 
Probability of quitting tobacco among ST initiators - ban on combustible flavored products 0.14 0.117 0.162 
Probability of continuing ST use among ST initiators - ban on combustible flavored products 0.374 0.363 0.382 
Probability of combustible tobacco use - status quo 0.167 0.148 0.187 
Probability of dual use among combustible initiators - status quo and ban on all flavored tobacco products  0.132 0.025 0.24 
Probability of quitting tobacco use among combustible initiators - status quo and ban on all flavored tobacco products 0.14 0.117 0.162 
Probability of switching to ST use among combustible initiators - status quo and ban on all flavored tobacco products 0.033 0.0165 0.066 
Probability of ST initiation – status quo 0.094 0.079 0.113 
Probability of switching to combustible use among ST users - status quo and ban on all flavored tobacco products 0.144 0.072 0.288 
Probability of quitting tobacco use among ST initiators - status quo and ban on all flavored tobacco products 0.14 0.117 0.162 
Probability of continuing to use ST among ST initiators - status quo and ban on all flavored tobacco products 0.386 0.376 0.397 




Figure 4-2. Tornado sensitivity analysis 
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Appendix 4-1. Results from the univariate sensitivity analysis - TreeAgePro output 
Variable VARIABLE 
RANGE 
LOW VALUE HIGH 
VALUE 
SPREAD SPREAD SQR RISK PCT CUMUL PCT VARIABLE 
INDEX 
Probability of combustible tobacco use 
under the status quo 
0.148 to 0.187 18.410831 20.584205 2.173374 4.723554544 0.46717182 0.46717182 0 
Probability of ST initiation under the status 
quo 
0.079 to 0.113 18.410831 19.903519 1.492688 2.228117465 0.220366608 0.687538428 1 
Health effect associated with dual 
(combustible/smokeless) tobacco use 
87.0 to 110.0 18.219113 19.439585 1.220472 1.489551903 0.147320554 0.834858982 2 
Probability of switching to ST use among 
combustible initiators under the status quo 
and when all flavored products are banned 
0.0165 to 0.066 18.418466 19.1541845 0.7357185 0.541281711 0.053534168 0.88839315 3 
Probability of quitting tobacco use among 
combustible initiators under the status quo 
and when all flavored products are banned 
0.117 to 0.162 18.559915 19.27384 0.713925 0.509688906 0.050409557 0.938802708 4 
Health effect associated with smokeless 
tobacco use 
5.0 to 20.0 18.658175 19.2851 0.626925 0.393034956 0.038872179 0.977674886 5 
Probability of quitting tobacco use among 
ST initiators under the status quo and 
when all flavored products are banned 
0.117 to 0.162 18.712485 19.114335 0.40185 0.161483423 0.01597113 0.993646016 6 
Health effect associated with former 
tobacco use 
0.0 to 5.0 18.726245 18.908945 0.1827 0.03337929 0.003301299 0.996947315 7 
Probability of continuing to use ST among 
ST initiators under the status quo and 
when all flavored products are banned 
0.376 to 0.397 18.816919 18.992605 0.175686 0.030865571 0.003052685 1 8 
Probability of dual use among combustible 
initiators under the status quo and when all 
flavored products are banned 
0.025 to 0.24 18.908945 18.908945 3.55271E-15 1.26218E-29 1.24833E-30 1 9 
Probability of quitting tobacco among ST 
initiators under a ban on flavored 
combustible tobacco products 
0.117 to 0.162 18.908945 18.908945 0 0 0 1 10 
Probability of continuing ST use among ST 
initiators under a ban of flavored 
combustible tobacco products 
0.363 to 0.382 18.908945 18.908945 0 0 0 1 11 
Probability of ST initiation under a ban of 
all flavored tobacco products 
0.092 to 0.093 18.908945 18.908945 0 0 0 1 12 
Probability of initiating combustible use 
under a ban on all flavored tobacco 
products 
0.152 to 0.162 18.908945 18.908945 0 0 0 1 13 
Probability of switching to combustible use 0.072 to 0.288 18.908945 18.908945 0 0 0 1 14 
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among ST users under the status quo and 
when all flavored products are banned 
Probability of combustible use among ST 
initiators, given flavored combustible ban 
0.135 to 0.143 18.908945 18.908945 0 0 0 1 15 
Probability of dual use among combustible 
initiators, given a flavored combustible ban 
0.133 to 0.14 18.908945 18.908945 0 0 0 1 16 
Probability of quitting tobacco among those 
who initiated with combustible tobacco, 
under a flavored combustible ban 
0.117 to 0.162 18.908945 18.908945 0 0 0 1 17 
Probability of initiating with smokeless 
tobacco, given a flavored combustible ban 
0.094 to 0.104 18.908945 18.908945 0 0 0 1 18 
Probability of initiating combustible tobacco 
use, given a ban on flavored combustible 
tobacco products 
0.152 to 0.162 18.908945 18.908945 0 0 0 1 19 
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Appendix 4-2. Results from the multivariate sensitivity analysis – TreeAgePro output  











status quo STRATEGY 
Expected 
utility value 
87 0.187 Ban on all flavored tobacco products 17.302531 
87 0.17725 Ban on all flavored tobacco products 17.302531 
87 0.1675 Ban on all flavored tobacco products 17.302531 
87 0.15775 Ban on all flavored tobacco products 17.302531 
87 0.148 Ban on all flavored tobacco products 17.302531 
92.75 0.187 Ban on all flavored tobacco products 17.596264 
92.75 0.17725 Ban on all flavored tobacco products 17.596264 
92.75 0.1675 Ban on all flavored tobacco products 17.596264 
92.75 0.15775 Ban on all flavored tobacco products 17.596264 
92.75 0.148 Ban on all flavored tobacco products 17.596264 
98.5 0.187 Ban on all flavored tobacco products 17.889997 
98.5 0.17725 Ban on all flavored tobacco products 17.889997 
98.5 0.1675 Ban on all flavored tobacco products 17.889997 
98.5 0.15775 Ban on all flavored tobacco products 17.889997 
98.5 0.148 Ban on all flavored tobacco products 17.889997 
104.25 0.187 Ban on all flavored tobacco products 18.18373 
104.25 0.17725 Ban on all flavored tobacco products 18.18373 
104.25 0.1675 Ban on all flavored tobacco products 18.18373 
104.25 0.15775 Ban on all flavored tobacco products 18.18373 
104.25 0.148 Ban on all flavored tobacco products 18.18373 
110 0.187 Ban on all flavored tobacco products 18.477463 
110 0.17725 Ban on all flavored tobacco products 18.477463 
110 0.1675 Ban on all flavored tobacco products 18.477463 
110 0.15775 Ban on all flavored tobacco products 18.477463 
110 0.148 Ban on all flavored tobacco products 18.477463 
87 0.187 Ban on combustible flavored tobacco products 17.687953 
87 0.17725 Ban on combustible flavored tobacco products 17.687953 
87 0.1675 Ban on combustible flavored tobacco products 17.687953 
87 0.15775 Ban on combustible flavored tobacco products 17.687953 
87 0.148 Ban on combustible flavored tobacco products 17.687953 
92.75 0.187 Ban on combustible flavored tobacco products 18.0076875 
92.75 0.17725 Ban on combustible flavored tobacco products 18.0076875 
92.75 0.1675 Ban on combustible flavored tobacco products 18.0076875 
92.75 0.15775 Ban on combustible flavored tobacco products 18.0076875 
92.75 0.148 Ban on combustible flavored tobacco products 18.0076875 
98.5 0.187 Ban on combustible flavored tobacco products 18.327422 
98.5 0.17725 Ban on combustible flavored tobacco products 18.327422 
98.5 0.1675 Ban on combustible flavored tobacco products 18.327422 
98.5 0.15775 Ban on combustible flavored tobacco products 18.327422 
98.5 0.148 Ban on combustible flavored tobacco products 18.327422 
104.25 0.187 Ban on combustible flavored tobacco products 18.6471565 
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104.25 0.17725 Ban on combustible flavored tobacco products 18.6471565 
104.25 0.1675 Ban on combustible flavored tobacco products 18.6471565 
104.25 0.15775 Ban on combustible flavored tobacco products 18.6471565 
104.25 0.148 Ban on combustible flavored tobacco products 18.6471565 
110 0.187 Ban on combustible flavored tobacco products 18.966891 
110 0.17725 Ban on combustible flavored tobacco products 18.966891 
110 0.1675 Ban on combustible flavored tobacco products 18.966891 
110 0.15775 Ban on combustible flavored tobacco products 18.966891 
110 0.148 Ban on combustible flavored tobacco products 18.966891 
87 0.148 Status quo (no ban) 16.66022 
92.75 0.148 Status quo (no ban) 16.950917 
98.5 0.148 Status quo (no ban) 17.241614 
87 0.15775 Status quo (no ban) 17.46017825 
104.25 0.148 Status quo (no ban) 17.532311 
92.75 0.15775 Status quo (no ban) 17.7582755 
110 0.148 Status quo (no ban) 17.823008 
98.5 0.15775 Status quo (no ban) 18.05637275 
87 0.1675 Status quo (no ban) 18.2601365 
104.25 0.15775 Status quo (no ban) 18.35447 
92.75 0.1675 Status quo (no ban) 18.565634 
110 0.15775 Status quo (no ban) 18.65256725 
98.5 0.1675 Status quo (no ban) 18.8711315 
87 0.17725 Status quo (no ban) 19.06009475 
104.25 0.1675 Status quo (no ban) 19.176629 
92.75 0.17725 Status quo (no ban) 19.3729925 
110 0.1675 Status quo (no ban) 19.4821265 
98.5 0.17725 Status quo (no ban) 19.68589025 
87 0.187 Status quo (no ban) 19.860053 
104.25 0.17725 Status quo (no ban) 19.998788 
92.75 0.187 Status quo (no ban) 20.180351 
110 0.17725 Status quo (no ban) 20.31168575 
98.5 0.187 Status quo (no ban) 20.500649 
104.25 0.187 Status quo (no ban) 20.820947 
110 0.187 Status quo (no ban) 21.141245 
 
 









ST initiation - 
status quo STRATEGY 
Expected 
utility value 
87 0.113 Ban on all flavored tobacco products 17.302531 
87 0.1045 Ban on all flavored tobacco products 17.302531 
87 0.096 Ban on all flavored tobacco products 17.302531 
87 0.0875 Ban on all flavored tobacco products 17.302531 
87 0.079 Ban on all flavored tobacco products 17.302531 
92.75 0.113 Ban on all flavored tobacco products 17.596264 
92.75 0.1045 Ban on all flavored tobacco products 17.596264 
92.75 0.096 Ban on all flavored tobacco products 17.596264 
92.75 0.0875 Ban on all flavored tobacco products 17.596264 
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92.75 0.079 Ban on all flavored tobacco products 17.596264 
98.5 0.113 Ban on all flavored tobacco products 17.889997 
98.5 0.1045 Ban on all flavored tobacco products 17.889997 
98.5 0.096 Ban on all flavored tobacco products 17.889997 
98.5 0.0875 Ban on all flavored tobacco products 17.889997 
98.5 0.079 Ban on all flavored tobacco products 17.889997 
104.25 0.113 Ban on all flavored tobacco products 18.18373 
104.25 0.1045 Ban on all flavored tobacco products 18.18373 
104.25 0.096 Ban on all flavored tobacco products 18.18373 
104.25 0.0875 Ban on all flavored tobacco products 18.18373 
104.25 0.079 Ban on all flavored tobacco products 18.18373 
110 0.113 Ban on all flavored tobacco products 18.477463 
110 0.1045 Ban on all flavored tobacco products 18.477463 
110 0.096 Ban on all flavored tobacco products 18.477463 
110 0.0875 Ban on all flavored tobacco products 18.477463 
110 0.079 Ban on all flavored tobacco products 18.477463 
87 0.113 Ban on combustible flavored tobacco products 17.687953 
87 0.1045 Ban on combustible flavored tobacco products 17.687953 
87 0.096 Ban on combustible flavored tobacco products 17.687953 
87 0.0875 Ban on combustible flavored tobacco products 17.687953 
87 0.079 Ban on combustible flavored tobacco products 17.687953 
92.75 0.113 Ban on combustible flavored tobacco products 18.0076875 
92.75 0.1045 Ban on combustible flavored tobacco products 18.0076875 
92.75 0.096 Ban on combustible flavored tobacco products 18.0076875 
92.75 0.0875 Ban on combustible flavored tobacco products 18.0076875 
92.75 0.079 Ban on combustible flavored tobacco products 18.0076875 
98.5 0.113 Ban on combustible flavored tobacco products 18.327422 
98.5 0.1045 Ban on combustible flavored tobacco products 18.327422 
98.5 0.096 Ban on combustible flavored tobacco products 18.327422 
98.5 0.0875 Ban on combustible flavored tobacco products 18.327422 
98.5 0.079 Ban on combustible flavored tobacco products 18.327422 
104.25 0.113 Ban on combustible flavored tobacco products 18.6471565 
104.25 0.1045 Ban on combustible flavored tobacco products 18.6471565 
104.25 0.096 Ban on combustible flavored tobacco products 18.6471565 
104.25 0.0875 Ban on combustible flavored tobacco products 18.6471565 
104.25 0.079 Ban on combustible flavored tobacco products 18.6471565 
110 0.113 Ban on combustible flavored tobacco products 18.966891 
110 0.1045 Ban on combustible flavored tobacco products 18.966891 
110 0.096 Ban on combustible flavored tobacco products 18.966891 
110 0.0875 Ban on combustible flavored tobacco products 18.966891 
110 0.079 Ban on combustible flavored tobacco products 18.966891 
87 0.079 Status quo (no ban) 17.498273 
92.75 0.079 Status quo (no ban) 17.7749285 
87 0.0875 Status quo (no ban) 17.906749 
98.5 0.079 Status quo (no ban) 18.051584 
92.75 0.0875 Status quo (no ban) 18.19953325 
87 0.096 Status quo (no ban) 18.315225 
104.25 0.079 Status quo (no ban) 18.3282395 
98.5 0.0875 Status quo (no ban) 18.4923175 
110 0.079 Status quo (no ban) 18.604895 
92.75 0.096 Status quo (no ban) 18.624138 
 119 
87 0.1045 Status quo (no ban) 18.723701 
104.25 0.0875 Status quo (no ban) 18.78510175 
98.5 0.096 Status quo (no ban) 18.933051 
92.75 0.1045 Status quo (no ban) 19.04874275 
110 0.0875 Status quo (no ban) 19.077886 
87 0.113 Status quo (no ban) 19.132177 
104.25 0.096 Status quo (no ban) 19.241964 
98.5 0.1045 Status quo (no ban) 19.3737845 
92.75 0.113 Status quo (no ban) 19.4733475 
110 0.096 Status quo (no ban) 19.550877 
104.25 0.1045 Status quo (no ban) 19.69882625 
98.5 0.113 Status quo (no ban) 19.814518 
110 0.1045 Status quo (no ban) 20.023868 
104.25 0.113 Status quo (no ban) 20.1556885 















ST initiation - 
status quo STRATEGY 
Expected 
utility value 
0.187 0.113 Ban on all flavored tobacco products 17.966623 
0.187 0.1045 Ban on all flavored tobacco products 17.966623 
0.187 0.096 Ban on all flavored tobacco products 17.966623 
0.187 0.0875 Ban on all flavored tobacco products 17.966623 
0.187 0.079 Ban on all flavored tobacco products 17.966623 
0.17725 0.113 Ban on all flavored tobacco products 17.966623 
0.17725 0.1045 Ban on all flavored tobacco products 17.966623 
0.17725 0.096 Ban on all flavored tobacco products 17.966623 
0.17725 0.0875 Ban on all flavored tobacco products 17.966623 
0.17725 0.079 Ban on all flavored tobacco products 17.966623 
0.1675 0.113 Ban on all flavored tobacco products 17.966623 
0.1675 0.1045 Ban on all flavored tobacco products 17.966623 
0.1675 0.096 Ban on all flavored tobacco products 17.966623 
0.1675 0.0875 Ban on all flavored tobacco products 17.966623 
0.1675 0.079 Ban on all flavored tobacco products 17.966623 
0.15775 0.113 Ban on all flavored tobacco products 17.966623 
0.15775 0.1045 Ban on all flavored tobacco products 17.966623 
0.15775 0.096 Ban on all flavored tobacco products 17.966623 
0.15775 0.0875 Ban on all flavored tobacco products 17.966623 
0.15775 0.079 Ban on all flavored tobacco products 17.966623 
0.148 0.113 Ban on all flavored tobacco products 17.966623 
0.148 0.1045 Ban on all flavored tobacco products 17.966623 
0.148 0.096 Ban on all flavored tobacco products 17.966623 
0.148 0.0875 Ban on all flavored tobacco products 17.966623 
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0.148 0.079 Ban on all flavored tobacco products 17.966623 
0.187 0.113 Ban on combustible flavored tobacco products 18.410831 
0.187 0.1045 Ban on combustible flavored tobacco products 18.410831 
0.187 0.096 Ban on combustible flavored tobacco products 18.410831 
0.187 0.0875 Ban on combustible flavored tobacco products 18.410831 
0.187 0.079 Ban on combustible flavored tobacco products 18.410831 
0.17725 0.113 Ban on combustible flavored tobacco products 18.410831 
0.17725 0.1045 Ban on combustible flavored tobacco products 18.410831 
0.17725 0.096 Ban on combustible flavored tobacco products 18.410831 
0.17725 0.0875 Ban on combustible flavored tobacco products 18.410831 
0.17725 0.079 Ban on combustible flavored tobacco products 18.410831 
0.1675 0.113 Ban on combustible flavored tobacco products 18.410831 
0.1675 0.1045 Ban on combustible flavored tobacco products 18.410831 
0.1675 0.096 Ban on combustible flavored tobacco products 18.410831 
0.1675 0.0875 Ban on combustible flavored tobacco products 18.410831 
0.1675 0.079 Ban on combustible flavored tobacco products 18.410831 
0.15775 0.113 Ban on combustible flavored tobacco products 18.410831 
0.15775 0.1045 Ban on combustible flavored tobacco products 18.410831 
0.15775 0.096 Ban on combustible flavored tobacco products 18.410831 
0.15775 0.0875 Ban on combustible flavored tobacco products 18.410831 
0.15775 0.079 Ban on combustible flavored tobacco products 18.410831 
0.148 0.113 Ban on combustible flavored tobacco products 18.410831 
0.148 0.1045 Ban on combustible flavored tobacco products 18.410831 
0.148 0.096 Ban on combustible flavored tobacco products 18.410831 
0.148 0.0875 Ban on combustible flavored tobacco products 18.410831 
0.148 0.079 Ban on combustible flavored tobacco products 18.410831 
0.148 0.079 Status quo (no ban) 16.532258 
0.148 0.0875 Status quo (no ban) 16.977199 
0.15775 0.079 Status quo (no ban) 17.34894725 
0.148 0.096 Status quo (no ban) 17.42214 
0.15775 0.0875 Status quo (no ban) 17.79388825 
0.148 0.1045 Status quo (no ban) 17.867081 
0.1675 0.079 Status quo (no ban) 18.1656365 
0.15775 0.096 Status quo (no ban) 18.23882925 
0.148 0.113 Status quo (no ban) 18.312022 
0.1675 0.0875 Status quo (no ban) 18.6105775 
0.15775 0.1045 Status quo (no ban) 18.68377025 
0.17725 0.079 Status quo (no ban) 18.98232575 
0.1675 0.096 Status quo (no ban) 19.0555185 
0.15775 0.113 Status quo (no ban) 19.12871125 
0.17725 0.0875 Status quo (no ban) 19.42726675 
0.1675 0.1045 Status quo (no ban) 19.5004595 
0.187 0.079 Status quo (no ban) 19.799015 
0.17725 0.096 Status quo (no ban) 19.87220775 
0.1675 0.113 Status quo (no ban) 19.9454005 
0.187 0.0875 Status quo (no ban) 20.243956 
0.17725 0.1045 Status quo (no ban) 20.31714875 
0.187 0.096 Status quo (no ban) 20.688897 
0.17725 0.113 Status quo (no ban) 20.76208975 
0.187 0.1045 Status quo (no ban) 21.133838 
0.187 0.113 Status quo (no ban) 21.578779 
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ABSTRACT	  
Introduction: The goals of this study were to determine acceptable ceiling costs for two 
policies that the FDA might consider to regulate the sale of flavored tobacco products in 
the United States, and to identify the minimum effectiveness standards at which these 
interventions would be considered cost-effective and cost-saving. 
Methods: Using a cost-utility analytic framework, we employed threshold analyses to 
establish cost and performance standards for two regulatory options: 1) a ban on the sale 
of flavored combustible tobacco products, and 2) a ban on the sale of all flavored tobacco 
products. We used a previously developed mathematical model to estimate the reduction 
in the number of adult smokers expected to occur 15 years after the implementation of 
each policy. We conducted sensitivity analyses to examine the results given pessimistic 
and optimistic parameter assumptions.  
Results: The maximum acceptable costs for a ban on the sale of flavored combustible 
tobacco products and a ban on the sale of all flavored tobacco products were calculated to 
be $18.7 ($16.2-$104.8) billion and $35.5 ($15.3–$337.2) billion, respectively. These 
values were substantially higher than the anticipated costs of the policies. We estimated 
that a ban on the sale of flavored combustible tobacco products would be cost-effective if 
217 (21–1,280) adult smokers were averted, and a ban on the sale of all flavored tobacco 
products would be cost-effective if 266 (6–1,580) adult smokers were averted. These 
threshold values were substantially lower than the expected number of adult smokers 
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expected to be averted as a result of these policies: we found that a ban on the sale of 
flavored combustible tobacco products and a ban on the sale of all flavored tobacco 
products would avert 357,185 (336,351–378,166) and 676,223 (316,397–1,216,879) adult 
smokers, respectively. Both policies were found to be cost-saving given optimistic 
parameter assumptions.  
Conclusions: The results of this study provide support for enacting either regulatory 
option considered. These results are limited by uncertain parameter values. 
 
INTRODUCTION	  
The 2009 Family Smoking Prevention and Tobacco Control Act banned the sale of 
flavored cigarettes, excluding menthol (1). In April 2014, the U.S. Food and Drug 
Administration (FDA) published a proposed ruling in which it requested research and 
data to support the extension of the flavored cigarette ban to non-cigarette tobacco 
products (2). 
 
In its proposed ruling, the FDA acknowledged the unique role that flavored tobacco 
products may play in facilitating tobacco use among young populations, noting that 
“many of the products proposed to be covered by this rule are offered in fruit and candy 
flavors, such as chocolate and grape flavors, making them especially attractive to children 
and young adults” (3). Further, in its request for comments on approaches to regulate 
flavored tobacco, the FDAs specifies that polices should “address the sale of candy 
and/or fruit-flavored tobacco products to children and young adults” (3). Indeed, 
qualitative data suggests that flavoring may drive tobacco use in adolescent and young 
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adult populations (4-6), and survey data shows that the prevalence of flavored tobacco 
use in higher in youth and young adults when compared to older adult populations (7, 8). 
National data from the Legacy Young Adult Cohort Study indicate that in 2011,18.5% 
(95% CI: 15.2-22.2) of young adults aged 18-34 who reported past 30-day use of any 
tobacco product used a flavored product (9). 
 
Given the FDA’s interest in regulating non-cigarette flavored tobacco products, the goals 
of this paper were to determine acceptable ceiling costs for two policies that the FDA 
might consider to regulate the sale of flavored tobacco products, and to identify the 
minimum effectiveness standards at which these policies would be considered cost-
effective and cost-saving. We established cost and performance standards for two 
regulatory options: 1) a ban on the sale of all flavored combustible tobacco products, and 




Using a cost-utility analytic framework, we employed threshold analyses to establish cost 
and performance standards for the two regulatory options described above. We chose this 
framework because the outputs of a cost-utility analysis are typically expressed in 
quality-adjusted life years (QALYs). This type of measure is useful because it accounts 
for both morbidity and mortality, and allows for comparisons across other types of 
interventions (10). 
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We performed sensitivity analyses to examine the results given pessimistic and optimistic 
parameter assumptions. Per standard practice, Quality Adjusted Life Years (QALYs) 
were discounted at 3% (11, 12). This analysis employs a societal perspective and presents 
all costs in 2013 U.S. dollars. We used Microsoft Excel 2011 to conduct this analysis.  
 
Most of the existing data on the costs of tobacco use and benefits of cessation have been 
estimated exclusively for cigarette smokers (13, 14). Thus, unless otherwise noted, the 
estimates for the costs of tobacco use and benefits of cessation employed in this analysis 
are cigarette-specific.  
 
Parameter definitions 
For this study, a “case” was defined as an individual aged 35 who continues to smoke 
combustible tobacco products until death. Combustible tobacco users included those who 
use combustible products exclusively, as well as dual users of combustible and smokeless 
products.  
 
We defined the following parameters as follows: 
A =  number of reduced cases expected 15 years after the implementation of the 
policy, compared to a scenario in which no additional flavor tobacco 
product bans have been enacted 
Q =  QALYs saved when a case is averted 
W =  amount society is willing to pay per one QALY 
T =  medical treatment costs saved per case averted 
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C =  cost of implementing the policy 
 
Analytic approach 
In order to determine the upper limit cost at which society would be willing to pay for the 
implementation of each policy, we solved for the parameter C such that:  
 
C = W(AQ) +AT 
 
The cost-effectiveness threshold, which is defined as the number of cases that would need 
to be averted for the policy to be considered cost-effective, was calculated using the 
equation: 
 
A = C/(T+(Q*W)) 
 
To calculate the cost-saving threshold, which is defined as the number of cases that 
would need to be averted for the policy to be considered cost-saving, we solved for A 
using the equation: 
  
 A = C/T 
 
We chose to conduct analyses to establish both acceptable upper limit costs and 
minimum effectiveness standards in order to address the uncertainty involved in 
quantifying the costs and benefits of the policies under consideration. That is, in order to 
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solve for the parameter C, we must estimate the value for the parameter A. Likewise, to 
solve for the parameter A, we must estimate the value for the parameter C. As discussed 
in depth below, the values for the parameters C and A were subject to uncertainty. Thus, 
we conducted analyses to determine both acceptable upper limit costs and minimum 
effectiveness standards for the policies in order to bolster confidence in recommendations 
to the FDA that arise as a result of this study. That is to say, the evidence supporting a 
recommendation to implement one or either policy is strengthened if the results of both 
analytic approaches support identical conclusions. 
 
Parameter	  Estimates	  
A summary of the parameter values can be found in Table 5-1. 
 
Reduction	  in	  the	  number	  of	  cases	  expected	  15	  years	  after	  policy	  implementation	  (A)  
We calculated the cases averted for each policy scenario using the decision tree 
previously described. We applied the decision tree probabilities to a cohort of 
73,359,000, representing the U.S. Census Bureau’s 2012 estimate of the number of 18-34 
year olds in the United States (15). We estimated the incremental values for A, when 
compared to the status quo, by calculating the difference between the number of 
combustible-only users and dual users (combustible and smokeless) under the policy and 
status quo scenarios. This analysis did not consider individuals who use smokeless 
tobacco exclusively to be “cases.”  
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QALYs	  saved	  when	  a	  case	  is	  averted	  (Q)	  
Using data published by Cromwell et al. for 25-29 year olds (16), Wang et al. estimated 
that 1.05 QALYs, discounted at 3%, are saved for each established smoker prevented 
(12). Per Cromwell et al.’s estimates, this calculation assumes a 45% rate of smoking 
relapse. This is a conservative estimate for the present analysis, because the individuals in 
this analysis are older than 25-29. Javtiz et al. calculated the QALYs saved when quitting 
occurs between the ages of 30-39 and found that, undiscounted, 7.14 QALYs were saved 
for men and 5.96 QALYs were saved per woman. Discounted at 3%, and assuming that 
men smoke 1.3 times as much as women, we estimated that 2.32 QALYs are saved per 
case averted in the optimistic scenario of the sensitivity analysis. This value assumes 
1.5% yearly spontaneous quit rate, and a 37% lifetime relapse rate. Other tobacco studies 
have employed these values (17). 
 
Society’s	  willingness	  to	  pay	  for	  one	  QALY	  (W)	  
Cost-effectiveness analyses conducted in the United States typically employ $50,000 per 
QALY as the estimate for W, although the origins of this value are unclear (18). This 
value is not updated regularly to adjust for inflation, and the scientific merit of using this 
benchmark for present-day analyses has been debated (19). In 2008, Braithwaite et al. 
(19) published a study in which they derived updated values for W. The authors of this 
study concluded that the lower and upper range for W should be $109,000-$297,000 per 
QALY saved.  
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In this analysis, we used a value of $50,000 per QALY in the base case analysis. 
Employing this estimate facilitates comparisons between the results of this analysis and 
other studies that have employed this value. We used Braithwaite et al.’s updated value of 
$109,000 for the optimistic scenario in the sensitivity analysis.  
 
Medical	  treatment	  costs	  saved	  per	  case	  averted	  (T)	  
The parameter T is the net present value of lifetime medical treatment costs saved per 
quit, discounted at 3%. According to an analysis conducted by Hodgson, when adjusting 
for mortality, smokers spend less than nonsmokers over the lifetime on medical 
expenditures (20). This occurs because former smokers live longer and incur more 
medical costs due to survival beyond continuing smokers. However, monetarily valuing 
death over life in the base case scenario does not reflect the societal goal of prolonging 
life. To manage this dilemma, tobacco economic evaluations have employed a value of 
$0 to estimate T (17, 21). We employ this value of $0 in the base case scenario in this 
analysis.  
 
The pessimistic scenario reflects the notion that smokers may spend less than nonsmokers 
on medical care over the lifetime. For the pessimistic scenario, we estimated T at -$4,253 
(2013 dollars, discounted at 3%), based on an adjustment to Warner et al.’s estimation of 
the additional medical costs that smokers who quit incur, as compared to continuing 
smokers (22).  
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For the optimistic scenario, we employed a value based on Hodgson’s estimate that male 
smokers spend $8,638 more on medical costs than male non-smokers, and female 
smokers spend $10,119 more on medical costs than female nonsmokers (1990 dollars, 
discounted at 3%) (20). Using the medical care component of the Consumer Price Index 
to convert these values to 2013 dollars, we estimated that male smokers spend $26,424 
more on medical costs than male non-smokers, and females spend $10,119 more on 
medical costs than female nonsmokers (23). Taking into account an estimate that the 
number of young adult males who smoke is approximately 1.3 times that of females (24), 
we estimated that, across both genders, smokers spend approximately $24,240 more than 
nonsmokers on medical costs. Related literature has employed this approach to estimating 
this parameter for base case and optimistic case scenarios (11).  
 
Cost	  of	  the	  intervention	  (C)	  
Despite the passage of the 2009 ban on flavored cigarettes, as well as the implementation 
of additional flavored product bans in New York City, Maine and elsewhere (25), we 
were unable to locate an estimate of the cost of implementing a ban on flavored tobacco 
products in a search of publically available local-level and federal documents. Thus, we 
estimated C based on FDA calculations of other tobacco control policies.  
 
The FDA recently published a Regulatory Impact Analysis (RIA) to assess the economic 
impact of extending regulations that currently apply to cigarettes, cigarette tobacco, roll-
your-own-tobacco, and smokeless tobacco to other types of tobacco products (13). These 
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regulations include those requiring product registration, disclosure of ingredients, product 
labeling, identification requirements, and warning statements for packages (13).  
 
In the RIA, the FDA considered two scenario – one in which all cigars (including 
premium cigars), pipe tobacco, hookah tobacco, electronic cigarettes and other novel 
tobacco products would be subject to current regulations, and one in which premium 
cigars would be exempt from these regulations (13). For each scenario, the FDA provided 
base case, lower bound and upper bound estimates of the upfront and annual costs (13). 
The FDA included costs to the tobacco industry in its estimates, as well as costs to the 
FDA. The costs to the industry included costs to comply with the FDA’s regulations, as 
well as other types of costs, such as expenditures for point-of-sale advertising. 
 
We used the FDA cost estimates for the policy scenarios examined in the RIA as a guide 
to obtain a reasonable range of values for the parameter C. We assumed that the cost of 
implementing the policies examined the RIA would be significantly higher than those for 
the policies considered in the present analysis. The primary costs of implementing a ban 
on flavored tobacco products would likely occur in the form of lost revenue to the 
industry, as well as administrative and enforcement costs to the FDA. Administrative 
costs for a ban on flavored tobacco products would be lower than those incurred for the 
policies examined in the RIA, as the RIA states that the a considerable portion of the 




We estimated base case, pessimistic and optimistic costs for the two policies considered 
in this analysis. We derived costs for a ban on all flavored tobacco products from the 
scenario, as described in the RIA, in which premium cigars were included in the analysis. 
We derived costs for a ban on combustible flavored tobacco products from the scenario in 
which premium cigars were excluded from the analysis. In our calculation of the 
optimistic estimate for C, we excluded costs to the industry. The pessimistic estimate of 
C included the value estimated by the FDA to market new tobacco products; other costs 
to the industry were not included, as they are not applicable for a product ban. The base 
case estimate for C included half of the undiscounted upfront primary cost to the FDA; 
we assumed that the costs of flavored tobacco bans would be incurred only in the short 
term and, thus, the annual costs were not included. The pessimistic estimates include only 
the undiscounted base case costs to the FDA. We used the undiscounted costs in this 
analysis in order to be as conservative as possible in estimating the costs, and because 
costs are assumed to be spent immediately.  
Table 5-1. Parameter values 






Reduction in the number of adult smokers expected as a 
result of a ban on combustible flavored products, 
compared to the status quo 
357,185 (336,351–378,166) Author’s 
calculation 
A 
Reduction in the number of adult smokers expected as a 
result of a ban on all flavored products, compared to the 
status quo 
676,223 (316,397–1,216,879) Author’s 
calculation 
T 
Medical treatment costs saved per case averted 
$0 (-$4,253 - $24,240) (11, 17, 20-
22) 
Q 
QALYs saved when a case is averted 
1.05 (1.05-2.32) (12, 16, 17, 
26) 
W 
The amount society is willing to pay for one QALY 
$50,000 $109,000 (18, 19) 
C 


















When compared to a scenario in which no additional flavored tobacco product bans have 
been implemented, we estimated that a ban on the sale of flavored combustible tobacco 
products would avert 357,185 (336,351–378,166) adult smokers, and a ban on the sale of 
all flavored tobacco products would avert 676,223 (316,397–1,216,879) adult smokers. 
These estimates capture the number of adult smokers averted 15 years after the 
implementation of the policies. These estimates assume that individuals have quit 
combustible tobacco by age 35 and do not relapse over their lifetime.  
 
The results of the cost threshold analysis can be found in Table 5-2. The maximum 
acceptable costs for a ban on the sale of flavored combustible tobacco products and a ban 
on all flavored tobacco products were calculated to be approximately $18.7 ($16.2-
$104.8) billion and $35.5 ($15.3–$337.2) billion, respectively. The wide ranges of 
possible values reflect uncertainty in the parameter estimates. However, the results of the 
sensitivity analysis indicated that, even given worst-case assumptions for all parameter 
estimates, spending for these interventions would need to reach well over a billion dollars 
in order for costs to extend beyond an acceptable amount. The pessimistic threshold value 
for a ban on all flavored tobacco products was calculated to be $15,265,206,059 in 2013 
dollars; this was the lowest threshold value estimated for either policy. Thus, even though 
the sensitivity analysis produced wide ranges as results, the results were consistent with 
regard to the scale (billions of dollars) that would need to be spent in order for the cost of 
either policy to be considered socially unacceptable.  
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Table 5-2. Results of the cost threshold analysis 
Scenario 
Expected cost for the 
policy 
Acceptable cost for the 
policy 
Difference between 
expected cost and 
acceptable cost for the 
policy 
Ban on combustible 
flavored products 
   
Base Case $11,380,000 $18,752,212,500 $18,740,832,500 
Pessimistic Case $61,760,000 $16,227,926,697 $16,166,166,697 
Optimistic Case $5,690,000 $104,797,361,920 $104,791,671,920 
Ban on all flavored 
products 
   
Base Case $13,970,000 $35,501,707,500 $35,487,737,500 
Pessimistic Case $76,210,000 $15,265,206,059 $15,188,996,059 
Optimistic Case $1,590,000 $337,221,508,480 $337,219,918,480 
 
The results of the cost-saving and cost-effectiveness threshold analyses can be found in 
Table 5-3. We do not report the results of the pessimistic-case scenarios for the cost-
saving threshold analyses because, by definition, the results represent the number of 
individuals who would need to continue smoking in order to make the policies cost-
saving. Given that the goal of the policies is to reduce smoking-related morbidity and 
mortality, this value is not relevant. Both policies are cost-saving only under the 
optimistic scenarios. The results of the cost-effectiveness threshold analysis indicate that, 
using pessimistic scenario values (the most conservative values), both policy options are 











Reduction in number of 
smokers need to meet cost-
saving threshold 
Reduction in number 








Base Case 357,185 ~11,380,000,000 217 
Pessimistic Case 378,166 X 1,280 
Optimistic Case 336,351 235 21 




Base Case 676,223 ~13,970,000,000 266 
Pessimistic Case 1,216,879 X 1,580 
Optimistic Case 316,397 66 6 
 
DISCUSSION	  
We estimated that the upper limit cost at which society would enact a ban on combustible 
flavored products was approximately $18.8 billion ($16.2 -$104.8 billion), and the upper 
limit cost at which society would enact a ban on all flavored products was approximately 
35.5 billion ($15.3 - $337.2). Using conservative values for the cost of these 
interventions, approximately 217 (21 – 1,280) individuals would need to quit combustible 
tobacco use by the age of 35 in order for a ban on combustible flavored products to be 
considered cost-effective, and approximately 266 (6 - 1,580) individuals would need to 
quit combustible tobacco use by the age of 35 in order for a ban on all flavored tobacco 
products to be considered cost-effective. Because we intentionally biased the value for 
the parameter T to acknowledge the increased medical costs of smoking cessation over 
smoking-attributable death, the cost-saving results did not favor these policies.  
 
The results of this study suggest that, from an economic perspective, it is reasonable for 
the FDA to implement either of the policies examined in this analysis. Even considering 
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uncertainty in the parameter values, the data indicate that the cost of both policies are 
likely to meet acceptable spending standards, and both policies likely represent cost-
effective approaches to reducing tobacco use in the United States. While a ban on all 
flavored tobacco products generated more favorable results than a ban on combustible 
flavored tobacco products, the uncertainty inherent in the parameters A and C, perhaps, 
weakens our ability to confidently recommend one policy approach over the other. The 
evidence supporting the implementation of either of the bans, as opposed to 
implementing no additional ban, however, is robust.  
 
The results of this analysis are limited by uncertainty in the parameter values. We 
discussed the limitations of the decision tree used to generate the cases averted by these 
polices in a previous paper. As noted in comments on the FDA’s RIA, estimates for the 
medical treatment costs saved per case averted need to be updated to reflect current 
tobacco use and health care use patterns (14). We estimated cost values by using the total 
estimated cost for other FDA interventions as ballpark benchmark values; this approach, 
while likely conservative, should be quantified directly by bodies implementing relevant 
flavored tobacco regulations in order to obtain a more accurate estimate. Additionally, we 
drew upon literature for the values for parameters Q and T that was specific to cigarettes. 
Future studies should investigate how the values for these parameter values might differ 
for other combustible and noncombustible products. With product-specific information 
on the costs and outcomes of tobacco use, we would be able to better estimate the effects 
of policies that target certain products. In the face of these limitations, we aimed to 
provide a conservative analysis. These analyses provide a framework for future studies; 
the results can be updated as more accurate and current data become available.  
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These results provide support for policies that decrease smoking prevalence among 
young adults. Developing tobacco control policies specifically for young adults appears 
to be a cost-effective strategy to reduce the economic and health burden inflicted by 
tobacco use in the U.S., assuming that the cost of such policies are not too high. That 
said, banning some or all flavored tobacco products would not resolve the tobacco 
epidemic. The regulatory options explored in this paper could be combined with other 
interventions aimed at reducing tobacco initiation and increasing cessation in this 
population in order to maximize the effectiveness of tobacco control policies.  
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Chapter	  6	  –	  INTEGRATION	  OF	  STUDY	  FINDINGS	  
 
INTRODUCTION	  
The purpose of this dissertation was to synthesize and translate research on flavored 
tobacco in the U.S. in order to inform regulatory decision-making at the U.S. Food and 
Drug Administration (FDA). The three related manuscripts presented in this dissertation 
provide an overview of how researchers have investigated the use and 
attitudes/knowledge/perception of flavored tobacco products; explore the potential health 
effects of implementing flavored tobacco product bans beyond the 2009 Family Smoking 
Prevention and Tobacco Control Act’s (FSPTCA’s) policy restricting the sale of flavored 
cigarettes; and establish cost and performance standards for potential policy approaches 
to regulate flavored tobacco products. This chapter summarizes the findings from those 
three manuscripts, and provides a general discussion on the strengths, limitations, and 
future directions of this research.  
 
SUMMARY	  OF	  RESULTS	  
The first manuscript in this dissertation described a systematic review that provided an 
overview of research examining the use and attitudes/knowledge/perception of flavored 
tobacco use in the U.S., specifically focusing on how age and nonflavored tobacco use 
are correlated with flavored tobacco use. The results of the review found that young age 
was associated with flavored tobacco use, and that flavoring in tobacco products is an 
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attractive trait for adolescent and young adult populations. The literature was 
inconclusive with regard to how flavored tobacco might facilitate tobacco initiation. 
Flavored tobacco use may be associated with dual use of other tobacco products. These 
findings represent a synthesis of data from 32 studies that exhibited a high level of 
heterogeneity with regard to their research questions, study designs, populations 
investigated and measures used.  
 
The results of the systematic review suggest that the field would benefit from additional 
research investigating the use and attitudes/knowledge/perception of flavored tobacco. 
Valid and reliable measures to investigate these concepts should be standardized to 
facilitate meta-analyses of multiple studies, and longitudinal data should be collected in 
order to track patterns of tobacco use in a generalizable population. Such data would 
provide evidence that more directly speaks to questions about the impact of flavored 
tobacco use on tobacco initiation, switching between products, dual use, and cessation.  
 
The second manuscript employed a decision tree to estimate the relative health effects, 
compared to the status quo, that would be expected to result from a) a ban on combustible 
flavored tobacco products and b) a ban on all flavored tobacco products. Given the 
model’s underlying structural and parameter assumptions, the decision tree found that a 
ban on all flavored tobacco products would likely produce the most favorable outcome of 
the policy options considered. The sensitivity analysis highlighted parameters that 
contributed to the majority of the uncertainty in the model: 1) the probability of 
combustible tobacco initiation under the status quo, 2) the probability of smokeless 
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tobacco initiation under the status quo, and 3) the health effect associated with dual 
(combustible/smokeless) tobacco use.  
 
The uncertainty represented by the first two parameters described above speaks to a need 
to monitor patterns of tobacco use more closely in order to gain a better understanding of 
the types of products with which non-users initiate tobacco and how their patterns of 
tobacco use change over time. The uncertainty represented by the third parameter – the 
health effect associated with dual tobacco use – points more specifically to a need to 
understand how adding, promoting or banning certain products within the tobacco 
marketplace may impact exposure to harm. Understanding the dynamics of these types of 
changes to the marketplace would provide insight into the extent that policymakers can 
reduce tobacco-induced harm by manipulating the products available to potential and 
current tobacco users. 
 
In the third manuscript, we used threshold analyses to determine acceptable ceiling costs 
for the policies considered in the second manuscript, and to identify the minimum 
effectiveness standards at which these interventions would be considered cost-effective 
and cost-saving. We employed conservative parameters for both analyses. The results of 
the cost threshold analysis found that the cost of either ban would need to reach well into 
the multi-billion dollar range in order for society to deem the cost of either of the policies 
to be unacceptable. The results of the cost-saving threshold analysis were only cost-
saving under the optimistic scenarios examined, because we intentionally biased the 
analyses to consider the additional medical costs that former smokers incur beyond those 
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of continuing smokers, who have shorter life expectancies than former smokers. The 
results of the cost-effectiveness threshold analysis show that both policy options would 
be cost-effective if less than 1% of the expected number of averted cases is actually 
averted.  
 
The results of these threshold analyses provide support, from an economic perspective, 
for banning combustible flavored tobacco products or all flavored tobacco products. 
These results are limited by uncertain parameter values with regard to the expected costs 
and effects of these policies, as well as potentially outdated values for the medical costs 
averted by quitting tobacco. Current estimates for the medical costs averted as a result of 
quitting tobacco were estimated at least a decade ago (1, 2). Additionally, these estimates 
are smoking-specific, and do not include the costs incurred by smokeless tobacco use.  
 
Taken together, the results of these three manuscripts found that the effects of a flavored 
tobacco product ban would likely reduce tobacco initiation among young adults, which 
would result in improved health at the population level. Uncertainty in quantifying the 
costs and effects of the two product bans under consideration, perhaps, weakens our 
ability to confidently recommend one approach over the other. However, the evidence 
supporting the implementation of either ban, as opposed to implementing no additional 
ban, is robust.  
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DISCUSSION	  OF	  FINDINGS	  
The development, execution and findings of this dissertation reflect the dynamics 
described in Holtgrave’s three-box model (3). The study questions and designs for the 
three manuscripts were conceptualized with the intention to inform FDA decision-
making. The first manuscript synthesized existing research on the use and 
attitudes/knowledge/perceptions of flavored tobacco products, and the subsequent 
manuscripts employed these findings to evaluate potential approaches to regulating the 
sale of flavored tobacco products in the U.S. The results of these studies provide data that 
are relevant to FDA interests and, by highlighting weaknesses and gaps in existing 
literature, they present questions that could be investigated in future research projects.  
 
While the results of this dissertation speak to FDA interests, limitations of the research 
should be considered when assessing the applicability of these findings to policy-making.  
The eligibility criteria for the systematic review were limited to studies that assessed the 
use and/or attitudes/knowledge/perception of flavored tobacco products. These criteria 
were developed in consultation with tobacco researchers and were chosen, in part, 
because it was thought that existing literature would benefit from being synthesized and 
assessed for quality. While the systematic review was successful in achieving these tasks, 
the review’s relevancy to the FDA’s questions is perhaps not as strong as it could have 
been. For example, in the proposed ruling that it published in April 2014, the FDA asked, 
“What is the likelihood that individuals who engage in flavored tobacco product use will 
initiate cigarette use and/or become dual users with cigarettes?” (4). The degree to which 
the attitudes/knowledge/perception of flavored tobacco products impacts cigarette 
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initiation or dual use warrants further investigation. While this, perhaps, represents a 
drawback in the applicability of the results of the systematic review, the study exhibits 
strong internal validity.  
 
While the second and third manuscripts address the limitation described above by asking 
questions that more directly speak to FDA requests for data, the models developed for 
these manuscripts are limited by uncertainty in their parameter values. This uncertainty 
reflects the type of data that is currently available to inform these models. The thorough 
description of the development of these models, however, which ensures the ability of 
other modelers to replicate the results, makes it possible for these models to be updated as 
relevant data is published. The construction of these models in the face of limited data is 
important, as the process highlights areas for future research. Indeed, “[i]f decision 
analyses were not used…there would still be uncertainty in the decision-making process. 
When decision analysis is used, the areas of uncertainty are clearly identified” (5). Along 
similar lines, these models may over-simplify tobacco use behaviors, as they do not take 
into account many of the complex factors that go into decisions to initiation, persist and 
quit tobacco use. Future models may build upon the ones developed for this dissertation 
and introduce complexities.  
 
This dissertation aims to strengthen the relationship between science and policy in 
tobacco control; however, it is important to note the limits of this relationship. The 
findings presented in these manuscripts represent one of many considerations that 
decision-makers must take into account when enacting policies. The economic evaluation 
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performed in the third manuscript highlights the importance of those other considerations. 
Using a negative value to estimate the medical costs averted when an individual quits 
smoking – which reflects the longer life that former smokers are likely to have compared 
to continuing smokers – does not accurately represent the value that society and 
government place on prolonging life. This limitation is inherent in the economic 
evaluation. While other values can be used to estimate the parameter so that the results of 
the analysis do not promote mortality, using these values perhaps represents a lapse in 
“scientific” practices; the researcher’s values explicitly impact the way in which the study 
is conducted. Acknowledging this does not suggest that economic evaluations similar to 
the one conducted for this dissertation should not be performed. Ignoring such nuances 
would weaken, rather than strengthen the linkage between science and policymaking. 
Rather, it emphasizes the limit of this methodology in its relation to informing this policy 
decision, and illustrates the need for decision-makers to think critically about enacting 
policies, even when the rationale for those policies are supported by scientific evidence.  
 
The regulatory approaches examined in the second and third manuscripts – and, indeed, 
any policy targeted at flavored tobacco products – represent one of many potential 
policies that the FDA could consider to minimize the attractiveness of tobacco products 
and to make tobacco use less pleasurable. For example, the FDA might consider plain 
packaging requirements, implementing additional restrictions on marketing and 
advertising, or making adjustments to pH and nicotine levels in tobacco products. Indeed, 
the implementation of a ban on some or all flavored tobacco products would not 
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completely resolve the tobacco epidemic. The FDA should consider a flavored tobacco 
product ban along with other policies. 
 
FUTURE	  DIRECTIONS	  AND	  RECOMMENTATIONS	  
The results of all three manuscripts highlighted the need for additional data to be 
collected to inform key questions about the harms that the sale of flavored tobacco 
products may present. Much of the available data employed in this dissertation was 
collected before new products, such as electronic cigarettes, were widely available and, 
thus, may not reflect current patterns of tobacco use. All three manuscripts would have 
benefited from the availability of longitudinal data that monitors tobacco initiation, 
switching behaviors, polytobacco use and cessation over time.  
 
Given the plethora of tobacco and nicotine products that are currently available to 
consumers, future research investigating use of tobacco would be improved by employing 
questions that ask about use of these products as specifically as possible. For example, 
one paper included in the systematic review, conducted by Villanti et al. (6), queried 
participants about their use of flavored tobacco two times – one question specifically 
asked participants to exclude their use of menthol products, and one did not. Making this 
type of distinction is important, as the results of these questions differed from one 
another; some participants may have considered menthol to be a flavor. Bearing in mind 
the importance of differentiating between “flavored” and “menthol” in a policy context, it 
is important to develop data collection techniques that accurately reflect the specific 
products being used. This consideration should be applied to research on flavored 
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products, as well as to research on other products. Consumers of electronic cigarettes, for 
example, may refer to these products by names such as “vape pens” and “e-hookahs,” and 
consumers may differentiate between these products in ways that researchers do not.   
 
Improvements in data collection would strengthen the models developed in the second 
and third manuscripts of this dissertation. While modeling techniques can be used to 
predict the outcomes of policies, their results are only as good as the data informing the 
model. The FDA has expressed interest in using mathematical modeling techniques to 
evaluate the population effects of its policies (7, 8). Thus, as better data is collected, these 
data should be applied to models that can help decision-makers evaluate the effects of 
potential regulatory approaches.  
 
Even before improved data is collected, however, the model presented in the second 
manuscript can serve as an important tool for understanding a range of tobacco control 
issues. The model developed for this paper provided a framework for examining 
regulatory approaches intended to reduce the attractiveness of tobacco products, and it 
weighed the impact of reducing the attractiveness of some tobacco products but not 
others while taking into consideration the varying levels of risk that those products 
present. Thus, this model could be used to think about a range of policy issues, such a the 
potential impact of making products such as e-cigarettes or nicotine replacement therapy 
more or less attractive than other tobacco products.  
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In addition to the recommendations described above, future research may benefit from 
knowledge generated in studies conducted with non-U.S. samples. Lessons learned from 
policies enacted in other locations may be useful to inform decision-making in the U.S. 
Conversely, the findings of this dissertation – and findings from other studies conducted 
in the U.S. – may be valuable for researchers and policymakers working internationally.    
 
CONCLUSION	  
This project synthesizes and translates the best available evidence to assess tobacco 
regulatory policies that the FDA may soon consider to regulate the sale of flavored 
tobacco products. The methodologies employed in this project are intended to be 
transparent, and to give a clear sense of what is known and what assumptions are being 
made to reach its conclusions. The framework developed for this analysis can be built 
upon and tweaked as better and more data is collected to inform the policy decision at 
hand. This project contributes to the growing field of systems sciences, as applied to 
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